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ABSTRACT
Adenosine is an endogenous neuromodulator that can impose 
an inhibitory action on synaptic transmission in the 
peripheral and central nervous system. In the central 
nervous system the mechanism by which adenosine acts is 
unclear. One proposed mechanism is by an action at 
presynaptic calcium channels to reduce calcium influx and 
subsequent neurotransmitter release.
Three approaches were used to study interactions between 
adenosine and calcium related events. A neurochemical 
approach was used to determine the action of adenosine on 
presynaptic calcium uptake in central nervous tissue. 
Electrophysiological techniques were employed in the 
hippocampal slice preparation to study a) the interactions 
between calcium channel blockers and adenosine compounds and 
b) the effect of magnesium free ACSF on the inhibition of 
synaptic transmission by adenosine.
Determination of the uptake of radiocalcium into rat 
brain synaptosomes across potassium activated voltage 
dependent calcium channels demonstrated that adenosine 
compounds could impose a small but significant inhibition on 
calcium uptake. A similar action was demonstrated on calcium 
uptake into hippocampal slices, an action that was 
effectively antagonized by the adenosine antagonist 
8-phenyltheophylline
xii
The dihydropyridine class of calcium channel blockers do 
not affect synaptic transmission in the hippocampal slice, 
but they do affect the action of adenosine and adenosine 
analogues. Nifedipine and BayK 8644, a dihydropyridine 
calcium channel blocker and activator respectively, both act 
to increase the inhibition of synaptic transmission by 
adenosine while attenuating the inhibitory action of the 
adenosine analogues. This interaction appears to involve an 
effect at both the adenosine receptor and the nucleoside 
transport system.
In the hippocampal slice the inhibitory action of 
adenosine on the synaptically evoked population potential 
was markedly attenuated, and in some cases totally 
abolished, when magnesium ions were omitted from the 
artificial cerebrospinal fluid bathing the slice. The 
proposed explanation for this effect is that activation of 
NMDA receptor associated channels directly reduces the 
inhibitory action of adenosine on synaptic transmission.
The results of this study into the action of adenosine on 
calcium channel associated actions confirm the ability of 
adenosine to reduce presynaptic calcium influx. It also 
highlights an interaction between adenosine and the 
dihydropyridines and provides evidence for an interaction 
between adenosine inhibition of synaptic transmission and 
activation of NMDA receptor operated calcium channels.
xiii
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INTRODUCTION
1INTRODUCTION
The field of purine research is a relatively new and 
complex area that still requires answers to many basic questions. 
It is now firmly established that adenosine and adenine 
nucleotides, such as ATP (adenosine 5'-triphosphate), play 
an important neuromodulatory role in both the peripheral and 
central nervous systems. What is not clear is the mechanism, 
or mechanisms by which adenosine exerts its effect on 
neuronal excitability. This thesis will look at one possible 
method by which adenosine may act, namely as a calcium 
channel "regulator”, and the interactions of adenosine with 
other calcium channel blockers, in particular the 
dihydropyridines, and other divalent cations, notably 
magnesium.
Adenosine - an historical overview.
The fact that adenosine or ATP could affect the activity 
of the body, in particular the heart, was known as far back 
as 1929 (Drury and Szent-Gyorgyi, 1929). In 1954, Holton and 
Holton suggested that ATP could be the transmitter released 
at peripheral and central terminals of sensory fibres after 
showing that ATP was the vasodilatory substance present in 
dried, powdered dorsal and ventral spinal root preparations. 
However, as an excitatory action was being looked for, this 
idea did not take off. The current interest in adenosine and 
ATP began with the realization of their potent inhibitory 
properties on neurones. In the peripheral nervous system the 
action of ATP as a specific neurotransmitter released from 
purinergic nerves was put forward by Burnstock (1972).
In the CNS, Phillis et al. (1974) demonstrated the potent 
depressant effects of iontophoretically applied adenosine in 
various regions of the brain. Around the same time, Sattin 
and Rail (1970) were studying the biochemical actions of 
adenosine and showed that adenosine could stimulate 
adenosine 3'5'-cyclic monophosphate (cAMP) formation in 
brain slices, while theophylline and caffeine could 
antagonize this response. However, research into adenosine 
as a possible neuromodulator or neurotransmitter was slow 
until specific binding techniques had been developed that 
demonstrated distinct extracellular sites for adenosine.
Adenosine receptors 
It subsequently became apparent that adenosine receptors 
could be classified into subtypes primarily characterized by 
their ability to affect adenylate cyclase activity. (Londos 
and Wolff, 1977; Van Calker et al., 1978, 1979). Thus A : 
receptors are high affinity receptors that reduce the 
activity of adenylate cyclase and preferentially bind the 
adenosine analogues R-PIA (R-phenylisopropyladenosine) and 
CHA (cyclohexyladenosine). A2 receptors are low affinity 
receptors that stimulate adenylate cyclase activity and 
preferentially bind NECA (5'-N-ethylcarboxamidoadenosine). 
These receptors are situated extracellularly and are 
antagonized by theophylline and caffeine. The P "receptor" 
is located intracellularly, has a low affinity, inhibits 
adenylate cyclase and binds dideoxyadenosine. However, as no 
evidence has so far been provided for a functional effect of 
this binding site, it is usually referred to as the P site
3(Stone, 1989). More recently further subdivisions have been 
proposed: the A3 receptor (Ribeiro and Sebastiao, 1986) that 
acts independently of adenylate cyclase and inhibits 
synaptic transmission, possibly by acting directly on 
calcium channels. The A2 receptor has also been subdivided 
into A2a and A2b (Bruns et al. , 1986), A2a being a high 
affinity receptor localized in striatum, and A2b a low 
affinity receptor widespread throughout the brain.
The initial observation of adenosine receptor coupling to 
adenylate cyclase was observed in cultured brain cells (Van 
Calker et al., 1978, 1979) and fat cells (Londos et al.,
1977). However, in the CNS, the association between cAMP 
activation and neurotransmitter release remains uncertain. 
Elevation of cAMP levels attributed to A2 receptor binding 
has been shown in brain slices (Daly et al., 1983; Fredholm 
et al., 1982), but inhibition of cAMP accumulation, 
representing an Ax receptor action, is difficult to 
demonstrate. cAMP levels have to be elevated by the use of 
forskolin or another adenylate cyclase activator,before a 
decrease by adenosine analogues can be demonstrated 
(Fredholm et al., 1983; Dunwiddie and Fredholm, 1989). In 
the case of Daly et al. (1983), A x adenosine receptor
mediated depression of cAMP was only observed in broken 
brain tissue membranes, not in more "intact" brain slices.
In parallel biochemical and electrophysiological studies 
looking at cAMP levels and synaptic depression, R-PIA was 
shown to be about 40 times more potent at depressing evoked 
orthodromic synaptic potentials in the hippocampus than at
increasing cAMP levels. (Reddington & Schubert, 1979)
Similarly, evidence that changes in cAMP levels directly 
affect neurotransmitter release is also weak and unclear. 
Increases in presynaptic cAMP levels have been shown to both 
increase (Langley and Weiner, 1978) and decrease 
neurotransmitter release (Silinsky et al., 1987). Addition 
of forskolin, which directly activates adenylate cyclase, 
can also increase (Von Uexkull, 1987) or decrease (Ebstein 
and Daly, 1982) neurotransmitter release. Consequently, it 
is not possible to establish a direct cause and effect 
relationship between the action of adenosine on adenylate 
cyclase activity, and an increase or decrease in neuronal 
excitability or neurotransmitter release.
The association of adenosine A 1 and A2 receptors with 
adenylate cyclase, and other possible functional sites, is 
thought to be linked via G-proteins (GTP binding "N" 
protein). Trussel and Jackson (1987) found that cultured 
hippocampal and striatal cells responded to adenosine by 
activating a potassium channel in patch clamp studies. 
Addition of GTP to cells that had been inactivated by 
perfusion with saline, restored the action of adenosine. 
Addition of pertussis toxin, which inactivates certain toxin 
sensitive G-proteins by ADP ribosylation of the protein, 
inhibiting their binding to adenylate cyclase, abolished the 
adenosine activation of potassium channels. Pertussis toxin 
has also been shown to reduce the inhibitory effect of 
adenosine analogues on glutamate release from cultured 
cerebellar cells. (Dolphin and Prestwich, 1985).
There is also evidence that regulation of the potassium 
channel by adenosine may not involve adenylate cyclase. In 
the study by Trussel and Jackson (1987) stimulation of 
adenylate cyclase by forskolin, or addition of cAMP, failed 
to influence the action of adenosine on the potassium 
channels. Gross et al. (1989), using voltage clamp 
techniques to study the inhibitory properties of 
2-chloroadenosine on N-calcium channels in mouse dorsal root 
ganglion cells, showed that treatment with pertussis toxin 
abolished the inhibition, but forskolin had no effect 
indicating that adenylate cyclase was not involved. It is 
also known that proteins exist which are very similar to the 
Gi inhibitory protein, but are not linked to adenylate 
cyclase (Bokoch and Gilman, 1984). It may be this protein j
that links directly to other possible sites of action for 
adenosine, such as potassium or calcium channels.
At present adenosine is proposed to act via three 
mechanisms: 1) activation of potassium channels to 
hyperpolarize the postsynaptic membrane. 2) inhibition of 
presynaptic calcium influx to reduce neurotransmitter 
release. 3) increase or decrease in adenylate cyclase J
activity. The last mentioned may control the potassium and calciumj 
channels or may act via secondary intracellular mechanisms
|
to reduce neurotransmitter release (Silinsky, 1986b). These
i
will be discussed later. However, at the receptor level, the 
biochemical route by which the adenosine receptor interacts 
with the effector mechanism is still unclear. Fredholm and 
Dunwiddie (1988) have postulated three possible systems:
61) Three subtypes of Ax receptor linked to the different 
effector mechanisms via different G-proteins. 2) A single Ax 
receptor that can interact with three different G-proteins.
3) A single receptor linked to a single G-protein that can 
interact and activate all 3 effector systems. The second 
system is the most compatible with the current data as there 
is little evidence for multiple A 1 receptor subtypes while 
the existence of pertussis toxin sensitive and insensitive 
G-proteins does not favour the third model.
Adenosine release.
The purines released from nervous tissue are thought to 
be largely in the form of adenosine, together with its 
breakdown products of inosine and hypoxanthine. Studies have 
been made of the purine overflow from perfused tissue by 
liquid chromatography (Fredholm and Vernet, 1979). By adding 
adenosine transport inhibitors, 5'-nucleotidase and 
adenosine deaminase to modify the production of the various 
purines (adenosine, ATP, ADP, AMP) in the effluent, it was 
possible to estimate the levels of the various purines 
released, adenosine being in the highest concentration. 
Similar studies using [3H]adenosine also showed adenosine to 
be the major purine released (Bender et al., 1981).
Adenosine efflux from brain slices can be elicited by 
electrical stimulation, increasing levels by up to 250 times 
(Pull and Mcllwain, 1973). Studies using focal stimuli to 
elicit overflow of [3H]adenosine in hippocampal slices have 
demonstrated enhanced efflux when perforant path fibres from 
the entorinal cortex to the dentate gyrus granule cells are
7stimulated, but not when CA1 pyramidal cells are stimulated 
antidromically via the fimbria (Lee et al.,1982). This 
indicates that presynaptic terminals need to be activated to 
initiate release, but whether this involves direct release 
of adenosine from presynaptic sites, or postsynaptic release 
as a result of neurotransmitter action, is not clear. The 
potential release of adenosine from glial cells has also 
been studied. Lewin and Bleck (1979) used cultured 
astrocytoma cells to study the uptake and efflux of 
adenosine. [14C]adenosine was rapidly taken up by the cells, 
but cells preloaded with [14C]adenine released inosine and 
hypoxanthine but very little adenosine, suggesting glial 
cells are sites of adenosine uptake but not release.
The release of ATP has also been shown endogenously from 
CNS tissue, both in vitro (Pull and Mcllwain, 1972; White,
1978) and in vivo (Schubert et al., 1976). It is possible 
that the released ATP may be broken down to adenosine by the 
5 1-nucleotidase known to be present extracellularly.
However, inhibition of this enzyme does not markedly reduce 
the levels of adenosine present in the extracellular fluid 
(Daval and Barberis, 1981) indicating that extracellular 
conversion of ATP to adenosine is not the major source of 
adenosine. Other studies, however, have shown a significant 
proportion of purines released to be in the form of adenine 
nucleotides, particularly in in vivo studies. (Jhamandas and 
Dumbrille, 1980).
The release and metabolism of adenosine in the CNS is 
controlled to give a constant basal concentration of
8endogenous adenosine. Measurement of endogenous adenosine 
levels is difficult, as changes are very rapid, particularly 
upon death of the animal. One technique employed by 
Zellerstrom et al. (1982) was to use a hollow dialysis 
tubing fibre to take cerebrospinal fluid (CSF) samples from 
the brain of anaesthetized and conscious rats.
Concentrations ranged from 1 to 2pM. In in vitro studies, 
Fredholm et al. (1984) equilibrated brain slices in a small 
volume of artificial CSF (ACSF) and obtained final fluid 
adenosine concentrations of 0.5-lpM. This indicated that the 
endogenous extracellular adenosine concentration, and 
adenosine levels released by brain slices are similar.
Adenosine uptake 
Endogenous adenosine is inactivated by two methods. 
Adenosine uptake mechanisms are rapid and efficient systems 
(Km=lpM, Bender et al., 1981) which suggests they are the 
predominant method by which endogenous levels are regulated. 
Adenosine is taken up and appears to be converted back into 
ATP intracellularly (Bender et al., 1981). The second method 
is via breakdown of adenosine to inosine by adenosine 
deaminase (Km=6-60pM, Arch and Newsholme, 1979). This does 
not appear to play a key role, as addition of adenosine 
deaminase inhibitors has very little effect on depression of 
hippocampal excitability, and levels of adenosine or cAMP 
are not affected by adenosine deaminase inhibitors, unlike 
uptake inhibitors that markedly increase levels (Fredholm et 
al., 1982; Davies et al., 1982).
9Localization of adenosine action
The classification of adenosine as a neurotransmitter has 
not been possible due to the inability to localize its 
effects to a specific "adenosine synapse". A number of 
studies have looked at the distribution of adenosine 
receptors in the rat brain by using autoradiographic studies 
of CHA binding. Adenosine receptor sites were most notable 
in the cerebellar cortex, superior colliculus, neocortex, 
striatum and hippocampus (Lewis et al., 1981; Goodman and 
Snyder, 1982). Adenosine receptor density is particularly 
rich in the hippocampus and is higher in the CA1 compared to 
the CA3 and dentate gyrus (Murray and Cheney, 1982).
Lesioning of specific neuronal pathways has been used to 
determine the localization of adenosine receptors. Goodman 
et al. (1983), looking at the effect of cortical ablation on 
CHA binding in the striatum, were unable to show any change 
in receptor number. Similarly, Lloyd and Stone (1985) showed 
that lesions of the nigrostriatal pathway had no effect on 
CHA binding in the striatum. Also, kainic acid lesions of 
striatal cell bodies produced only a 30% decrease in CHA 
binding density. These results indicate that adenosine 
receptors are not confined solely to pre- or postsynaptic 
sites, or to specific neurones in a particular brain region.
Studies on the rat hippocampus have shown the density of 
Ax receptors to be differentially distributed through the 
CA1 region of the hippocampus, with a greater density in the 
dorsal region compared to ventral (Lee et al., 1983).
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Autoradiographic and lesion studies have shown that, within 
the CA1 region, adenosine receptors appear to be present on 
presynaptic axon terminals from CA3 cells and on 
postsynaptic dendrites and cell bodies of the CA1 pyramidal 
cells (Tetzlaff et al., 1987; Deckert and Jorgensen, 1988; 
Onodera and Kogure, 1988).
Determination of the sites of activity of adenosine 
deaminase and the localization of adenosine uptake sites 
have also been made, but these do not correlate particularly 
well with the receptor distribution. Bisserbe et al. (1985), 
using rat brain to study the binding of
nitrobenzylthioinosine (NBI), an antagonist at the adenosine 
uptake site, showed high densities of uptake sites in the 
superior colliculus, thalamus, striatum, nucleus tractus 
soliterius and geniculate nuclei. However, relatively little 
NBI binding was observed in the hippocampus or cerebellum, 
regions rich in adenosine receptors. The use of 
dipyridamole, another adenosine uptake blocker, showed a 
slightly different distribution to that shown by NBI, 
suggesting a heterogeneous population of adenosine uptake 
sites. However, the dipyridamole binding site distribution 
also was not comparable with the adenosine receptor 
distribution (Bisserbe et al., 1986, Deckert et al., 1988).
Adenosine deaminase immunoreactivity studies show a good 
correlation with the distribution of NBI binding sites (Nagy 
et al., 1985). An extensive plexus of adenosine deaminase 
containing neurones have been shown in the basal 
hypothalamus (Nagy et al., 1984), an area largely devoid of
adenosine receptors (Lewis et al., 1981; Goodman and Snyder, 
1982). A possible explanation for this particular lack of 
correlation between receptor density and adenosine deaminase 
activity, put forward by Stone (1989), is that the 
hypothalamic nuclei require protection from high levels of 
blood adenosine that occur during times of hypoxia or 
increased neuronal activity.
The localization of adenosine itself has also been 
studied using immunocytochemical techniques (Braas et al., 
1986). This has shown adenosine activity to be highest in 
the pyramidal layers of the hippocampus and dentate gyrus, 
thalamic nuclei, amygdala, hypothalamus and olfactory 
cortex. The activity was observed only on neuronal cells, 
not glia.
The inability to correlate the distribution of adenosine 
receptors solely to synaptic terminals or with adenosine 
uptake sites means that adenosine cannot be classified as a 
classical neurotransmitter. However, adenosine has a 
definite action on other neurotransmitters, largely 
inhibiting their effect, and is released endogenously. This 
release may be as a cotransmitter along with other 
neurotransmitters from different nerve terminals (Burnstock, 
1976). Thus, adenosine can be classified as a neuromodulator 
at least until such time as a more specific role, or roles, 
can be ascribed to its presence in the CNS.
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Functional effects of adenosine
Electrophysiological experiments have characterized the 
inhibitory properties of adenosine. Recordings of neuronal 
firing have demonstrated a marked depressant action of 
adenosine in virtually all brain regions tested including 
cerebral cortex, hippocampus, thalamus, cerebellum and 
superior colliculus. (Phillis et al., 1974; Phillis and 
Kostopoulus, 1975). This depressant action is thought to be 
mediated by reducing presynaptic neurotransmitter release, 
as adenosine has been shown to depress the release of the 
majority of established neurotransmitters in the brain 
including acetylcholine (Vizi and Knoll, 1976; Murray et 
al., 1982), 5HT (Harms et al., 1979), noradrenaline (Ebstein 
and Daly, 1982; Fredholm et al., 1983), dopamine (Michaelis 
et al., 1979), GABA (Hollins and Stone, 1980) and glutamate 
(Dolphin and Archer, 1983; Corradetti et al., 1984).
Studies of excitatory synaptic transmission in neuronal 
structures that lend themselves to such studies, such as 
olfactory cortex (Okada and Kuroda, 1980) and hippocampus 
(Schubert and Mitzdorf, 1979; Dunwiddie and Hoffer, 1980), 
have shown that adenosine can reduce the size of evoked 
synaptic potentials via an adenosine receptor, since 
theophylline and related xanthine analogues can antagonize 
this effect. The inhibition is apparent as a decrease in the 
size of the excitatory postsynaptic potential (EPSP) but 
adenosine has no effect on the presynaptic fibre volley.
This indicates that adenosine is acting at the synapse to 
reduce synaptic transmission. Intracellular recordings have
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confirmed that EPSPs, and IPSPs, are significantly reduced 
by adenosine (Segal, 1982; Proctor and Dunwiddie, 1983).
Adenosine also has inhibitory effects on responses that 
are non-synaptic. In particular, adenosine is able to block 
spontaneous neuronal firing induced by lowering the 
extracellular calcium concentration, which blocks synaptic 
transmission. In the hippocampal slice, antidromic 
stimulation of the pyramidal cells in calcium free medium 
results in secondary spikes, after the initial antidromic 
spike, that can be blocked by adenosine (Schubert and Lee,
1986). Adenosine also blocks spontaneous firing of neurones 
in brain slices that have been largely deafferented as a 
result of the slice preparation e.g locus coeruleus and 
cerebellum. It is thought that this non-synaptic action of 
adenosine is elicited by hyperpolarization of the 
postsynaptic membrane via potassium channels. Studies of 
single hippocampal pyramidal cell ion currents (Haas and 
Green, 1984) have shown a hyperpolarization of the 
postsynaptic cell together with an enhancement of the after 
hyperpolarization (AHP) that follows the action potential.
In cells that had been pretreated with tetrodotoxin (TTX) to 
block sodium channels, and barium to enhance calcium channel 
flux and antagonize IBKiand delayed rectifier potassium currents, 
a depolarizing current pulse elicited repetitive slow calcium 
spikes that were superimposed upon a long lasting 
depolarized plateau. Addition of adenosine (50pM) decreased 
both the amplitude of the calcium spikes and the duration of 
the depolarized plateau. Input resistance was not affected
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by adenosine. Haas and Green (1984) suggested that these 
results were due to a calcium dependent increase in 
potassium conductance by adenosine. In cultured mouse 
striatal neurones, adenosine seemed to activate potassium 
currents that induced a hyperpolarization. This effect could 
be blocked by theophylline and was voltage dependent 
(Trussel and Jackson, 1985). Thus, the action of adenosine 
is to increase outward potassium conductance, apparent by 
the increase in the AHP which hyperpolarizes the 
postsynaptic membrane, as well as reducing the calcium 
spikes that are thought to originate in the dendritic 
region. Increased potassium conductance may also occur 
presynaptically and reduce the release of neurotransmitter 
from the synapse, or reduce the probability of the synapse 
firing when stimulated.
Adenosine has been shown to be particularly potent in 
blocking spontaneous depolarizations induced in brain slices 
by various methods including the application of GABA 
antagonists and altering the extracellular ion 
concentrations. Ault and Wang (1986) studied spontaneous 
activity, also called epileptiform bursts, induced by the 
GABA antagonist bicuculline, in the CA3 region of the rat 
hippocampus. They tried a number of adenosine analogues and 
found them to be very potent anticonvulsants, adenosine 
inhibiting the bursts with an IC50 of 1.5pM. o 'Shaughnessy et al. 
(1980) also tried a range of analogues on bursts induced in 
the rat cortical slice by magnesium free ACSF. Again they 
demonstrated a potent anticonvulsant effect of adenosine,
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the IC50 being 25pM. Adenosine in low micromolar 
concentrations can also reduce bursts induced by penicillin 
(Lee et al., 1984) and low calcium, both evoked 
(Lee et al., 1984) and spontaneous (Haas et al., 1984). As 
low calcium largely inhibits synaptic transmission this 
suggests that adenosine is not acting presynaptically but 
may be acting by hyperpolarizing the postsynaptic membrane 
to inhibit the bursts.
There is substantial evidence that adenosine acts to 
reduce calcium availability for presynaptic neurotransmitter 
release. This will be discussed briefly here, but a more 
detailed discussion forms the basis for the introduction to 
chapter 3.
Electrophysiological studies have demonstrated the 
ability of adenosine to modify ion current mediated events. 
Henon and McAfee (1983), using rat superior cervical 
ganglion, showed a decrease by adenosine of the amplitude 
and rate of rise of the calcium mediated spike recorded in 
solutions containing TTX and TEA to block sodium and 
potassium channels. 2-chloroadenosine had no effect on the 
neurone when cobalt and high magnesium were added to block 
calcium channels. In contrast to the work by Haas and Green 
(1984), a depression of the AHP was observed with adenosine, 
R-PIA and 2-chloroadenosine. This effect was enhanced by 
dipyridamole and blocked by theophylline. Henon and McAfee 
(1983) suggested that these effects are mediated by a direct 
action of adenosine on calcium conductance mechanisms, as 
opposed to enhancement of calcium dependent potassium
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currents. A similar conclusion was drawn by Proctor and 
Dunwiddie (1983) as an explanation for their observation of 
suppression of calcium spikes by adenosine in hippocampal 
neurones.
Macdonald et al. (1986) used voltage clamp techniques on 
cultured mouse dorsal root ganglion cells to show that 
adenosine reduced depolarization evoked calcium conductance 
without altering the membrane conductance, indicating that a 
block was imposed directly on the calcium channel rather 
than being inactivated by an altered membrane charge.
Further studies showed this effect to be confined solely to 
the N-calcium channel, and to be G-protein dependent but 
independent of adenylate cyclase activity 
(Gross et al., 1989). These results also imply a direct 
suppression of calcium movement by adenosine. Direct 
measurement of calcium flux by using radioisotopes or 
calcium sensitive dyes have also provided evidence for 
regulation of calcium movements by adenosine. This is 
discussed in chapter 3.
Thus, it appears that adenosine may act in a number of 
ways: a) to directly suppress calcium influx 
presynaptically, b) indirectly, via calcium movements, to 
enhance calcium dependent potassium currents, or c) directly 
to activate potassium currents and induce a 
hyperpolarization either postsynaptically, or possibly 
presynaptically, although there is little evidence for this. 
The fact that the majority of electrophysiological evidence 
for regulation of calcium currents has been obtained in
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peripheral neuronal tissue, while potassium current data is 
more readily obtainable from central neurones, may indicate 
that there are different mechanisms of action for adenosine 
between the peripheral nervous system (PNS) and central 
nervous system (CNS). Alternatively, this may simply be due 
to the difficulty of studying presynaptic ion channels in 
the CNS.
Behavioural effects of adenosine
Central or systemic administration of adenosine analogues 
into an animal causes a number of behavioural effects. 
Reported effects include loss of motor coordination, 
analgesia, and changes in food intake, sleep, respiration 
rate and cardiovascular control (Feldberg and Sherwood,
1954; Haulica et al., 1973). Anticonvulsant actions have 
also been reported.
The most obvious behavioural effect is an overall 
reduction in activity, the animal appearing lethargic and 
sedated. With rodents, the animal remains conscious, 
responds to noxious stimuli with the appropriate behaviour, 
and does not lose the righting reflex. In cats and dogs, the 
effect is more intense with periods of full unconsciousness 
(Feldberg and Sherwood, 1954). Studies of sleep patterns 
show that adenosine analogues increase the duration of deep 
sleep and, at lower doses, increase REM sleep (Radulovacki 
et al., 1983). Haulica et al. (1973) observed increases in 
endogenous adenosine of up to 70% in rats deprived of sleep, 
while studies involving REM sleep deprivation in rats showed
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an upregulation of A x receptors in the brain (Yanik and 
Radulovacki, 1987). As adenosine analogues do not directly 
induce sleep in rodents, it is possible that adenosine helps 
to induce and maintain sleep rather than being a direct 
cause of sleep.
Cessation of spontaneous motor activity is another 
prominent behavioural action of adenosine. At relatively 
high doses, the animals are nearly immobile, although not 
rigid. The adenosine analogues R-PIA, NECA and 
2-chloroadenosine are particularly potent, with R-PIA having 
an EC50 of 50pg/kg for the depression of locomotive activity 
in rodents (Dunwiddie and Worth, 1982). Adenosine itself is 
much less effective, probably due to its rapid metabolism.
The behavioural depression is generally antagonized by the 
methylxanthines (Dunwiddie and Worth, 1982) demonstrating 
the receptor mediated nature of the analogues. The actual 
adenosine receptor subtype involved in these effects is not 
so clear. Barraco et al. (1983) reported a potency order of 
NECA > R-PIA > 2-chloroadenosine > S-PIA on locomotive 
depression. Dunwiddie and Worth (1982), however, found 
2-chloroadenosine to be more potent. The solubility of the 
respective compounds, R-PIA being more hydrophobic than 
NECA, and the site of administration, centrally or 
systemically, may explain some of the discrepancies. 
Hydrophobic A l agonists would appear more potent if given 
systemically as they cross the blood brain barrier more 
easily, whilst hydrophilic A2 agonists act faster if given 
intraventricularly as they do not pass into lipid membranes
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and therefore travel through the brain faster (Dunwiddie, 
1985). This difference is also manifested in brain slice 
experiments where hydrophobic analogues have longer onset 
and washout times than the hydrophilic analogues.
Adenosine analogues have also been reported to have 
analgesic effects in various behavioural tests, such as the 
hot plate test. (Yarbrough et al., 1981; Crawley et al., 
1981). This effect may be exerted via an interaction with 
the opiate system, although analgesic effects have been 
shown to be antagonized by adenosine antagonists, but not 
naloxone (Yarbrough et al., 1981). Agonist profiles suggest 
the effect may be exerted via A2 receptors (Delander and 
Hopkins, 1987). In vivo and in vitro electrophysiological 
and neurochemical studies support the behavioural evidence 
for an interaction between adenosine and the opiate system. 
Morphine at low micromolar concentrations can enhance the 
release of adenosine from the surface of the cerebral cortex 
of anaesthetized rats after systemic administration of the 
opiate (Phillis et al., 1980). This enhanced release has 
also been shown in brain slices when adenosine release is 
induced by depolarizing agents (Stone, 1981a; Fredholm and 
Vernet, 1978).
Role of endogenous adenosine
Despite the extensive effects of adenosine in the nervous 
system, its exact role, or roles are still not clear. One 
possibility is as a feedback modulator of synaptic 
transmission. Adenosine may be released by postsynaptic
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membranes to regulate the release of neurotransmitters from 
the afferent nerve terminals. This regulation may occur 
continually at a basal level, not just during levels of 
increased excitability, as added adenosine antagonists 
increase the level of excitability in resting 
(i.e. non-stimulated) brain slices (Dunwiddie and Hoffer, 
1980). Studies by Dunwiddie (1981) involved repetitive 
stimulation of hippocampal brain slices in the presence of 
theophylline or adenosine. With theophylline the response to 
repetitive stimuli decreased rapidly, presumably as the 
neurotransmitter pools were depleted. With adenosine the 
initial response was depressed, but the decline in the 
response with repeated stimuli was antagonized. This 
suggests that adenosine is inhibiting neurotransmitter 
release, reducing the rate at which the neurotransmitter 
pool is depleted. This also provides further evidence for a 
presynaptic site of action of adenosine.
This regulation of neurotransmitter release may play a 
role in sleep/waking cycles in normal neuronal activity, 
although there is little evidence for this other than an 
increase in adenosine levels during sleep deprivation 
(Haulica et al., 1973). Adenosine receptor levels have also 
been shown to fluctuate throughout the day, possibly to 
regulate sleep (Virus et al., 1984).
Adenosine may also play a part as an endogenous 
anticonvulsant, terminating the spontaneous neuronal 
activity that occurs during an epileptic seizure. The 
evidence for this is quite convincing. During seizures, the
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level of adenosine in the brain increases rapidly (Winn et 
al., 1980; Schrader et al., 1980). Maitre et al. (1974) 
showed that adenosine could block audiogenic seizures in 
susceptible mice. Dunwiddie and Worth (1982) compared CHA, 
R-PIA and 2-chloroadenosine against a number of convulsant 
drugs and reported a moderate anticonvulsant activity, with 
partial antagonism by theophylline in rat studies. The 
effectiveness of the analogues varied depending on the 
method of seizure induction. CHA and 2-chloroadenosine were 
effective against picrotoxin convulsions, but had little 
effect on kainate and leptazol induced bursts. R-PIA was 
moderately effective against all bursts. A possible Ax 
receptor action was postulated due to the high potency of 
R-PIA compared to S-PIA, but the possibility of Ax receptor 
subtypes was also suggested to explain the varying potency 
of the analogues on different bursts. Murray et al. (1985) 
reported similar results, with theophylline antagonizing the 
effect.
Barraco et al., (1984) showed that intraventricular 
injections of NECA and R-PIA could antagonize 
amygdaloid-kindled seizures in rats. Intraventricular 
injections of adenosine and adenosine uptake inhibitors had 
a dose dependent anticonvulsant effect on kindled seizures 
in the rat (Dragunow et al., 1985), while Dragunow and 
Goddard (1984) showed that the adenosine antagonist 
aminophylline could accelerate amygdaloid kindling.
Similarly, use of theophylline and caffeine facilitated the 
spread and extended the duration of electrically induced 
seizures (Albertson et al., 1983). This occurred even at low
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doses of the antagonists, suggesting there were no secondary 
effects involved on other neurochemical actions such as 
inhibition of phosphodiesterase activity (Amer and 
Krieghbaum, 1975), increased noradrenaline activity 
(Galloway and Roth, 1983) or decreased dopamine and 5HT 
activity (Govoni et al., 1984; Corrodi et al., 1972).
Adenosine receptor binding sites in relation to seizures 
have also been studied. Chronic theophylline treatment 
caused an upregulation of CHA binding sites, together with 
an elevation of seizure threshold (Szot et al., 1987). 
Treatment with leptazol to induce seizures has been 
associated with a reduction in the Ax receptor density in 
rat cerebellum (Wybenga et al., 1981), although potential 
tissue damage due to the treatment was not assessed as a 
possible reason for the reduction.
It may also be postulated that a breakdown or reduction 
in the efficacy of the adenosine metabolic pathway may 
actually give rise to epileptic seizures. The addition of 
xanthines to neuronal tissue in vivo can enhance kindled 
seizures, as described above (Albertson et al., 1983), while 
the infusion of methyxanthines into animals can induce 
spontaneous seizures (Chu, 1981). In the hippocampal slice, 
addition of theophylline or adenosine deaminase can induce 
spontaneous depolarizations (Ault and Wang, 1986), 
suggesting a tonic anticonvulsant action of endogenous 
adenosine. However, studies on the effect of adenosine on 
kindled seizures in the amygdala show that adenosine has no 
effect on the threshold of seizures, only their duration and 
severity (Dragunow et al., 1985). The authors suggest that
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adenosine is released in response to seizures to limit their 
duration, but as it seems to have no effect on the 
initiation of the seizure, adenosine cannot be said to act 
in a seizure prevention role. So, the above data provides 
some evidence that endogenous adenosine may control 
epileptic seizures. The development of suitable drugs to 
increase the efficacy of endogenous adenosine may be of 
particular pharmaceutical value in the prevention and 
treatment of epilepsy.
A number of neurological disorders are thought to be 
associated with a disorder of the purinergic system. The 
inherited condition, Lesch-Nyhan Syndrome, inflicts the 
sufferer with involuntary movements, as well as mental 
retardation, self mutilation and hyperuricaemia. The cause 
of this is a lack of hypoxanthine-guanine
phosphoribosyltransferase (HGPRT) activity, an enzyme which 
salvages excess purine nucleotides, converting them to, 
among other things, inosine 5'-monophosphate which is a 
substrate for adenosine synthesis (Fig.2.). Low levels of 
adenosine are observed in Lesch-Nyhan patients and this may 
play a part in the neurological problems, particularly the 
spasticity that affects the patient (Stone, 1981c).
Another hereditary neurological disorder is Gilles de la 
Tourette’s syndrome, characterized by involuntary tics and 
limb jerks, as well as self-mutilation and involuntary 
outbursts. This has also been linked to a reduction of HGPRT 
activity (Van Woert et al., 1977), and some of the symptoms 
may be a result of reduced adenosine activity.
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Adenosine compounds
The properties of the main adenosine analogues used in 
the experiments of this thesis are described below. Their 
structures are shown in Fig.l.
Adenosine
Adenosine is the endogenous ligand for adenosine 
receptors. It is active at both A2 and A2 receptors and is 
readily taken up by the nucleoside transport system. The 
hemisulphate salt of adenosine was used in the present 
experiments. This is readily soluble in water but otherwise 
has identical properties to free base adenosine.
Endogenously, adenosine is formed primarily from AMP via the 
action of 5 1-nucleotidase and is inactivated by conversion 
to inosine by adenosine deaminase (Fig.2.). Adenosine is not 
a principal product of the de novo synthesis of purine 
metabolism, but is a metabolite of the nucleotides and can 
be reconverted to AMP by adenosine kinase (Stone, 1981c).
The adenosine molecule is the basic structure for the 
adenosine analogues, with small changes to the molecule 
altering the potency and receptor selectivity.
2-chloroadenosine
An analogue of adenosine that, like the other adenosine 
analogues, is not taken up by the nucleoside transport 
system (Clanachan et al., 1986). This makes it approximately 
lOx more potent than adenosine on hippocampal CA1 evoked 
potentials. 2-chloroadenosine acts at Ax receptors with some 
affinity for the A2 receptor.
N-ethylcarboxamidoadenosine (NECA)
Analogue used as a ligand for the A2 receptor in binding 
studies, but has potent inhibitory action on hippocampal 
cells. If the receptor has a greater affinity for NECA than 
R-PIA, this is used as a criteria for classification as an 
A2 receptor.
R (-)-(phenylisopropyl)adenosine (R-PIA)
A potent adenosine analogue selective for the A1 
receptor. The receptor affinity ratio of R-PIA and its less 
active S isomer is used to classify A1 receptors, the ratio 
being greater for A1 receptors. This compound is hydrophobic 
and requires an ethanol or DMSO vehicle. Its hydrophobic
nature gives it a long onset and washout time in functional
studies.
Cyclohexyladenosine (CHA)
A potent analogue highly selective for the A 1 receptor. 
The compound is hydrophobic, requires an ethanol or DMSO
vehicle and has a long onset and washout time in functional
studies.
Cyclopentyladenosine (CPA)
A potent analogue with a slightly higher selectivity than 
CHA for the A x receptor. This compound is also hydrophobic, 
requires an ethanol or DMSO vehicle and has a long onset and 
washout time in functional studies.
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Fig. 1. Molecular structures of the most frequently used 
adenosine compounds.
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Calcium channels
The inhibitory action of adenosine in the CNS is 
postulated to involve an action on neuronal calcium 
channels, reducing calcium influx. There is also evidence of 
interactions of adenosine with the dihydropyridine class of 
calcium channel blockers, which might possibly involve a 
combined action at neuronal calcium channels. As an 
introduction to an investigation into these effects, the 
nature of the different types of calcium channels and 
calcium channel antagonists will be discussed.
The calcium gradient between the inside and outside of 
cells is large, extracellular calcium being 10-3M compared to 
10-7M intracellularly. This gradient is maintained by the 
relative impermeability of the cell membrane and by active 
extrusion mechanisms. These include a specific calcium 
ATPase that actively removes calcium from inside the cell, 
and a sodium / calcium exchange system that exchanges three 
or more sodium ions for one calcium ion. Calcium is also 
stored intracellularly in the smooth endoplasmic reticulum, 
mitochondria and bound to proteins such as calmodulin. 
Maintenance of a large calcium gradient is particularly 
important in excitable tissues such as cardiac and smooth 
muscle, and neuronal tissue. Depolarization of the cell 
membrane results in an influx of calcium down the gradient 
which aids in the activation of the tissue functions. In 
cardiac cells, calcium ions prolong the action potential to 
regulate the rate of cardiac contraction. In muscle cells, 
calcium is required for contraction of the muscle fibre,
while in neuronal tissue, calcium influx facilitates the 
release of neurotransmitter from the synaptic terminal. 
Depolarization of the presynaptic terminal opens voltage 
sensitive calcium channels and the resulting increase in 
intracellular calcium triggers the release of 
neurotransmitter by a mechanism that is, as yet, not fully 
understood. Thus the voltage sensitive calcium channel is a 
principal site for the regulation of neuronal excitability.
The calcium influx occurring along voltage sensitive 
calcium channels (VSCC) is one of the two main routes of 
controlled calcium entry, the other being receptor operated 
calcium channels. The voltage sensitive calcium channel is a 
large membrane spanning glycoprotein molecule that allows 
controlled entry of calcium ions into the cell down the 
concentration gradient. Part of this molecule can alter to 
open or close the channel. The probability of this gate 
being open is dependent on the depolarized state of the 
membrane and can also be altered by hormones, 
neurotransmitters and neuromodulators (such as adenosine).
It is not known whether separate populations of channels are 
affected by the various modulators, or whether channels of a 
similar type can be affected by a variety of receptor and 
voltage actions. Part of the channel also acts as a 
selectivity filter, possibly momentarily binding calcium as 
it passes through to prevent other ions passing. Certain 
divalent metal ions can bind tightly to this filter and 
block the channel (Stanfield, 1986).
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Studies of cell membrane calcium channels have 
characterized three subtypes of VSCC distinguishable by 
their voltage dependencies, selectivity and pharmacology as 
well as their kinetic signature under single channel 
recording. Nowycky et al. (1985) used chick dorsal root 
ganglion cells to study and characterize the calcium 
channels. Studies of other tissues have found the 
characteristics to be largely consistent, so the 
nomenclature is used for VSCCs in most tissues.
The channels have been named T, N and L calcium channels:
T (transient) channels are activated by weak 
depolarizations (>-70mv), inactivate very rapidly 
(20-50msecs) and are open only transiently during a period 
of depolarization. This channel is largely resistant to 
block by cadmium but not nickel and is insensitive to 
dihydropyridine calcium channel blockers and w-conotoxin. 
Because of its rapid inactivation rate it has been 
postulated that the channel is involved in the control of 
rhythmic activity, such as heart pacemaker potentials, or 
bursts of neuronal activity.
L (long opening) channels are activated by a relatively 
strong depolarization (>-10mv) but remain open for long 
periods of time (>500msecs) during the depolarization. They 
are sensitive to block by cadmium but resistant to nickel.
The dihydropyridines act principally on this channel while 
w-conotoxin exerts only a weak block. The L-channel is found 
in most tissues, but principally in cardiac and smooth
31
muscle, and is thought to be involved in the action 
potential and contraction of muscle tissue, and possibly in 
neuronal action potentials.
N (neither T nor L, or neuronal) channels are activated 
at relatively strong depolarizations (>-30mv) from a very 
negative resting membrane potential (-120 to -30mv). They 
inactivate moderately fast (50-80msecs) but continue to open 
and close during a depolarization. They are sensitive to 
block by cadmium and w-conotoxin, but insensitive to the 
dihydropyridines. They are found predominantly in neuronal 
tissue and may be located at the synapse to regulate 
neurotransmitter release.
The above voltage parameters are for the chick dorsal 
root ganglion. In other tissues these may vary. For example, 
in rat sympathetic neurones, the inactivation rate for N 
channels can be around 500msecs. It is likely that further 
studies will increase the number of channel classifications. 
Suszkiew et al. (1989) has already proposed a different 
calcium channel type for mammalian brain synaptosomes. Also, 
studies of skeletal muscle show channels that do not fit any 
of the above classifications.
Calcium channel blockers.
A range of calcium channel antagonists are available that 
are principally used in the treatment of smooth muscle and 
cardiac related problems such as hypertension, angina and 
cardiac arrhythmias. The principal compounds are: the 
phenylalkylamines, originally synthesized by Hoechst in
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1963, which include verapamil and gallopamil (D600); the 
benzothiazepines, in particular diltiazem, developed by 
Tanabe Seiyaku Co., Japan in 1975; and the dihydropyridines 
(DHP), including nifedipine, nimodipine, nitrendipine, and 
nisoldipine, as well as the agonist BayK 8644 which were 
originally developed by Bayer around 1969. The structures of 
the principal compounds are show in Fig.3. All three classes 
of drugs have potent calcium channel blocking properties in 
smooth and cardiac muscle; verapamil is equally effective in 
both types of tissue, while the dihydropyridines are more 
effective in smooth muscle. (Reviews: Van Zwieten, 1982; 
Fleckenstein, 1983). However, their effects on neuronal 
calcium channels are much weaker and possibly, in the case 
of verapamil, may also affect sodium channels (Norris and 
Bradford, 1985). The main drugs of interest in this study 
are the dihydropyridines, but the other calcium channel 
blockers will be briefly discussed to put the significance 
of their effects into perspective.
The phenylalkylamines, verapamil and its methoxy 
derivative D600, are well established calcium channel 
antagonists that have potent inhibitory effects on smooth 
muscle contractility, (e.g. ID50 on K+ stimulated contraction 
of rabbit aorta, 27nM, Schuman et al., 1975). Verapamil is 
used clinically to treat angina and cardiac arrhythmias. In 
neuronal tissue the effect is much less potent, requiring 
micromolar concentrations to have any effect on calcium 
movement, although Norris and Bradford (1985) were able to 
show a significant reduction in 45Ca uptake into cortical
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synaptosomes by verapamil at 0.5pM. (In a subsequent paper, 
however, they were unable to show an effect below 25pM,
(White and Bradford, 1986)). At high concentrations it is 
very likely that verapamil is exerting its effect via sodium 
channels rather than calcium channels (Naschen and 
Blaustein, 1975; Erdricht et al., 1983). To quote Miller and 
Freedman (1984), "At concentrations above 10_6M, verapamil 
and D600 will block virtually every biological process known 
to man."
Diltiazem is also very active in smooth muscle and is 
used to treat angina. It is thought to bind to the same site 
as verapamil, although there is some controversy over this. 
Both diltiazem and verapamil bind to a separate site from 
the dihydropyridines, but can displace them via allosteric 
interactions in binding studies (Ehlert et al., 1982). 
Diltiazem, like verapamil, has a very weak action on 
neuronal calcium influx (ID30=70pM, Wei and Chiang, 1986).
The dihydropyridines
The binding of dihydropyridines (DHP) to sites in central 
nervous tissue can be readily shown (Gould et al., 1982; 
Belleman et al., 1983) and appears to have differing 
regional distributions, certainly within the rat brain 
(Skattebol and Triggle, 1987), the highest density being 
found in the hippocampus and olfactory bulb. However, the 
binding sites do not appear to correlate with a functional 
effect of the DHPs. Daniell et al. (1983), studying 45Ca 
uptake into rat whole brain synaptosomes, were unable to 
show any effect of nisoldipine, nimodipine or nitrendipine
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on uptake at concentrations from 0.InM to lOpM. Only at low 
extracellular calcium concentrations (0.12mM) with strong 
potassium depolarization (109mM) were they able to show any 
significant decrease in uptake. Using the same technique 
Rampe et al. (1984) were unable to show any effect of the 
DHP calcium channel agonist BayK 8644 on uptake, despite the 
fact that high affinity [3H]nitrendipine binding could be 
shown that was competitively antagonized by BayK 8644.
A similar lack of effect was reported by Massieu and Tepia 
(1988).
Inhibition of 45Ca influx can be shown by other calcium 
channel blockers. Wei and Chiang (1985, 1986) showed that 
flunarizine and D600 could reduce potassium stimulated 
influx into rat cortical synaptosomes at low micromolar 
concentrations (flunarizine ID30 0.7pM), while nifedipine and 
nitrendipine were effective only at high concentrations 
(nifedipine ID30 lOOpM), despite the high affinity binding 
displayed by [3H]nitrendipine. As stated by the authors, 
this is in contrast to the potent effect of the DHPs in 
smooth muscle and indicates that the calcium channels are 
different from those in non-neuronal tissue. Similar results 
were obtained by Adron Harris et al. (1985).
The above studies have so far been carried out using 
freshly prepared brain synaptosomes. The use of cultured 
neuronal cells presents a different picture. Carboni and 
Wojcik (1985, 1988) used primary cultures of cerebellar 
granule cells to show a single high affinity binding site 
for [3H]nitrendipine, the binding of which could be
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displaced by nitrendipine, nifedipine and BayK 8644 at 
nanomolar concentrations. However, in this preparation, they 
were able to show a 40% inhibition of potassium stimulated 
45Ca influx by nifedipine and nitrendipine at O.lpM, although 
this was not increased at higher concentrations. BayK 8644 
gave a similar increase (30-35%) in calcium influx. The 
authors concluded that a subclass of DHP sensitive calcium 
channels were present in the cerebellar cells comprising 40% 
of the total population. Subsequently, Thayer et al. (1986) 
showed that cultured cells from different regions of the 
rodent brain exhibited varying sensitivities of VSCC block 
by DHPs. Hippocampal cells showed a 79% inhibition with 
nitrendipine (lpM) while striated neurones showed only a 31% 
inhibition. On the other hand, BayK 8644 showed a doubling 
of intracellular calcium in all cells studied, including 
mixed cell cultures. The cells were depolarized by potassium 
and the concentration of intracellular free calcium was 
measured using fura 2 and a microspectrofluorimeter. The use 
of fura 2 means that the source of the calcium cannot be 
determined, the DHPs may be acting by preventing release 
from intracellular calcium stores. However, the different 
sensitivities to the DHPs between brain regions correlates 
with binding studies and the distribution of rapid calcium 
uptake sites (Skattebol and Triggle, 1987).
Electrophysiological studies have also demonstrated the 
action of DHPs in neuronal tissue. Using voltage clamp 
techniques on hippocampal cells in slices, Docherty and 
Brown (1986) were able to show that nimodipine was able to
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reduce a persistent calcium current (possibly an L channel) 
by 5 5% at 2pM. Lower doses gave a correspondingly lower 
inhibition, but a total block was not possible even at lOpM. 
A second calcium current, possibly a T or N channel, was 
also observed, but this was largely insensitive to the DHPs. 
BayK 8644 (5pM) was able to enhance the persistent current 
in some cells, although this effect was not constant.
The organic calcium channel blockers affect the flux of 
calcium through the voltage sensitive calcium channel. It is 
likely that the dihydropyridine receptor is associated 
directly with the VSCC and that binding sites for the DHPs 
also represent the distribution of VSCCs (Miller and 
Freedman, 1984). The DHP binding site in skeletal muscle has 
been characterized as a four polypeptide molecule 
incorporating the calcium channel and sites for binding of 
the DHPs, verapamil and diltiazem (Campbell et al., 1988). 
Whether this is the structure for neuronal DHP binding sites 
is not certain, but possible. The problem of why the high 
density of DHP binding sites does not correlate with a 
functional action may possibly be explained by a structural 
difference between the calcium channel subtypes. The DHPs 
may be capable of binding to all the VSCCs, but only the DHP 
sensitive (L) calcium channels respond by closing. Assuming 
neuronal calcium channels are predominantly N type channels, 
with only a small proportion of L channels, then only a 
minimal effect of the dihydropyridines might be expected to 
be observed in neuronal tissues. Another possibility is a 
difference in the experimental techniques used to study
calcium channels. Neuronal cells in vivo are subject to 
multiple inputs from neighbouring excitatory and inhibitory 
neurones as well as neuromodulatory influences. This largely 
determines the resting membrane potential and the degree of 
depolarization upon stimulation of the cell. When these 
cells are broken up in the preparation of synaptosomes the 
regulatory inputs are lost and the voltage dependent 
channels may respond in a different manner to that which 
occurs in vivo. Primary cultured and clonal neuronal cells, 
on the other hand, develop largely without any regulatory 
inputs and the channels in these cells may therefore exhibit 
different properties to "fresh" cells. The modulated 
receptor hypothesis (Hondeghem and Katzung, 1984) proposes 
that certain drugs can only bind to channels when the 
channel is in an open state. This hypothesis has been 
applied to the dihydropyridine sensitive calcium channel by 
Chin (1986) to try and explain the differential sensitivity 
of calcium channels to the dihydropyridines. Assuming that 
voltage sensitive calcium channels in isolated synaptosomes 
and cultured neuronal cells differ in their active state as 
a result of their developmental environment, this hypothesis 
may explain why dihydropyridine action is more apparent in 
clonal cells than in synaptosomes.
Behavioural effects of the dihydropyridines 
Reports of the psychopharmacological effects of the 
dihydropyridines in animal behavioural studies are 
relatively scarce, but there is some evidence that the 
dihydropyridines do exert an effect in the CNS.
Hoffmeister et al. (1982) compared the effects of 
nimodipine with a number of neuroleptics and anxiolytics in 
a wide range of behavioural studies. The nimodipine was 
administered peripherally in all experiments. In mice, 
nimodipine impaired the ability of the animal to balance on 
a rod, and reduced aggressive behaviour. It inhibited 
seizures induced by pentylenetetrazol, but had no effect on 
seizures induced by electroconvulsive shock. Nimodipine 
exhibited no cataleptic effects and did not antagonize 
catalepsy induced by butyrylperazine in mice or rats. 
However, it potentiated the cataleptic effect of reserpine 
in rats, an effect normally only seen with the major 
tranquillizers. Studies of resting EEG, recorded from leads 
chronically implanted in a number of brain regions in the 
cat, showed nimodipine to have no effect on the various EEG 
patterns of sleep and waking states. However, nimodipine did 
appear to inhibit the slow sleep EEG elicited by 
administered 5-hydroxytryptophan (precursor of serotonin) in 
cats chronically pretreated with parachlorophenylalanine to 
decrease endogenous monoamine levels, suggesting that 
nimodipine impairs serotonin formation or action. A 
subsequent report on the inhibition of flurazepam induced 
sleep by nifedipine in rats may be the result of a similar 
action on serotonin by nifedipine (Mendelson et al., 1984).
A final positive effect of nimodipine was to reduce amnesia 
caused by electroshock or hypoxia in rats and mice. The 
animals were more likely to remember to avoid an area 
associated with an electric shock if given nimodipine before 
the amnesic stimuli.
The effects of nimodipine in the behavioural models 
described above cannot be explained by an effect on the 
cerebrovasculature, but suggest a direct effect on neuronal 
functions. However, the effects as a whole are not very 
significant, particularly in comparison with established 
psychopharmacologically active drugs. There may be a mild 
anxiolytic effect, as suggested by suppression of aggressive 
behaviour, and a possible anticonvulsant action on drug 
induced seizures. There were, however, no major behavioural 
effects that could be attributed solely to nimodipine.
The dihydropyridine calcium channel agonist BayK 8644 has 
been shown to have slightly more pronounced behavioural 
effects. Bolger et al. (1985), studying the effect of i.p. 
administered BayK 8644 in mice, reported a marked ataxia 
together with acute muscle tension; arching of the back and 
limb extension. This did not appear to be a direct
effect on the muscles themselves as the animal could exhibit 
periods of rapid motor activity if provoked. There was also 
an increase in auditory sensitivity, with wild running and 
audiogenic seizures in response to loud noises in some 
cases. A similar set of behavioural effects could be induced 
with reserpine, suggesting that BayK 8644 may be acting to 
decrease the action of a number of neurotransmitters 
including 5HT, noradrenaline and dopamine. The effect of 
BayK 8644 could be blocked by the administration of 
nifedipine. This was not due to an effect of nifedipine on 
the cerebral vasculature as prazosin, another vasodilator,
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had no effect on the action of BayK 8644. Nifedipine on its 
own had no obvious behavioural effects.
Thus, the dihydropyridines have been shown to have mild 
behavioural effects in animals that can be ascribed to an 
action on the CNS as opposed to any peripheral action on the 
vasculature. BayK 8644 appears to have the most marked 
effect. However, all the effects could possibly be explained 
by interactions of the dihydropyridines with endogenous 
neurotransmitters and neuromodulators, rather than from any 
direct action of the dihydropyridines via calcium channel 
actions.
The hippocampal slice.
Slices of mammalian CNS tissue, maintained in vitro, were 
originally shown to be physiologically viable by Yamamoto 
and Mcllwain (1966). Subsequently, the hippocampus proved to 
be a useful brain structure from which stable electrical 
activity could be recorded over a number of hours (Skrede 
and Westgaard, 1971; Bliss and Richards, 1971; Yamamoto, 
1972; Schwartzkroin, 1975). The hippocampal slice is now 
used extensively for a wide range of neurochemical and 
electrophysiological experiments, its use being reported in 
over 117 publications during 1988 (Medline). Techniques that 
can be used in conjunction with the hippocampal slice 
include radiolabelled neurotransmitter release studies and 
calcium uptake studies. Electrophysiological techniques can 
be employed to study three principal regions of the 
hippocampal slice; the CA1, CA3 and dentate gyrus. The 
pyramidal cells of the CA regions can be activated both 
orthodromically and antidromically to study pre- and 
postsynaptic actions of the cells and are also useful for 
single cell and intracellular studies. The neuronal pathways 
of the hippocampus readily exhibit spontaneous activity 
under a variety of conditions; particularly useful as 
in vitro models of epilepsy.
The hippocampus is organized in layers which fold over in 
a loop to form the CA (Cornu ammonis) areas 1 to 4, and the 
dentate gyrus. In the CA1 region, the layers consist of the 
alveus, which principally contains the axons of the 
pyramidal cells that pass out of the hippocampus along the
fimbria of the fornix. Below this is the Stratum oriens up 
through which the pyramidal cell axons pass. Collateral 
fibres from adjacent pyramidal cell axons travel through 
this area down to the Stratum radiatum, and small inhibitory 
basket cells are present that synapse with the pyramidal 
cells. The next layer, the Stratum pyramidale, contains the 
cell bodies of the pyramidal cells. These are clearly 
visible as a dark band which makes positioning of electrodes 
relatively easy. The Stratum radiatum is below this and 
contains the apical dendrites of the pyramidal cells 
together with the Schaffer collaterals which are collateral 
branches from axons of pyramidal cells in the CA3 region.
The apical dendrites pass down into the next layer, the 
Stratum lacunosum-moleculare, where they branch profusely. 
The Schaffer collaterals from CA3 pyramidal cells and 
commissural fibres from the contralateral hippocampus 
synapse onto these dendrites. A stimulating electrode placed 
on these collateral and commissural fibres will enable the 
synapses to be activated. The resulting depolarization of 
the pyramidal cells can be observed as a characteristic 
potential that is representative of the level of synaptic 
transmission and the number of depolarizing pyramidal cells 
(Andersen et al., 1971). The pyramidal cells, together with 
their axons and dendritic trees, as well as the Schaffer 
collaterals and commissural fibres, all lie in parallel such 
that a transverse slice of the hippocampus will contain an 
intact section of cells complete with connections to other 
cells in the parallel plane of the slice.
The advantages of an in vitro brain slice preparation 
over in vivo brain electrophysiological studies are many. 
There are no problems with pulse and respiration movements, 
no anaesthetic problems and no blood pressure and 
respiration levels to observe and maintain. The preparation
is relatively easy and quick with no lengthy
pre-experimental surgery to contend with. Positioning of the 
electrode is easy, with a relative degree of certainty as to 
its location with respect to specific areas, such as the 
cell body or synaptic regions. Application of drugs, whether 
by bath application or iontophoresis, results in a rapid 
response and wash out. With no input from other brain 
regions, absence of neurohumoral effects and a limited 
number of cells it is possible to be fairly certain that a
response to a drug or experimental manipulation is from a
single population of cells, rather than a vast number of 
possible interactions with other brain regions.
A number of studies have looked at the viability and 
integrity of the hippocampal slice. Schurr et al. (1984) 
carried out a detailed study on the viability of the slice 
over time. CA1 evoked population potentials reached a stable 
level after 1-2 hours incubation and remained stable for a 
minimum of 6 hours (mean 11.7+ 4). Electron microscopic 
studies showed "healthy" pyramidal cells with large nuclei 
containing finely dispersed chromatin and a prominent 
nucleolus. Cytoplasmic components were apparent with ovoid 
mitochondria, RER, golgi complexes, microtubules and 
microfilaments. Between 6 and 12 hours there was a general
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degeneration of the cells with the appearance of vacuoles in 
the cytoplasm, "burst" mitochondria, pycnotic nuclei and 
general swelling of dendrites. The progression of this 
degeneration was rapid after onset and electrical activity 
disappeared soon after onset. The duration of the 
experiments carried out for this thesis did not last longer 
than 5 hours including preincubation.
Determination of the metabolic stability of the rat 
hippocampal slice by Whittingham et al. (1984) showed the 
energy charge (determined by measuring adenylate levels) and 
ATP/phosphocreatine ratio values to be close to in vivo 
hippocampal levels. Total levels of ATP, adenylate, creatine 
and phosphocreatine were about half the in vivo levels, but 
attempts to improve the metabolic profile by adding 
adenylate precursors and amino acids have little effect 
(Mcllwain et al., 1951).
The thickness of the slice is an important consideration. 
A layer of damaged tissue, between 10-100pm thick, is 
present on either side of the slice (Reid et al., 1988) and 
in slices thicker than 500pm, there may be a core of anoxic 
tissue where oxygen is unable to diffuse (Whittingham et 
al., 1984). A slice thickness of between 400-500pM is 
therefore preferred.
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As with any in vitro preparation there are a number of 
disadvantages that need to be considered and controlled if 
possible. Responses elicited from cells may not be typical 
of the cells when in vivo. Excitatory and inhibitory inputs 
from other cells have been cut, in particular GABAergic 
inhibitory neurones which run longitudinally in the 
hippocampus and are cut when the hippocampus is sliced 
transversely. Neurohumoral control is absent or abnormal.
The slices contain a large number of damaged and 
degenerating cells as a result of the preparation. These may 
release factors that affect other cells, including amino 
acids (Balcar and Johnston, 1975), or partially damaged 
cells may contribute to the observed response, giving 
abnormal results. The ACSF used to bathe the tissue may give 
good, reproducible responses, but whether it provides the 
tissue with conditions close to those found in vivo is not 
clear (Whittingham et al., 1984). Although a sample of CSF 
can be analyzed for its ionic constituents, the ionic 
concentration in the extracellular space is not easily 
determined.
If these advantages and limitations are taken into 
account, and the aims and interpretations of the experiments 
determined accordingly, then the brain slice can be a very 
useful and informative experimental preparation.
CHAPTER 1
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CHAPTER 1
THE ROLE OF MAGNESIUM IN THE INHIBITORY ACTION OF ADENOSINE.
1.1. INTRODUCTION
The effect of adding adenosine to an in vitro C.N.S. 
preparation is, in most cases, to depress neuronal 
excitability. This is in addition to a tonic inhibition of 
excitability imposed by endogenous levels of adenosine known 
to be present both in vivo (Zellestrom et al.,1982) and in 
vitro (Fredholm et al.,1984). The addition of adenosine 
antagonists, or the removal of endogenous adenosine by 
adenosine deaminase, results in an increase in excitability 
that convincingly demonstrates tonic inhibition (Ault and 
Wang, 1986; Snyder et al.,1981). A reduction in the 
endogenous concentration of adenosine in vivo might 
conceivably lead to an increased neuronal excitability that 
would manifest as convulsions and epileptic seizures. This 
is the case with experimentally reduced levels of adenosine 
in vitro (Ault and Wang, 1986), but pathological or 
hereditary conditions may also lead to epilepsy via a 
reduction in adenosine efficacy. One possible area that 
might affect adenosine is the composition of the ions in the 
cerebrospinal fluid (CSF).
The composition and concentration of ions in the CSF 
bathing neuronal tissue is very finely balanced. Any 
alteration can often lead to detrimental changes in neuronal 
activity. In vitro models of epilepsy have frequently 
employed changes in extracellular ion concentration to
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induce spontaneous neuronal activity. A change in the 
concentration of most of the ions in the ACSF will alter the 
excitability of the tissue:
Elevating extracellular potassium to around 8.5mM 
produces spontaneous depolarizations in the hippocampal 
slice. This is thought to be due to a reduction in resting 
potassium currents that alters the balance of inward and 
outward ion currents, increasing the probability of neuronal 
firing. There may also be a reduction in GABA mediated IPSPs 
as a result of an increased intracellular chloride 
concentration, possibly due to the elevated potassium 
activating inward KC1 pumps or via passive influx. (Korn et 
al.,1987).
Possibly via a similar mechanism, ACSF in which 60% of 
the chloride has been replaced by an inert negative ion such 
as methylsulphate, results in epileptiform bursting after a 
brief electrical stimuli. This is thought to be due to 
reduced GABAergic input as a result of the low chloride 
concentration (Chamberlin and Dingledine, 1988).
Epileptiform activity also occurs in low extracellular 
calcium (0.2mM). This is thought to be a result of 
nonsynaptic excitatory interactions generating a strong 
positive feedback in the neuronal network as a result of 
lost calcium dependent inhibitory and stabilizing 
mechanisms. There may also be an increased potassium 
concentration as a result of reduced calcium activated 
potassium conductances (Konnerth et al.,1986).
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Increases in the bicarbonate concentration induce 
spontaneous activity possibly as a consequence of increasing 
the pH (Church and McLennan, 1988), although there may be a 
specific action of the bicarbonate ions on the membrane 
excitability (Aram and Lodge, 1987).
Finally, reduction in the extracellular magnesium induces 
spontaneous activity (Stanton et al.,1987). This may be due 
to a loss of magnesium block on the NMDA receptor operated 
channel, activating channels that are normally inactive 
during synaptic transmission (Coan and Collingridge, 1987). 
Magnesium also acts as an endogenous calcium channel 
regulator (Hagiwara and Byerly, 1981), so removal will 
increase calcium influx into cells and presynaptic terminals 
and increase the overall excitability. There may also be a 
reduction in the screening charge on the membrane.
Obviously, the in vitro brain slice preparation is very 
susceptible to changes in the ionic balance. This leads to 
the possibility that changes in the in vivo CSF ion 
composition may be a contributing factor to pathological 
seizures. Extracellular potassium is known to rise during 
spontaneous discharges (Fisher et al.,1976), although 
whether this is a cause or effect is not known. Calcium 
deficiency syndromes are frequently associated with seizures 
which can be corrected by giving calcium (Millichap, 1969). 
Eclampsia, seizures occurring in pregnant women, can be 
treated by giving magnesium salts (Valenzuela and Munson, 
1987).
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The influence of endogenous ions is not only confined to 
the major ions. Trace elements, such as copper, zinc, 
manganese, cobalt and iron are found endogenously and have 
been implicated in neuronal disorders. Intracranial 
injections of metal ions, such as iron, copper and cobalt, 
cause spontaneous seizures (Ward, 1972; Zhao et al.,1985), 
while clinical symptoms of metal poisoning typically include 
cerebral seizures (Le Quesne, 1981). A number of studies 
have looked at the concentrations of endogenous metal ions 
in epileptic animals and humans; a common feature being an 
increase in aluminium and zinc, and a decrease in the levels 
of manganese and cobalt in epileptics (Davidson and Ward, 
1988; Dupont and Tanaka, 1985; Hurley et al.,1963). Chung 
and Johnson (1983) measured the concentration of copper and 
zinc in the brains of audiogenic and normal mice. They found 
a small but significantly greater concentration of zinc and 
copper in the seizure prone mice as compared to the normal 
mice. The increase was apparent in the whole brain, but the 
difference was accentuated in the hippocampus and the 
superior and inferior colliculi. Experiments where two 
successive generations of normal mice were kept on a high 
zinc diet failed to cause an increase in brain zinc levels, 
indicating that the raised metal ion concentration in the 
audiogenic mice is an inherent rather than an environmental 
defect. Metal ion concentrations were very constant, never 
varying more than 2% among animals of the same litter, 
regardless of brain size variations. The method by which 
elevated metal ion concentrations might cause epileptic
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seizures is not clear. Chung and Johnson (1983) suggested 
that the involvement of metal ions in enzymatic processes is
a likely site for an imbalance of the biochemical
homeostasis. In particular, the enzymes glutamine synthetase 
and glutamate decarboxylase are known to be dependent on the 
metal ion concentration. An excess of metal ions may 
conceivably result in a decrease in activity of these 
enzymes as has been found in biochemical studies, although 
with concentrations of metal ions 20 times higher than that 
found in the brain. The result of decreased enzyme activity
would be an increase in glutamate and a decrease in GABA
concentrations, a situation that would inevitably increase 
neuronal excitability.
Zinc was found to be the second most concentrated trace 
element, after iron, in the study by Chung and Johnson 
(1983), and is also known to be highly concentrated in the 
synaptic terminals (Haug, 1967; Perez-Clausell and Danscher, 
1985). Peters et al. (1987) studied the effect of zinc, 
applied by pressure ejection, on membrane potential 
responses to excitatory amino acids in cultured mouse 
cortical cells. They found that zinc selectively blocked 
NMDA receptor mediated depolarizations while having no 
effect on the membrane potential or responses to kainate or 
quisqualate. This response was very similar to the block 
imposed by magnesium ions, but zinc was able to further 
depress the response to NMDA in the presence of magnesium 
(ImM). This suggests that zinc may be adding to the effect 
of magnesium at the channel, or possibly acting at the
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receptor to reduce NMDA binding. As zinc has been shown to 
be released from synaptic terminals, both spontaneously 
(Perez-Clausell and Danscher, 1986), and in response to 
depolarization (Sloviter, 1985; Assaf and Chung, 1985), the 
possibility arises that zinc may play a role in the 
regulation of NMDA responses together with the more 
ubiquitous magnesium. Unfortunately, this hypothesis is in 
contrast to the role of zinc and other metal ions as 
causative agents in epilepsy (Chung and Johnson, 1983), as a 
block of NMDA receptors would be expected to reduce neuronal 
excitability. However, it is apparent from the above studies 
that endogenous levels of metal ions, including the trace 
elements, have a role to play in the regulation of neuronal 
excitability, and that changes in these ions can give rise 
to neuronal abnormalities.
Ligand binding studies have frequently highlighted the 
importance of endogenous ions for efficient binding of 
ligands to their receptors. Baudry and Lynch (1979) showed 
that the binding of glutamate to its receptor is regulated 
by a number of cations; sodium, lithium, rubidium, caesium 
and potassium reducing binding with increasing 
concentrations; calcium and manganese enhancing it. 
Pretreatment of the membranes with EDTA, to remove membrane 
bound ions, markedly reduced ligand binding, indicating that 
endogenously bound ions are important for ligand binding. 
Similarly, binding to a-adrenergic receptors has been shown 
to be enhanced by magnesium and reduced by sodium in
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platelets (Tsai and Lefkoistz, 1978) and rat and bovine 
brain (U,Prichard and Snyder, 1980). Other receptor types 
reported to be affected by endogenous ions include opiate 
receptors (Childers and Snyder, 1980), histamine receptors 
(Chang and Snyder, 1980) and GABA receptors (Hill and 
Bowery, 1981).
1.1.1.The NMDA receptor operated channel.
The relationship between adenosine, calcium channels and 
magnesium inevitably involves interactions with other 
receptor operated membrane channels. It is therefore 
necessary to provide a brief explanation of the involvement 
of the most relevant of these, the NMDA receptor operated 
channel.
The dicarboxylic amino acids, L-glutamate and L-aspartate 
are widely thought to act as neurotransmitters in the 
mammalian CNS. At present, there are three subclasses of 
receptors at which the excitatory amino acids can act; the 
kainate, quisqualate and NMDA (N-methyl-D-aspartate) 
receptors, named after the original exogenous ligands usedto 
characterize them. The NMDA receptor is the most well 
characterized, mainly due to the availability of specific 
antagonists and its unique property of being sensitive to 
block by physiological concentrations of magnesium. Studies 
of the nature of the receptors have shown the NMDA receptor 
operated channel to be a voltage sensitive ion channel, most 
probably a calcium channel as it can be blocked by verapamil 
and cobalt (Dingledine, 1983). The voltage dependent nature
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of the NMDA channel differentiates it from the kainate and 
quisqualate receptor operated channels which give an 
increase in membrane conductance with subsequent increased 
neuronal excitability upon addition of the agonists 
(McDonald et al.,1982). The NMDA channels require a higher 
level of membrane depolarization before NMDA and other 
specific agonists can induce an increase in membrane 
conductance (Dingledine, 1983). Evans et al. (1977) 
originally reported the ability of magnesium ions to block 
responses mediated by activation of NMDA receptors, but it 
was a while before it was realized that the voltage 
sensitivity of NMDA conductance changes was a result of the 
voltage dependence of the ability of magnesium to interfere 
with the channels involved (Nowak et al.,1984; Mayer et 
al.,1984). This occurred at physiological concentrations of 
magnesium (l-2mM) and removal of the magnesium allowed NMDA 
to produce a voltage independent increase in membrane 
conductance (Crunelli and Mayer, 1984). The distribution of 
NMDA receptors is particularly high in the hippocampus 
(Monaghan and Cotman, 1985) and it is thought that the 
excitatory amino acids are the principal neurotransmitters 
in the hippocampus, particularly in the CA1 region (Fagg et 
al.,1986). Synaptic transmission via the NMDA receptor is 
not thought to be active in "normal" conditions due to the 
block by magnesium (Koerner and Cotman, 1982; Collingridge 
et al.,1983). Only in conditions where the necessary 
depolarization is provided, such as a reduction in synaptic 
inhibition, high frequency stimulation or a reduction in
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uptake, are the NMDA receptors activated (Coan and 
Collingridge, 1987).
The excitatory nature of glutaminergic and aspartergic 
neurotransmission has led to the suggestion that it is 
involved in epileptic seizures (Meldrum, 1984). Kainic acid 
is a particularly potent excitatory neurotoxin. Systemic 
administration causes seizures that are associated with 
neurodegeneration of areas of the limbic system, 
particularly the hippocampus (Nadler et al.,1978; Lothman et 
al.,1981), while addition of kainic acid to hippocampal 
slices causes epileptiform activity (Westbrook and Lothman, 
1983). The NMDA receptor, in particular, has been implicated 
as a mediator of epileptiform activity. The removal of 
magnesium from solutions bathing in vitro brain slice 
preparations, in particular neocortical (01Shaughnessy et 
al.,198g) and hippocampal slices (Mody et al.,1987), results 
in spontaneous epileptiform burst activity, as well as 
multiple potentials following an evoked depolarization 
(Herron et al.,1985; Schneiderman and MacDonald, 1987). The 
fact that 2-AP5 and other NMDA antagonists can block these 
bursts and reduce the secondary evoked potentials suggests 
strongly that NMDA receptor activation is the main cause of 
the increased excitability. The increased excitability 
observed in the absence of GABA inhibition is also thought 
to be mediated by NMDA receptors. Dingledine et al. (1986) 
showed that epileptiform burst firing in the absence of 
GABAergic inhibition appears to be mediated via NMDA
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receptors. They studied orthodromically evoked CA1 
population potentials in the presence of picrotoxin and 
bicuculline to abolish GABAergic synaptic inhibition. 
Electrically evoked, and occasionally spontaneous, 
epileptiform burst firing occurred that could readily be 
abolished by 2-AP5, a specific NMDA receptor antagonist.
2-AP5 had no effect on normal disinhibited field potentials. 
Intracellular recordings of the pyramidal cells indicated a 
voltage dependent component of the excitatory postsynaptic 
potential; 2-AP5 selectively abolished this voltage 
dependent component in disinhibited slices. This indicates 
that the excitatory transmission in the absence of GABA 
inhibitory postsynaptic potentials is mediated via NMDA 
receptors activated by the reduced membrane voltage 
potential. Ashwood and Wheal (1987) looked at specific 
lesions of the hippocampal CA3-CA4 region, induced by 
chronic administration of kainic acid, which causes 
epileptiform activity, thought to be the result of a loss of 
GABAergic inhibition. This increased excitability is also 
thought to be mediated via NMDA receptors.
The strong evidence for a role of NMDA receptors in 
epileptiform activity has led to the idea of using NMDA 
receptor antagonists for the control, or possible 
prevention, of epileptic seizures (Croucher et al.,1982; 
Meldrum, 1984). Intracellular injections of specific NMDA 
antagonists, in particular 2-AP5 and 2-AP7 
(2-amino-7-phosphonoheptanoic acid), potently blocked
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seizures in audiogenic seizure susceptible mice. Their 
potency was as good as the benzodiazepines, the most potent 
established anticonvulsants. 2-AP7 was also effective 
against seizures in photosensitive epileptic baboons when 
administered i.v.f although the potency was much lower due 
to poor entry into the brain.
Another drug with potent anticonvulsant properties is 
MK801 (Clineschmidt et al.,1982). This also appears to act 
on the NMDA receptor operated channel but via a different 
mechanism to 2-AP5. Mk801 binds to the phencyclidine (PCP) 
receptor which is thought to be located within the NMDA 
receptor operated channel (Fagg, 1987) and blocks the 
channel directly (Heuttner and Bean, 1988). Recent evidence 
suggests that rapid association with the PCP receptor only 
occurs through the activated open channel (Javitt and Zukin, 
1989). Also, addition of 2-AP5 is thought to "freeze" the 
channel, holding MK801, and magnesium ions, in the channel 
(Sokolovsky and Kloog, 1988). Thus it appears that increased 
NMDA receptor activation is implemented in acute 
epileptiform activity in in vitro models, and the addition 
of NMDA specific antagonists can prevent chronic epileptic 
seizures in susceptible animals.
The question is, what do NMDA receptors do in the CNS, 
apart from cause epileptic seizures if over activated?. At 
present it is thought that NMDA receptors are involved in 
long term potentiation (LTP), whereby tetanic stimuli can 
potentiate synaptic transmission in a particular pathway for
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long periods of time, up to 3 days (Bliss and Gardner- 
Medwin, 1973). This is a prominent feature of excitatory 
synapses in the hippocampus and is hypothesized to be 
involved in memory and learning (Collingridge and Bliss, 
1987). LTP is particularly sensitive to NMDA antagonists, 
which prevent it, while blockade of GABAergic inhibition 
facilitates LTP (Wigstrom and Gestaffson, 1985). Both 
effects suggest strongly that NMDA receptors are involved in 
LTP and this may be a major role of the NMDA receptor, at 
least in the hippocampus. Adenosine has also been shown to 
block LTP (Dolphin, 1983), possibly suggesting an 
association between NMDA and adenosine receptors.
The idea of looking at a possible relationship between 
adenosine and magnesium was prompted by a comparison of the 
data from two similar studies looking at the effect of 
adenosine on epileptiform bursts. Ault and Wang (1986) 
looked at the effect of adenosine and a range of adenosine 
analogues on epileptiform bursts induced by bicuculline in 
the CA3 region of the rat hippocampal slice. They observed a 
potent inhibition of the bursts; adenosine giving an IC50 of 
1.5pM; 2-chloroadenosine, 0.144pM and
R-phenylisopropyladenosine, 0.012pM. 0 1Shaughnessy et al. 
(1988) looked at bursts induced by magnesium free ACSF in 
the rat cerebral cortex slices. They recorded IC50 values for 
the decrease in burst frequency of 30pM for adenosine; 
2-chloroadenosine, 5pM and R-phenylisopropyladenosine,
0.24pM. This represented a 20 fold difference in potency
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between the two studies. This could have been due to a 
number of factors, including the different brain regions 
used, the different recording techniques, electrodes as 
opposed to the grease gap technique of recording changes in 
potential difference, or a difference in the method of 
inducing epileptiform bursts. The latter possibility, in 
conjunction with ligand binding studies, was the basis for 
this study into a possible relationship between adenosine 
and magnesium.
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1.2. MATERIALS AND METHODS
1.2.1. Chemicals and Biochemicals.
General laboratory reagents were "Analar" grade and were 
purchased from BDH Chemicals Ltd., UK, unless otherwise 
stated. Adenosine analogues and other neuroactive compounds 
were purchased from the Sigma Chemical Co, UK, or Research 
Biochemicals Inc. unless otherwise stated.
Compounds were dissolved in the appropriate vehicle as a 
stock solution. In most cases the vehicle was ACSF. When 
other vehicles were used, control experiments were carried 
out to ensure there was no effect from the vehicle.
1.2.2. Animals.
Rats (male, Wistar 150-250g) were obtained from the 
breeding colony at St George's Hospital Medical School.
These were housed in a controlled environment with a 12 hour 
light/dark cycle and free access to food and water.
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1.2.3. Media.
Artificial Cerebrospinal Fluid-bicarbonate solution (ACSF). 
KH2P04, 2.2mM; MgS04/ 1.2mM; KC1, 2.0mM; Glucose, lO.OmM; 
NaHC03, 25.OmM; NaCl, 115.OmM; CaCl2, 2.5mM.
Nominally magnesium free ACSF-bicarbonate solution.
KH2P04, 2.2mM; KC1, 2.OmM; Glucose, 10.OmM; NaHC03, 25.OmM; 
NaCl, 115.OmM; CaCl2, 2.5mM.
Contamination by magnesium from other constituents 
calculated from manufacturers data to be llpM.
When 8.5mM potassium was used, the KCl was adjusted to 
obtain the required concentration.
The above media were saturated with a mixture of 95% 
oxygen/5% carbon dioxide obtained from BOC., Ltd.
1.2.4. Recording electrodes.
The recording electrodes were made from fibre containing 
glass capillary tubing, 2mm diam. (Clark Electromedical 
Instruments. U.K.) pulled on a Kopf vertical electrode 
puller. The tip was bumped back under a microscope to a 
diameter of around 2pm, resistance 1-2 Mfl. The electrode was 
backfilled with 3M sodium chloride.
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1-2.5. Preparation of rat hippocampal brain slices.
Male Wistar rats were decapitated and the brain quickly 
removed into a petri-dish containing ice cold artificial 
cerebrospinal fluid (ACSF) saturated with 95% 02/5% C02.
The cerebellum was separated by means of a coronal cut at 
the rostral end of the cerebellum. Next, a sagittal cut was 
made to separate the two hemispheres. The cortex of each 
hemisphere was reflected by means of two fine spatulas, and 
the hippocampus scooped out.
The hippocampus was then transferred to a Mcllwain tissue 
chopper and placed on filter paper. Transverse slices were 
then prepared (500pm thickness) and the filter paper 
supporting the serial sectioned hippocampus was transferred 
into another petri-dish containing sufficient ACSF to just 
cover the slices. Individual slices were then separated 
using a pair of fine glass seekers. Only slices from the 
dorsal region of each hippocampus were used.
Finally, the slices were transferred to an incubation 
chamber and placed on a filter paper with sufficient ACSF to 
just cover the slices. They were maintained in an 
oxygenated, humidified environment at room temperature until 
required.
This operation from decapitation to incubation took place 
within five to eight minutes.
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1.2.6. Experimental procedure.
After a minimum of 1 hour incubation, single slices were 
transferred to the recording chamber, volume 1ml, and 
superfused by gravity feed at 4mls/min with ACSF prewarmed 
to 30°c. The slices were submerged and held in place with a 
circle of fine wire that was attached to, and lowered in to 
place by, a micromanipulator. A concentric bipolar 
stimulating electrode was placed on the Schaffer 
collateral/commissural pathway near the CA2 region, and a 
glass recording microelectrode was placed in the pyramidal 
cell body layer of the CA1 region (see Fig.1.1 in results).
The orthodromic evoked potentials were displayed, via a 
Neurolog preamplifier and filters, on a digital storage 
oscilloscope from which the potentials were recorded on a 
chart recorder. Stimuli were of 0.06ms duration, delivered 
at 0.1Hz from a constant current stimulus isolator. Stimulus 
strength was set to give a submaximal population potential 
size of about 75% of maximum (150-300pA) to facilitate 
obtaining reproducible responses to adenosine.
Drugs were bath applied via the gravity feed system and 
the changes in population potential measured from the chart 
records.
Control responses to adenosine were obtained before and 
after the magnesium free periods to ensure no significant 
changes in the response, e.g. due to a deterioration in 
slice condition or a shift in electrode position.
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Magnesium free solution was superfused for 20 minutes before 
the first adenosine application in this medium. Test 
applications of adenosine were for 8 minutes followed by 15 
minutes recovery period.
1.2.7. Epileptiform bursts.
Epileptiform bursts were recorded via a single 
microelectrode positioned in the CA3 region. A satisfactory 
orthodromic evoked potential was first obtained to confirm 
the viability of the region, the stimulating electrode was 
then removed and the nominally magnesium free medium 
introduced.
After approximately 10 minutes, spontaneous bursts of 
electrical activity were observed on the oscilloscope. The 
spontaneous activity was recorded on the chart recorder 
direct from the neurolog amplifier at xlOOO. The burst 
frequency was recorded as deflections of the chart recorder 
pen. Individual bursts could be stored on the oscilloscope 
and plotted onto the chart recorder to give a qualitative 
record of the epileptiform burst.
The number of bursts occurring over a 10 minute period 
were counted and the burst frequency per minute was 
determined. Results were presented as a percentage change in 
the burst frequency with respect to the control period 
immediately before the drug addition concerned.
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1.2.8. Analysis of results.
The storage oscilloscope was set so that only the primary 
population potential of the evoked field potential was 
displayed on the screen. This was recorded on the chart 
recorder as deflections representative of the potential 
size. The size of the deflection was measured from the 
baseline to the maximum negative deflection of the 
population potential. (See fig.1.2 in results.)
Results were analysed as a percentage change in the size 
of the negative population spike with respect to potential 
size immediately before each adenosine application.
In some experiments, the signal from the amplifier was 
passed through an averager and the average of 8 sweeps 
recorded. A qualitative record of the whole evoked field 
potential was then plotted out on the chart recorder.
1.2.9. Statistical analysis.
All results are expressed as mean ± standard error of the 
mean (sem) unless stated otherwise. Statistical significance 
was determined using a paired sample t-test on the Oxstat 
statistical analysis computer programme.
I.3 . RESULTS
1.3.1. The evoked CA1 field potential.
The positioning of the stimulating and recording 
electrodes used to obtain evoked field potentials from the 
CA1 region is shown in fig. 1.1.
A printout of a typical evoked field potential is shown 
in fig. 1.2. This was elicited by stimulation of the 
Schaffer collaterals in the Stratum radiatum. This is a 
composite potential consisting of a small presynaptic fibre 
volley followed by the excitatory postsynaptic potential 
(EPSP) upon which is superimposed the population potential, 
representative of the depolarization of the pyramidal cell 
bodies (Andersen et al., 1971).
The portion of the potential recorded and measured on the 
chart recorder is the distance from the baseline to the 
maximum deflection of the negative going population 
potential. The percentage reduction in this is taken to be 
representative of the level of inhibition at the synapses on 
the pyramidal dendrites.
The ability of adenosine to reduce the synaptically 
evoked potential is apparent in fig.1.3. If magnesium is 
omitted from the ACSF, then the effect of adenosine is 
markedly reduced.
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Fig.1.1.
Positioning of electrodes in the hippocampal slice for 
recording of CA1 evoked field potentials. The Schaffer 
collaterals (SC) from CA3 pyramidal cells together with 
commissural fibres (COMM) from the contralateral hippocampus 
are stimulated and activate pyramidal cells of the CA1 via 
synaptic connections on the pyramidal cell dendrites. A 
representative pyramidal cell is shown at the tip of the 
recording electrode.
Tmv
1 msec
Fig.1.2. Evoked CA1 field potential.
1. Stimulus artifact.
2. Presynaptic fibre volley.
3. Excitatory postsynaptic potential.
4. Population potential.
5. Deflection measured to determine percentage change 
potential size.
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1.3.2. The effect of magnesium on the inhibition of the CA1 
population potential by adenosine and 2-chloroadenosine.
Dose response curves to adenosine were determined in the 
presence of different concentrations of extracellular 
magnesium (Fig.1.4.).
Control responses to adenosine were performed before and 
after the period of altered magnesium. Results were 
discarded if the post-altered magnesium responses were more 
than 10% different from the control. Adenosine was perfused 
for 8 minutes per concentration with a washout time of 15 
minutes between each concentration. Responses to adenosine 
were apparent as soon as the adenosine reached the slice and 
a maximum response was reached within 2-3 minutes. ACSF with 
altered magnesium concentrations were perfused for 30 
minutes before the first application of adenosine. Any 
changes in the potential size due to changes in magnesium 
were normally observed within 10-15 minutes.
The inhibition of the population potential by adenosine 
was enhanced in high magnesium (4mM) and reduced in low 
magnesium (0.4mM). Omission of magnesium altogether severely 
attenuated the action of adenosine.
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Fig.1.4. Dose response curves of the effect of adenosine on 
CA1 population potentials at different concentrations of 
extracellular magnesium.
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The effect of adenosine on the evoked CA1 population 
potential at different concentrations of extracellular 
magnesium. In control 1.2mM Mg2+ ACSF, the IC50 for adenosine 
is 37 ± 3.4pM, n=30 (mean ± s.e.m). In 0. 4mM Mg2+ the IC50 
increases to 56 + 7.5pM (n=5).In 4mM Mg2+ the IC50 is reduced 
to 11.7 ± 2pM (n=5). In magnesium free ACSF inhibition is 
greatly reduced with lOOpM adenosine giving only a 31 + 6.4% 
(n=10) decrease compared to 92.1 ± 2.5% in normal ACSF.
Error bars show the s.e.m when these are greater than the 
symbol size.
There is a significant difference (P<0.05, paired t-test) 
between the normal and 4mM magnesium, and between the normal 
and magnesium free points, except at lOpM adenosine.
At concentrations of adenosine lower than lOpM in 
magnesium free ACSF, there was a small increase in the 
potential size.
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The slope of the magnesium free dose response curve 
appeared to be reduced with respect to the control curve. To 
determine whether this change was statistically significant, 
the points between 20pM and lOOpM were plotted for each 
magnesium free experiment. The slope of each line was 
determined for control (0.78 ± 0.05, n=10) and magnesium 
free (0.25 + 0.07, n=10) experiments and compared using a 
paired t-test.
The regression coefficients for the majority of the lines 
were close to 1, so it was valid to fit a straight line to 
the points.
There was a highly significant difference (P<0.001) 
between the slopes with the magnesium free dose response 
curve being significantly shallower than the control.
A Schild plot of the data was not possible as there were 
insufficient concentrations of magnesium (the "antagonist") 
below the control 1.2mM magnesium to give a suitable plot.
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Adenosine is rapidly taken up and metabolized in vitro 
(Bender et al., 1981). The possibility that uptake processes 
were being enhanced by the low magnesium was controlled for 
by using 2-chloroadenosine, an analogue of adenosine with a 
low affinity for the uptake system (Jarvis et al., 1985).
The potency of 2-chloroadenosine was also affected by 
varying the magnesium concentration (Fig.1.5.).
Further experiments were carried out to determine the 
maximum attainable depression by adenosine in magnesium free 
ACSF (Fig.1.6.). Adenosine was added at increasing 
concentrations, with washout periods of 15 minutes between 
each concentration, up to a concentration of ImM or until 
there was a 100% inhibition of the potential.
The IC50 for adenosine in magnesium free ACSF was 125 + 
15pM (n=6). In some slices a complete inhibition of the 
population potential was not possible even at concentrations 
of ImM adenosine.
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Fig.1.5. Dose response curve for the effect of
2-chloroadenosine on the population potential at different 
magnesium concentrations.
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The effect of 2-chloroadenosine on the CA1 evoked 
population potential in different extracellular magnesium 
concentrations. The IC50 for 2-chloroadenosine in normal 
magnesium is 320 ± 50nM. Points are mean ± s.e.m of 5 
slices. Error bars show the s.e.m when these are greater 
than the symbol size. All points are significantly different 
from control (1.2mM) magnesium levels. (P<0.05 PTT).
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Fig.1.6. The effect of a lack of magnesium on the maximum 
attainable inhibition of the CA1 population potential by 
adenosine.
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The percentage inhibition of the CA1 population potential 
by increasing concentrations of adenosine. The IC50 for 
adenosine is 35 ± 4.6pM in 1.2mM Magnesium and 125 ± 15pM in 
magnesium free ACSF. Points are mean ± sem of 6 
determinations.
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1.3.3. The contribution of increased cell excitability to
the reduction in adenosine inhibition.
The effect of altering the magnesium concentration is to 
increase or decrease the size of the population potential. 
Altering the magnesium concentration from 1.2mM to nominally 
magnesium free resulted in an increase in potential size of
11.8 ± 2.2% (n=14) (P<0.05, paired t-test) together with the 
appearance of secondary potentials (Fig.1.3.). An increase 
in magnesium from 1.2mM to 4mM decreased the potential by 
19.2 ± 5.16% (n=7) (P<0.05, paired t-test).
The possibility arises that the apparent efficacy of 
adenosine in magnesium free ACSF is being reduced by the 
overall increase in excitability. To control for this, a 
number of experiments were carried out to reduce the 
excitability without reintroducing the magnesium.
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1.3.3 (i). NMDA receptor mediated excitation.
One possible result of removing the extracellular 
magnesium is to open NMDA receptor operated channels, which 
would result in increased cell excitability (Stanton et al., 
1987). To control for this, 2-aminophosphonopentanoic acid 
(2-AP5), an antagonist at the NMDA receptor was added to the 
ACSF at a concentration of 50pM.
% decrease by adenosine (50pM) % decrease 
by 2-AP5
in Mg freecontrol(1.2mM Mg) Mg free Mg Free + 2-AP5(50pM)
81.4 ± 6.47 13.2 ± 6.8*** 14.5 ± 4.5*** 0.12 ± 2.1
Table 1.1. Values are the percentage decrease of the 
population potential. Mean + sem of 6 determinations. Values 
are significantly different from control. (*** = P<0.001, 
PTT) .
In this and subsequent tables, "control" refers to the 
normal response to adenosine in the standard ACSF. The size 
of the evoked population potential in the absence of any 
compounds is taken to be a 0% change in potential size.
The addition of 2-AP5 had no effect on the size of the 
potential, or the effect of adenosine in magnesium free 
ACSF.
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1.3.3.(ii). Reduced extracellular calcium.
A second approach was to reduce the calcium content of 
the ACSF to reduce the calcium influx through presynaptic 
calcium channels and subsequently reduce neurotransmitter 
release. The calcium concentration of the magnesium free 
ACSF was reduced until the primary population potential was 
reduced to a size that was close to that observed in normal 
ACSF. A calcium concentration of 1.2mM was normally 
sufficient to reduce the potential.
% decrease by adenosine (50pM) % decrease 
by Mg free/low Ca
control(1.2mM Mg) Mg free Mg Free/ 
low(1.2mM)Ca
84.6 ± 1.86 26.9 ± 7.4*** 28.8 ± 3.4*** 31.4 ± 5.9
Table 1.2. Values are the percentage decrease of the 
population potential. Mean + sem of 6 determinations.
(*** = p<o.01, PTT).
The reduced calcium did not return the characteristics of 
the potential to that seen in normal ACSF, i.e. a single 
primary potential, but reduced the overall size of both 
primary and secondary population spikes. The ability of 
adenosine to reduce the population potential was not 
restored in low calcium.
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1.3.3.(iii). Addition of cobalt.
The final method was to add a metal ion known to have 
calcium channel blocking properties (Tsien et al., 1987). 
Cobalt was used, as this has a relatively weak action and 
does not totally abolish the potential. It was also the only 
ion that could be added to the bicarbonate ACSF without 
precipitation of the bicarbonate.
% decrease by adenosine (50pM) % decrease by 
cobalt(500pM)
control(1.2mM Mg) Mg free Mg Free + 
cobalt (500pM)
21.9 + 3.773 ± 8.5 26.8 + 7.8***
- ■
82.0 + 6 . lns
Table 1.3. Values are the percentage decrease of the 
population potential. Mean + sem of 6 determinations.
(*** = pco.001 PTT, ns = not significantly different from 
control).
In this instance, the potency of adenosine was restored 
to control levels.
From these results it appears that the increase in 
excitability is not due to an increase in NMDA receptor 
mediated action and that a reduction in synaptic 
transmission by lowering the calcium concentration does not 
restore the potency of adenosine. However, a reduction in 
excitability by blocking calcium influx with cobalt does 
return adenosine inhibition to control levels.
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1.3.4.The action of adenosine on epileptiform bursts.
The original idea for this study was to determine if 
there was any difference in the potency of adenosine on 
epileptiform bursts induced by different methods. The effect 
of adenosine and 2-chloroadenosine on epileptiform bursts 
induced by magnesium free ACSF in the CA3 region was 
determined (Fig.1.7).
The IC50 values for inhibition of the spontaneous activity 
were 3.6 + 0.22pM (n=4) for adenosine and 247 ± 22nM (n=4) 
for 2-chloroadenosine.
Epileptiform activity is normally recorded in the CA3 
region because bursts are generated here and are stronger 
and more likely to occur (Wong and Traub, 1983).
Epileptiform activity is occasionally apparent in the CA1, 
possibly triggered by spontaneously depolarizing cells in 
the CA3. In some slices bursts were apparent in both the CAl 
and CA3. Responses to adenosine were determined in both 
regions in these slices to determine if there was any marked 
difference in potency (Fig 1.7c).
There was no significant difference in the potency of 
adenosine or 2-chloroadenosine between the CAl and CA3 
regions.
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Fig.1.7. The anticonvulsant action of adenosine and 
2-chloroadenosine on magnesium free ACSF induced spontaneous 
activity in the CA3.
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Fig.1.7a. The inhibition of spontaneous activity by 
adenosine. Values are the percentage decrease of the burst 
frequency. Points are mean + sem of 5 determinations. The 
IC50 is 3.6 ± 0.22pM (n=5).
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Fig.1.7b. The inhibition of spontaneous activity by 
2-chloroadenosine. Values are the percentage decrease of the 
burst frequency. Points are mean ± sem of 5 determinations. 
The IC50 is 247 ± 22nM (n=5).
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Fig.1.7c. The inhibition of spontaneous activity by 
adenosine in the CAl as compared to the CA3. Values are the 
percentage decrease of burst frequency. Points are mean ± 
sem of 5 determinations.
83
1.3.5.Excitation by adenosine
Returning to the low calcium experiments, an interesting 
effect of adenosine was observed when it was added to slices 
bathed in magnesium free/1.2mM calcium ACSF. In a small 
number of slices, the adenosine produced a marked increase 
in potential size. It was decided to study this further to 
determine the reason for this effect.
In 35 of 50 slices studied, addition of adenosine (50pM) 
induced a response comparable to that seen in magnesium free 
ACSF, i.e. a small or absent decrease in the potential. 
However, in the remaining 15 slices, there was an increase 
in potential size with adenosine or a related analogue, 
adenosine giving an increase of 65 + 14.2% (n=6). The 
increase could be blocked by superfusion with 
8-phenyltheophylline (lOpM) but varying the adenosine 
concentration did not affect the size of the increase, 
indicating a lack of dose dependency.
One possibility was that an A2 receptor response, 
increasing neuronal excitability, was being observed in the 
absence of the inhibitory A: response. The addition to the 
superfusing medium of the A2 receptor agonists 
2-phenylaminoadenosine (CV-1808, lOpM), 
fluorenyl-methyladenosine (PD117,413, 50pM) and 
N-ethylcarboxamidoadenosine (NECA, O.lpM), gave variable 
increases in potential size (NECA 23 + 9%, n=3;
CV-1808 84 + 18.7%, n=3; PD117 400%, n=l). Responses were 
not always repeatable upon addition of a second dose and, in 
some cases, there was a latency of up to 5 minutes before an 
increase occurred.
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Fig.1.8. shows sample chart records of the increase in 
potential size seen with some adenosine analogues.
In some slices, the A1 antagonist 8-cyclopentyl-l,3- 
dipropylxanthine (DPCPX) lOnM, was added to try and enhance 
any A2 receptor response. No enhancement of excitation by 
adenosine was observed and addition of the xanthine did not 
increase the occurrence of adenosine excitation in control, 
magnesium free or magnesium free/low calcium conditions, 
again lending no support to a possible A2 receptor action.
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Chart records of responses to adenosine analogues m  
magnesium free / 1.2mM calcium ACSF.
a) 50pM adenosine.
b) 0 . lpM NECA, antagonized by lOpM 8-phenyltheophylline
c) lOpM 2-phenylaminoadenosine (CV-1808).
d) lOpM PD117,413, partially antagonized by 50pM 
theophylline.
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The pattern of delayed onset and lack of dose dependency 
gave the impression of a removal of inhibition rather than 
an active excitation.
The recording conditions were altered to record activity 
in the slice direct from the amplifier. This revealed 
spontaneous depolarisations at a frequency of around 7Hz in 
the CA1 region during superfusion with magnesium free/low 
calcium ACSF. These bursts were completely inhibited by 50pm 
adenosine and the cessation of the bursts corresponded with 
an increase in the evoked potential size (Fig.1.9.).
The addition of the NMDA receptor antagonist 2-AP5 
(50pM), the PCP receptor antagonist MK801 (lpM), the GABAb 
agonist baclofen (10pM), the anaesthetic procaine (500pM), 
and the endogenous anticonvulsant kynurenic acid (500pM) all 
inhibited the epileptiform bursts and gave a parallel 
increase in evoked potential size.
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i min
Fig.1.9.
Simultaneous recordings of spontaneous activity (top) and 
evoked population potentials (bottom). Effect of 50pM 
adenosine.
Top trace shows activity recorded directly from the 
amplifier, the majority of deflections represent the evoked 
potential and stimulus artifact. A high level (0_. 7Hz) of 
spontaneous activity is also present that is completely
abolished by adenosine.
Bottom trace records the population potential only, 
recorded via a storage oscilloscope as normal.
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1.3.6.Experiments to reduce spontaneous activity without
affecting evoked potentials.
The possibility that the spontaneous activity had 
influenced the results of the earlier magnesium free/low 
calcium experiments (Table 1.2.) had to be considered. These 
experiments were repeated under conditions where spontaneous 
activity was reduced. Two methods were used to inhibit 
spontaneous activity in magnesium free/low calcium 
conditions without affecting the recording of evoked 
potentials.
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1.3.6.(i)Removal of the CA3 region.
The CA2-CA3 region of the slice has been shown by Wong 
and Traub# (1983) to be the initiation site for spontaneous 
activity. This involves a small group of cells that are 
activated when inhibitory inputs are blocked by bicuculline 
or penicillin, which can then trigger adjacent cells in the 
CA1. As spontaneous activity in magnesium free ACSF was more 
apparent in the CA2-CA3 region, it is reasonable to assume 
that these cells also initiate the bursts that occur in the
absence of magnesium. This region was cut from a number of
slices within 10 minutes of the initial preparation, and the 
slices left to recover for 1 hour. CA1 orthodromic evoked 
potentials were then recorded as normal.
In magnesium free/low calcium media, spontaneous 
depolarisations were still apparent, although smaller (0.8mv 
compared to 2.6mv) and less frequent (0.11 + 0.001 Hz, n=3) 
than in intact slices. The bursts were apparent only when 
the stimulator was turned off, not during evoked potentials. 
The addition of 50pM adenosine failed to reduce the evoked 
potential size, while in some slices there was a small
increase in potential size. However, as a small level of
spontaneous activity was still present, the results from 
these experiments were not quantitatively analysed.
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1.3.6. ( ii) BacJLofen
Baclofen can reduce spontaneous activity at low 
concentrations, while requiring a much higher concentration 
before any effect on synaptic transmission is observed 
(Scott Swartzwelder et al., 1986). lpM baclofen was added to 
the bathing medium and inhibited spontaneous depolarisations 
without significantly reducing the evoked potential. In 
these experiments, the calcium concentration had to be 
reduced to 0.8mM before a significant reduction in the 
potential size was obtained.
% decrease by adenosine (50pM) % decrease by 
Mg free/low Ca
control(1.2mM Mg) Mg free 
fbaclofen
Mg Free/ 
low(0.8mM)Ca 
+baclofen
57.4 ± 7.45 7.5 ± 3*** 11.8 ± 3.9*** 29.6 ± 8.2
Table 1.4. Values are the percentage decrease of the 
population potential. Mean + sem of 6 determinations.
(*** = p<o.01 PTT)
Baclofen (lpM) was present throughout the magnesium free 
period of the experiment and had no effect on the evoked 
potential in magnesium free ACSF. No spontaneous activity 
was observed in magnesium free or magnesium free/low calcium 
ACSF. The inhibition by adenosine was still significantly 
lower than in magnesium containing ACSF after the potential 
size had been reduced.
This data supports the earlier low calcium experiments 
(Table 1.2.) confirming the experimental evidence that the 
action of adenosine in magnesium free ACSF is not restored 
when synaptic transmission is reduced by low calcium.
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1.3.7.Interactions between NMDA channels and adenosine.
Following a report that 2-AP5 can block magnesium free 
ACSF induced bursts if added prior to the magnesium free 
ACSF but is much less effective if added afterwards 
(Stratton et al.,1989), the 2-AP5 experiments were repeated 
with 2-AP5 being added before or with the introduction of 
the magnesium free ACSF.
Control 
50pM adn
OMg + 2-AP5(50pM) OMg + 2-AP5(50pM) 
50pM adn
OMg 
50pM adn
64.6 + 4.8 5.4 ± 2.5 55.8 ± 6.8** 12.4 + 1.9***
Table 1.5. Values are the percentage decrease of the 
population potential. Mean ± sem of 6 determinations. 
(*** = p<o.001, ** = P<0.05, PTT).
There was now no increase in the potential size upon 
going into magnesium free ACSF when 2-AP5 was present. The 
addition of adenosine produced an inhibition that was still 
significantly less than the control, but the inhibition was 
close to the control level of inhibition and was 
significantly greater than that observed in magnesium free 
ACSF when the 2-AP5 was removed (P<0.01, PTT).
Thus, it appears from these results that the relationship 
between adenosine and magnesium is in fact linked to the 
NMDA receptor operated channel, contrary to the earlier 
results in table 1.1. The possibility arises that activation 
of NMDA receptors inactivates or reduces the efficacy of 
adenosine. To study this possibility, two approaches were 
used.
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1.3.7.(i)The action of adenosine in magnesium free ACSF when 
NMDA channels are blocked.
To block NMDA receptor operated channels, the 
phencyclidine (PCP) receptor ligand MK801 was used together 
with 2-AP5. This combination of NMDA antagonists should 
remove any activation of NMDA receptor operated channels 
regardless of the presence of magnesium.
In magnesium free ACSF, MK801 (lOpM) was added and a 
brief 2 minute pulse of NMDA (lOpM) was given that partially 
depressed the potential. This was repeated at 10 minute 
intervals until the depression by NMDA was abolished, at 
which point MK801 was deemed to be blocking the majority of 
NMDA receptor operated channels. 2-AP5 (20pM) was then added 
and the response to adenosine determined.
% decrease by 50pM adenosine
Control 
(1.2mM Mg)
Mg free ACSF MK801 + 2-AP5 
in Mg free ACSF
55.3 + 7.1 11.8 ± 5.2*** 41.8 ± 7 . 5ns
Table 1.6. Values are the percentage decrease of the 
population potential. Mean + sem of 6 determinations.
(*** = p<o.01 PTT, ns = not significantly different from 
control)
Antagonism of NMDA receptor and channel activation by 
2-AP5 and MK801 in magnesium free ACSF effectively restored 
the potency of adenosine to control levels. MK801 and 2-AP5, 
on their own, had no effect on the potential.
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1.3.7.(ii) The action of NMDA channel activation on 
inhibition by adenosine.
The second approach was to activate NMDA receptor 
operated channels in the presence of normal (1.2mM) 
magnesium concentrations and to determine the effect on the 
inhibitory action of adenosine.
NMDA was added at a concentration of 5pM and perfused for 
10 minutes until a stable depression of the potential size 
by NMDA had been obtained. Adenosine was then added in the 
presence of NMDA.
control 
50pM adenosine
5pM NMDA 5pM NMDA+ 
50pM adenosine
53.2 ± 5.26 15.6 ± 3.54 32 ± 2.14***
Table 1.7. Values are the percentage decrease of the 
population potential. Mean ± sem of 5 determinations.
(*** = p<0.01 PTT).
NMDA (5pM) gave a small decrease in the size of the 
population potential. In the presence of NMDA the effect of 
50pM adenosine was significantly reduced in comparison to 
control.
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On a separate set of slices, adenosine (50pM) was 
perfused to give a steady depression of the population 
potential for at least 10 minutes. NMDA (5pM) was then 
perfused in the presence of adenosine.
50pM adenosine 5pM NMDA+ 
50pM adenosine
61.0 ± 5.5 39.0 ± 5 . 2***
Table 1.8. Values are the percentage decrease of the 
population potential. Mean + sem of 5 determinations.
(*** = p < o .001 PTT).
The depression by adenosine was attenuated by NMDA within 
a minute of NMDA onset. This attenuation could be maintained 
for as long as the NMDA was perfused. Slightly higher 
concentrations of NMDA (8-10pM) resulted in a total 
abolition of the population potential.
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1.3.8. The effect of high potassium induced excitability on 
adenosine inhibition with NMDA channels inhibited.
The above results support the idea that activation of 
NMDA receptor operated channels can reduce the inhibitory 
action of adenosine. However, it is possible that increased 
excitability mediated via NMDA channel activation is 
lowering the action of adenosine by a simple masking action. 
To control for this, the excitability of the slice was 
raised by increasing the potassium concentration of the 
normal ACSF to 8.5mM. NMDA channel action was blocked by 
adding 2-AP5 prior to the 8.5mM potassium. The action of 
adenosine was then determined under these conditions.
% decrease by adenosine (50pM)
control 50pM 2-AP5 8.5mM K+
+ 5 OpM 2-AP5
8.5mM K+
61.3 + 3.49 60.3 ± 2.17 51.7 + 1.7*** 6.0 + 2.03***
Table 1.9. Values are the percentage decrease of the 
population potential. Mean ± sem of 4 determinations. 
(*** = P<0.01 PTT).
Increasing the potassium concentration caused an increase 
in the excitability of the slice in the presence of 2-AP5 
apparent by the appearance of spontaneous activity. There 
was no significant increase in the evoked potential size.
The inhibitory action of adenosine was only slightly reduced 
in 8.5mM potassium with 2-AP5 present. When the 2-AP5 was 
removed there was no noticeable change in the potential size 
or increase in spontaneous activity, but the action of 
adenosine was significantly attenuated.
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1.4. DISCUSSION
The key observation of the experiments reported in this 
chapter is the marked reduction in the potency of adenosine 
and 2-chloroadenosine in reducing the hippocampal CA1 evoked 
population potential when magnesium is omitted from the 
ACSF. The possible reasons for this, and the possible 
implications for the role of adenosine as an endogenous 
neuromodulator, are discussed below.
Omitting the magnesium from the ACSF bathing the 
hippocampal slice can be expected to increase the overall 
excitability of the cells. This could be due to three 
principal effects: 1) A reduction in surface charge. The 
surface charge on a membrane will determine the level of 
excitability of the cell. This charge, determined by the 
charge on the phospholipids and proteins making up the 
membrane, will be influenced by the ions present in the 
surrounding medium. A decrease in the number of divalent 
cations, principally magnesium and calcium, will decrease 
the stability of the neurone, making it more likely to 
depolarize (McLaughlin et al.,1971); 2) An increase in 
calcium influx across voltage sensitive calcium channels, 
magnesium acting as an endogenous regulator of calcium 
influx (Hagiwara and Byerly, 1981); or 3) An increase in 
activity of the NMDA receptor operated calcium channel.
These last two possibilities may occur together. Enhanced 
presynaptic calcium influx across voltage sensitive calcium 
channels would increase neurotransmitter release while NMDA
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receptor channels, thought to be located primarily on the 
postsynaptic membrane (Fagg and Matus, 1984), would be more 
readily activated in the absence of magnesium resulting in 
an increased excitability of the pyramidal cells in response 
to the increased neurotransmitter release.
Whatever the reason for the increased cell excitability, 
the effect may simply be to mask the inhibition by adenosine 
such that, although the adenosine is applying the same level 
of inhibition at a given concentration, the increased 
excitability makes the inhibition less apparent. From the 
nature of the population potentials observed (Fig.1.3) it is 
apparent that, in magnesium free ACSF, the cells are firing 
two or more times after a stimulation. This suggests there 
is an increased availability of neurotransmitter and/or 
increased postsynaptic sensitivity. The small (12%) increase 
in the primary potential size suggests there are a greater 
number of cells firing as well. Thus, adenosine may be 
required to act on a greater number of cells as well as 
having to reduce the increased neurotransmission.
The dose response curves to adenosine (Fig.1.4) show a 
parallel shift to the left or right as the magnesium 
concentration is raised or lowered. This indicates a 
"competitive antagonism" of adenosine action by magnesium 
or, more specifically, a reduction in the percentage 
inhibition by adenosine due to the increased excitability of 
the cells. However, when magnesium is omitted altogether,
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the slope of the dose response curve is significantly 
reduced (PC0.001, PTT). This suggests that the inhibitory 
action of adenosine is actively impaired in the absence of 
magnesium, as opposed to a masking effect as a result of the 
increased cell excitability. Also, the maximum attainable 
inhibition by adenosine is reduced so that, in some slices, 
a 100% decrease of the population potential was not possible 
even at concentrations as high as ImM adenosine (Fig.1.6).
Experiments were carried out to determine the 
relationship between the increased excitability of the 
slice, apparent by an increase in the evoked population 
potential size, and the reduced adenosine inhibition. This 
involved reducing the excitability of the slice without 
reintroducing magnesium.
During the course of this study three hypotheses were 
considered as explanations for the reduction in adenosine 
inhibition. The first, as discussed above, is that the 
increased cell excitability is masking the action of 
adenosine. The second is the possibility that there is a 
requirement for magnesium ions at the adenosine receptor or 
channel to aid in effective adenosine action. The third 
hypothesis is that activated NMDA receptor operated channels 
can directly antagonize the inhibition of synaptic 
transmission by adenosine. These hypotheses will be referred 
to during the discussion of these experiments.
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1.4.1. Low calcium.
The effect of reducing the extracellular calcium 
concentration in magnesium free ACSF was probably to reduce 
synaptic transmission by reducing the calcium available for 
uptake into synaptic terminals (Dingledine and Somjen,
1981). The primary potential was reduced under these 
conditions, although the secondary potentials were still 
apparent. The inhibitory action of adenosine was still 
significantly reduced despite the reduced synaptic 
transmission. However, it became apparent that spontaneous 
activity might be interfering with the evoked potentials 
(see section 1.4.2. below).
To counteract the spontaneous activity two approaches were 
tried:
1) Removal of the CA2-CA3 region of the slice, the 
initiation site for spontaneous activity (Wong and Traub, 
1983), reduced but did not abolish spontaneous activity. A 
similar observation has been reported by Traynelis and 
Dingledine (1989) in CAl "minislices" where the CA3 had been 
removed. A reduction of calcium and magnesium from 1.5mM to 
1.2mM in the presence of 8.5mM potassium resulted in 
spontaneous interictal activity that was not normally 
observed at the higher concentrations of magnesium and 
calcium. This effect was ascribed to a reduction in membrane 
surface charge.
2) Addition of the GABA agonist baclofen to the slice.
The effect of adding a low concentration of baclofen was to 
reduce the spontaneous epileptiform bursting while having no
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observable effect on the evoked population potential. The 
reason for this differential potency of baclofen is not 
clear but may be related to the postulated existence of two 
GABAb receptor subtypes (Scott Swartzwelder et al.,1986), 
one postsynaptic high affinity receptor acting via potassium 
channels to hyperpolarize cells, the other presynaptic low 
affinity receptor suppressing synaptic transmission possibly 
via action at a calcium channel. The net result was to 
eliminate interference from spontaneous activity. Evoked 
potentials were reduced in low calcium ACSF, secondary 
potentials were still apparent but fewer in number and 
greatly reduced. In most slices, the extracellular calcium 
had to be reduced to 0.8mM before a significant reduction in 
potential size was observed. Under these conditions the 
response to adenosine was still significantly smaller than 
control levels. This indicates that the effect of adenosine 
was still impaired in magnesium free ACSF despite the 
reduced synaptic transmission due to the low calcium. This 
supports the possibility that a lack of magnesium actively 
impairs the action of adenosine, as opposed to an indirect 
effect via increased calcium influx and neurotransmitter 
release.
1-4.2. Apparent excitatory action of adenosine.
This is a convenient point to digress from discussion of 
the reduced excitability experiments to consider an effect 
of adenosine observed during the use of magnesium free/low 
calcium ACSF. In some experiments the action of adenosine,
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when added to a slice bathed in magnesium free/low calcium 
ACSF, was to cause an increase in the size of the potential. 
The original hypothesis, that there is a requirement for 
magnesium at the adenosine receptor, was extended to include 
the possibility that magnesium is required only at the Ax 
adenosine receptor. When binding of adenosine to this 
receptor is impaired in magnesium free ACSF, activation of 
the A2 excitatory receptors becomes apparent. A2 receptors 
have been shown to occur in the hippocampus as determined by 
[3H]NECA binding in the presence of R-PIA (Lee and 
Reddington, 1986) although they are in relatively low 
density as compared to other regions of the brain such as 
the striatum (Bruns et al.,1986).
However, use of A2 specific agonists and A2 antagonists 
failed to show a consistent effect that could be attributed 
to a pharmacological action of the adenosine compounds. When 
the recording conditions were altered to provide a 
continuous recording of electrical activity in the slice it 
became apparent that the "excitation" was a result of 
inhibition of spontaneous activity by adenosine. Under 
magnesium free ACSF conditions there was no spontaneous 
activity apparent when the slice was being stimulated. 
However, under magnesium free / low calcium conditions, the 
excitability of the cells appears to be increased so that 
they fire rapidly during the 10 second interval between 
stimuli. This action is independent of presynaptic 
neurotransmitter release and is therefore unaffected by
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reduced presynaptic calcium influx and presynaptic adenosine 
action (see section 1.4.5. below). The reason for the 
increased excitability is not clear, but may be due to a 
further reduction in membrane surface charge (McLaughlin, 
1971). This increased excitability would "exhaust" the 
cells, with depletion of presynaptic neurotransmitter 
reserves and a greater number of cells in the hyperpolarized 
state that follows immediately after a depolarization. When 
the slice is stimulated, the total number of cells able to 
fire is reduced, as is the size of the recorded potential. 
Adenosine inhibits the spontaneous activity and allows the 
cells to recover, a change reflected in an increase in the 
population potential size. This recovery can take up to 5 
minutes, which explains the long onset time to response seen 
in some experiments.
A re-examination of the chart records showed that the 
increase in potential size with adenosine was never greater 
than the potential size in magnesium free ACSF, so no true 
excitation or increase in potential size by adenosine can be 
claimed. In the slices that exhibited this effect the 
calcium concentration presumably was not low enough to 
reduce synaptic transmission or, alternatively, the 
depression of the evoked potential by spontaneous activity 
was greater than that imposed by the reduced calcium. In the 
majority of slices the "excitation" by adenosine was not 
observed, presumably because the low calcium was reducing 
synaptic transmission which was the original premise for 
using low calcium.
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1.4.3. Cobalt.
Returning to the reduced excitability experiments, the 
addition of cobalt to the ACSF reduced the overall 
excitability of the cells, as was apparent by the reduction 
in the size of the primary potential and the abolition of 
the secondary potentials. It also restored the potency of 
adenosine to control levels. The original premise for adding 
cobalt was to block a proportion of the presynaptic calcium 
channels and so reduce neurotransmitter release. The fact 
that the inhibition by adenosine was restored to control 
levels when cobalt was added could be explained in two ways. 
If adenosine requires magnesium for its interaction with its 
effector mechanism or receptor, then it is also possible 
that cobalt can effectively substitute for magnesium in this 
interaction. Reddington et al.(1987) showed that cobalt can 
effectively substitute for magnesium in enhancing [ H]CHA 
binding in rat brain membranes. The enhancement was not as 
great as with magnesium, but the addition of magnesium did 
not increase the [3H]CHA binding further, suggesting that 
cobalt was acting at the same site as magnesium to enhance 
CHA binding. Chin and DeLorenzo (1985) also reported that 
cobalt stimulates the binding of 2-chloro[ H]adenosine to a 
novel A3 receptor (discussed in chapter 3, p242), while the 
action of magnesium ions on binding was comparatively low. 
This receptor is proposed to be associated with calcium 
channels and, if it exists, it can be postulated that cobalt 
Nay restore the action of adenosine by stimulating binding 
to an A3 receptor which is not inactivated by a lack of
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magnesium ions. However, this possibility has to be treated 
as speculative at present, as evidence for this particular 
A3 receptor has so far been provided by only one group.
An alternative, that has to be considered in light of the 
NMDA receptor involvement (see below), is the fact that 
cobalt has been shown to block selectively the NMDA receptor 
channel (Riveros and Orrego, 1986; Peet et al.,1986). It 
could therefore be acting to block calcium influx across 
NMDA receptor channels which appear to be the principal 
sites of increased calcium influx under conditions of 
magnesium free ACSF.
1.4.4. 2-Amino-5-Phosphonopentanoic acid (2-AP5).
The addition of 2-AP5 (50pM) to the hippocampal slice 
after the introduction of magnesium free ACSF had no effect 
on the size of the primary population potential and the 
inhibitory properties of adenosine were not restored. This 
was taken to indicate that NMDA receptor operated channels 
were not a major contributing factor to the potential size 
increase. However, later experiments showed that the 
situation was more complex than this. Although the size of 
the secondary potentials was not recorded in all 
experiments, the effect of 2-AP5 when added in magnesium 
free ACSF was to reduce, but not abolish, the secondary 
potentials, while having no effect on the primary potential. 
Similar experiments by Coan and Collingridge (1987) showed 
that the effect of 2-AP5 on the CA1 evoked potential in
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magnesium free ACSF was dependent on the stimulus size. A 
low stimulus intensity allowed 2-AP5 to reduce or abolish 
the primary potential, while a higher stimulus intensity 
prevented this action and actually produced an increase in 
potential size at 30-50v. In some slices, notably those that 
were also exhibiting spontaneous activity, Coan and 
Collingridge (1987) showed that 2-AP5 was only partially 
effective in abolishing the secondary potentials. The 
stimulus size in the present experiments was set to give a 
population potential 75% of maximum in normal ACSF. This was 
not altered throughout the experiment. In magnesium free 
ACSF the effective stimulus intensity may have been 
sufficient to prevent 2-AP5 from exerting an effect on the 
primary potential. However, this does not explain why 2-AP5 
was more effective in preventing an increase in excitability 
when it was added prior to the magnesium free ACSF.
The addition of 2-AP5 to the perfusion medium before or 
with the introduction of magnesium free ACSF prevented the 
increased excitability and also prevented the loss of 
adenosine inhibition. This was not the case if 2-AP5 was 
added after a period of magnesium free ACSF. A possible 
explanation for this could be that 2-AP5 is locking 
magnesium into the NMDA receptor operated channel 
(Sokolovsky and Kloog, 1987), effectively maintaining the 
magnesium block. Once the magnesium has been washed out, the 
trapped magnesium ions are still present to keep the NMDA 
receptor operated channel inactive. If 2-AP5 is added after
magnesium is omitted, 2-AP5 binds to the receptor but is 
less effective at inactivating the NMDA receptor operated 
channel once these have been activated by removal of 
magnesium. The concept of 2-AP5 "freezing" the channels was 
provided by Sokolovsky and Kloog (1987) to explain the 
decrease of MK801 and TCP binding in the presence of 2-AP5. 
These ligands bind to the PCP receptor located in the NMDA 
receptor operated channel. However, 2-AP5 is an effective 
inhibitor of magnesium free spontaneous epileptiform bursts 
(Stanton et al.,1987), so it is able to exert a certain 
level of antagonism in the absence of magnesium ions. 
Alternatively, 2-AP5 may be aided in its binding by the 
presence of magnesium ions, in the same manner as is 
postulated for the binding of adenosine. This seems unlikely 
as 2-AP5 is a commonly, and effectively, used antagonist of 
NMDA receptors in magnesium free ACSF.
Another possibility is that activation of NMDA receptors 
is required for the initiation of increased neuronal 
excitability, but secondary mechanisms act to maintain the 
increased level of excitability. These mechanisms could be 
via a reduction in GABAergic input or efficacy, an increase 
in the extracellular potassium concentration or a reduction 
in neuromodulatory control, possibly by adenosine. Evidence 
for this possibility can be given by the observation that 
spontaneous activity invoked by removing the magnesium is 
frequently difficult to abolish upon reintroduction of 
magnesium• This has been observed in the neocortex
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(Smith et al.,1989), where reintroduction of magnesium after 
a period of one hour in magnesium free ACSF reduced, but 
failed to abolish, the spontaneous depolarizations. In some 
slices, the spontaneous activity was not abolished even when 
magnesium levels were increased 2.5 times above control. A 
similar phenomenon was observed in the dentate gyrus 
(Stratton et al.,1988). This, however, was not the case in 
the CA1 in the present studies, where reintroduction of 
magnesium abolished any spontaneous activity and reduced the 
size of the primary potential. In the study by Coan and 
Collingridge (1987), addition of magnesium reduced the 
secondary potentials, although they did not compare the size 
of the primary potential with control levels, or state 
whether any spontaneous activity was abolished.
None of these possibilities provide a completely 
satisfactory explanation for the differential effects of 
2-AP5. However, the experiments carried out with MK801 show 
that the NMDA channel can be blocked after the magnesium has 
been removed and this restores the action of adenosine. 
Effectively, MK801 is acting as a replacement for the 
magnesium ions and blocking the channel, while 2-AP5 only 
acts at the receptor to close the channel. It can only do 
this effectively if magnesium, or MK801, is present in the 
channel. Thus, this scenario is the most likely explanation 
for the effects observed.
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It therefore appears from these experiments that an 
increase in NMDA receptor operated channel action is 
responsible for a significant proportion of the increased 
neuronal excitability.
The increase in the size of the primary population 
potential when 2-AP5 is present is small compared to the 
average increase upon going into magnesium free ACSF 
(5.4 ± 2.5% compared to 12 + 1.6%). There is also a lack of 
secondary potentials in the presence of 2-AP5. This suggests 
that activation of NMDA receptor channels is the principal 
action responsible for the increased excitability.
The involvement of NMDA channels can also explain the 
significant decrease in the slope of the dose response curve 
to adenosine in magnesium free ACSF (Fig.1.4). As discussed 
in the introduction to this chapter, magnesium ions impose a 
voltage sensitive block on NMDA receptor operated channels 
(Nowak et al.,1984) which reduces the contribution of NMDA 
channels to normal synaptic transmission (Coan and 
Collingridge, 1986). When magnesium is removed, the NMDA 
channel is no longer voltage dependent and is readily 
activated by glutamatergic neurotransmission. When the 
extracellular magnesium concentration is increased to 4mM or 
decreased to 0.4mM, there is a parallel shift of the dose 
response curve which is most likely due to an action of 
Magnesium at voltage sensitive calcium channels and/or a 
surface charge effect. When magnesium is omitted altogether, 
NMDA receptor operated channels are also activated,
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resulting in a large increase in neuronal excitability. This 
is the most likely explanation for the large reduction in 
adenosine inhibition in magnesium free ACSF.
However, the fact that, in some slices, a maximum 
inhibition of the population potential could not be reached 
in magnesium free ACSF, even at concentrations of adenosine 
as high as ImM (Fig. 1.6), suggests that NMDA channel 
activation not only masks the inhibition by adenosine but 
can also actively impair the inhibitory action of adenosine.
The final set of experiments carried out in this study 
lend support to a direct interaction between adenosine and 
NMDA receptors or channels. The addition of a low 
concentration of NMDA (5pM) reduced the level of inhibition 
by adenosine (Table 1.7), while a stable depression of the 
evoked potential by adenosine could be attenuated by NMDA 
(Table 1.8). If it were possible to use higher 
concentrations of NMDA in the presence of adenosine, this 
may have attenuated the action of adenosine further.
However, higher concentrations of NMDA rapidly depressed the 
evoked potential altogether, presumably by depolarizing 
and/or increasing the conductance of the CA1 neurones 
(Collingridge et al.,1983).'Lower NMDA concentrations may 
have been insufficient to overcome the magnesium block 
completely, acting on only a small number of cells where 
magnesium block of NMDA channels was weaker. Alternatively 
the low NMDA concentration may act to reduce the action of 
adenosine, by proposed mechanisms discussed below, but have
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little or no effect on postsynaptic excitability.
The possibility that the reduced adenosine inhibition was 
simply a result of increased cell excitability due to NMDA 
was studied by increasing cell excitability without 
activating NMDA channels. An increased concentration of 
potassium (8.5mM) was used to increase excitability as this 
has been shown to act independently of NMDA channel action 
(Traynelis and Dingledine, 1989) unlike GABA antagonist 
mediated excitability (Dingledine et al.,1986). In the 
presence of 8.5mM potassium and 2-AP5 there was a small but 
significant decrease in the action of adenosine possibly due 
to the increased excitability. When the 2-AP5 was removed, 
however, the action of adenosine was severely attenuated in 
a similar way to that observed in magnesium free ACSF. Thus, 
despite the increased excitability of the CA1 cells, 
adenosine was still able to exert an inhibitory action that 
was only slightly reduced. When the block on NMDA channel 
activation by 2-AP5 was removed, the voltage dependent NMDA 
channels would be activated by potassium depolarization of 
the cell membrane resulting in a reduction in adenosine 
inhibition. This supports the idea that activation of NMDA 
channels directly reduces inhibition by adenosine.
1*4.5.Action of adenosine on spontaneous activity^.
In contrast to the effect of adenosine on the evoked 
potential, determination of the action of adenosine on 
magnesium free induced spontaneous activity demonstrates the 
potent anticonvulsant properties of adenosine. Both
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adenosine and 2-chloroadenosine inhibited epileptiform 
bursts recorded in the CA3 region with IC50 values of 3.6 and
0.25pM respectively. A similar potency was observed on 
bursting recorded in the CA1 region. The original idea for 
looking at adenosine in magnesium free ACSF was to determine 
the reason for the marked difference in potency of adenosine 
between the studies by Ault and Wang (1986) and 
0'Shaughnessy et al.(1988). The potency of adenosine in the 
present study is comparable to that observed by Ault and 
Wang (1986) on bicuculline induced bursts in the hippocampal 
slice and suggests that the difference is not due to the 
different techniques used to induce the bursts. As suggested 
by O ’Shaughnessy et al.(1988) the disparity is more likely 
to reflect the lower density of adenosine receptors found in 
the neocortex (Goodman and Snyder, 1982) or possibly the 
different neuronal networks in the two brain regions.
The main significance of these results is the comparison 
between the action of adenosine on magnesium free 
spontaneous activity and its action on the evoked population 
potentials. If the action of adenosine is dependent on the 
presence of magnesium ions, then the anticonvulsant 
potential of adenosine would be expected to be lower on 
magnesium free ACSF induced bursts as compared to other 
models of epileptiform activity. A possible explanation for 
the difference between adenosine action on spontaneous 
activity and evoked potentials, is that adenosine is acting
a different site or via a different mechanism to reduce
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spontaneous activity. Lee et al.(1984) showed that adenosine 
can inhibit after-discharges observed during antidromic 
stimulation of CA1 pyramidal cells in calcium free ACSF,
i.e. in the absence of synaptic transmission. This strongly 
supports a postsynaptic site of action for adenosine.
The A potassium channel, in particular, is thought to 
control repetitive firing (Segal et al.,1984) and has been 
shown to be responsible for abolishing repetitive firing 
upon addition of adenosine. Schubert and Lee (1986) showed 
that inhibition by adenosine of postsynaptic repetitive 
firing, observed with antidromic stimulation of CA1 
pyramidal cells in low calcium medium, could be abolished if 
the A channel specific blocker 4-aminopyridine was added. 
Tetraethylammonium (TEA), a non-specific potassium channel 
antagonist, had no effect on the anticonvulsant action of 
adenosine. The A potassium channel is a transient, rapidly 
inactivated channel and is inactivated at slightly 
depolarized membrane potentials. The action of adenosine may 
be to hyperpolarize membranes and bring the A channel into 
play to abolish spontaneous activity (Schubert and 
Kreutzberg, 1987). Alternatively, adenosine may act directly 
on the A channel to activate it and abolish spontaneous 
activity. This action of adenosine appears to be distinct 
from the presynaptic inhibitory action of adenosine that is 
involved in inhibiting evoked, synaptically mediated 
activation of cells. It also appears to be unaffected by the 
lack of magnesium ions.
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A recent report by Schubert and Mager (1989), looking at 
changes in extracellular calcium ion concentrations in 
response to repetitive stimuli, showed that postsynaptic 
calcium influx into CA1 pyramidal cells was depressed by 
endogenous adenosine levels in the absence of magnesium.
This they took to indicate that postsynaptic receptors were 
magnesium insensitive, in contrast to presynaptic adenosine 
receptors that appear to be magnesium sensitive (see below, 
Schubert and Kreutzberg, 1987).
A further point that should be noted is that spontaneous 
activity is already regulated by endogenous adenosine. This 
is apparent from the observation that adding adenosine 
antagonists to spontaneously depolarizing slices increases 
the burst firing rate further (Ault and Wang, 1986). Also, 
endogenous adenosine release has been shown to be increased 
by adding glutamate to rat cortical slices (Hoehn and White, 
1989). An increased glutamate release in magnesium free ACSF 
might therefore be expected to increase the endogenous 
adenosine concentration. This may act on the postsynaptic 
adenosine receptors to reduce significantly the spontaneous 
bursts, but not abolish them altogether. Under these 
conditions a very low concentration of added adenosine would 
be sufficient to abolish the bursts altogether. This would 
enhance the potency of adenosine on spontaneous activity, 
but not evoked potentials which appear to be regulated 
mainly by presynaptic magnesium sensitive adenosine action.
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1.4.6.Possible explanations for the reduction in adenosine
inhibition.
The most straightforward explanation for the effects of 
magnesium on adenosine reported in this chapter is that NMDA 
channel activation increases the excitability of the 
pyramidal cells and, as a result, reduces the apparent 
inhibition by adenosine by masking its action. Increased 
postsynaptic NMDA channel activation of CA3 pyramidal cells 
could increase presynaptic neurotransmitter release from 
synapses in the CA1 region as it is the collateral 
projections from the CA3 cells that form the presynaptic 
terminals being studied in this system.
Alternatively, if it is assumed that NMDA channels exist 
on presynaptic nerve terminals (see below), presynaptic 
calcium influx may occur along these channels and 
effectively reduce the presynaptic action of adenosine by 
providing a second route of calcium influx. This would also 
explain why adenosine is unable to abolish synaptic 
transmission totally in magnesium free ACSF as calcium would 
be able to enter via presynaptic NMDA channels regardless of 
the concentration of adenosine applied. The experiments 
where the extracellular calcium concentration was lowered to 
reduce synaptic transmission, failed to restore adenosine 
inhibition to control levels. However, if calcium influx 
does occur across presynaptic NMDA channels, then a 
reduction in calcium availability would not prevent calcium 
influx across the NMDA channel and adenosine action would 
still be unable to reduce the calcium influx. It is also
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possible that the affinity of the NMDA channel for calcium 
may be greater than that of the adenosine regulated calcium 
channels, resulting in calcium influx occurring 
preferentially across the NMDA channel.
It is therefore possible to ascribe all the results of 
this study to an increase in calcium influx across NMDA 
receptor operated channels, but only if the existence of 
presynaptic NMDA channels is assumed. However, the results 
could equally well be ascribed to a direct inhibition of 
adenosine action by NMDA channel activation. A requirement 
for magnesium ions for adenosine action may also be 
involved. Both these possibilities will be discussed in 
detail below.
1.4.6a.A magnesium requirement for the action of adenosine.
From the evidence of the 2-AP5 experiments, it appears 
that the action of NMDA receptor channels significantly 
inhibits the action of adenosine. It should be noted, 
however, that the percentage inhibition by adenosine in 
magnesium free ACSF with prior addition of 2-AP5 is still 
significantly less than control (p<0.05, Table 1.5.). This 
may be due to a small effect from the reduced surface 
charge. However, the original hypothesis, that adenosine 
requires the presence of magnesium ions for it to exert an 
inhibitory action, is still of interest not least because of 
the large body of evidence that supports this possibility. 
These studies, and the possible ways by which magnesium may 
interact with adenosine are discussed below.
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(i) Magnesium requirements of adenosine binding.
In ligand binding studies there is good evidence for a 
regulation of adenosine binding by the ions present in the 
extracellular fluid. Goodman et al.(1982) originally 
demonstrated an effect of divalent cations on adenosine 
receptor binding. Using guinea-pig brain membranes they were 
able to show an enhancement of [3H]CHA binding with 
magnesium, manganese and calcium ions. Manganese was the 
most potent, maximal enhancement of binding occurring at 
0.3mM, while magnesium and calcium effects were maximal at 
ImM. The effect of the cations is to increase the receptor 
affinity as well as increase the number of binding sites, as 
determined by Scatchard analysis. Pretreatment of the 
membranes with EDTA resulted in a 50% loss of receptor 
binding, while addition of the divalent cations enhanced 
binding by 150-170%. Without EDTA pretreatment the cations 
only increased binding by 40%. This indicates that membrane 
bound ions are aiding in adenosine receptor binding.
Gavish et al.(1982) showed that, if bovine brain 
membranes were solubilized to isolate adenosine receptors, 
the enhancement properties of magnesium ions on adenosine 
binding were lost. In a study by Linden et al.(1987) the 
requirement of magnesium for effective ligand binding was 
decreased in solubilized receptors. Either way, the presence 
of magnesium or a suitable divalent cation is required on, 
or adjacent to, the membrane located adenosine receptor for 
maximal binding to take place.
Linden et al.(1987) used rat brain cortical membranes to 
study the effect of MgCl2 and NaCl on 125I-ABA 
(aminobenzyladenosine) binding. Binding to membranes 
pretreated with lOmM EDTA was shown to be MgCl2 dependent 
with concentrations of 2-5mM MgCl2 required for maximal 
binding. The addition of NaCl at concentrations between 30 
and 2000mM reversed the MgCl2 dependent binding with an EC50 
of 200mM. NaCl in the absence of MgCl2 had no effect, 
binding being virtually zero. It is thought that monovalent 
cations, such as Na+, can convert adenosine receptors to a 
medium affinity receptor state while the presence of Mg2+ 
ions maintains the receptor in a high affinity state (Green, 
1984). Conversely, addition of guanine nucleotides and NEM 
converts the receptor to a low affinity state, possibly by 
disassociating the subunits of the G-proteins and thus 
uncoupling the receptors (Asoni and Ogasawara, 1986).
In adipocyte plasma membranes Yeung et al.(1985) found a 
slightly different situation, where addition of magnesium to 
the ligand binding experiments decreased [3H]CHA binding, as 
did the addition of GTP. Scatchard analysis indicated this 
was as a result of decreased receptor number. However, if 
the two were added together, [3H]CHA binding was greatly 
enhanced. The addition of NEM abolished this effect and also 
the effect of magnesium alone, but had no effect on the GTP 
reduction in binding. The authors proposed that a specific 
magnesium site exists that is required for the interaction 
of the adenosine receptor with its effector site, possibly
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at the site of receptor coupling with a G-protein. They also 
reported that sodium ions, when added with magnesium, 
enhanced binding which was additive with the effects of low 
concentrations of GTP.
The effects observed by Yeung et al.(1985) are in 
contrast to those reported by Goodman et al.(1982) and 
Linden et al.(1987). No obvious reason for this is apparent. 
It is possible that there are differences between CNS 
membranes and adipocyte membranes. Alternatively, the fact 
that the membranes were not pretreated with EDTA in the 
study by Yeung et al.(1985) may suggest they were looking at 
an indirect effect of receptor affinity and availability as 
determined by interactions of magnesium and GTP on the 
intracellular side of the membrane, while Goodman et 
al.(1982) and Linden et al.(1987) were looking at an effect 
of divalent cations on direct binding of adenosine to its 
receptor, i.e. an extracellular effect only apparent when 
the membrane bound cations are removed by EDTA. The 
conclusion of Yeung et al.(1985) presupposes an 
intracellular site of action for the interaction of the 
divalent cations with adenosine effector mechanisms, as 
these biochemical processes are known to occur on the inside 
of the plasma membrane. In an intact system it would be 
difficult to conceive of a situation where removal of 
extracellular ions would be sufficient to reduce the ions 
available intracellularly for enzyme interactions, 
Particularly as the loss of adenosine potency is apparent 
after 10-20 minutes in zero magnesium ACSF.
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(ii) Biochemical requirements for magnesium.
The biochemical requirements for magnesium ions also need 
to be looked at as a possible site for interactions of 
magnesium with adenosine. Magnesium acts as a cofactor for a 
number of enzymes, in particular it forms a complex with ATP 
which is important as a cofactor in many biochemical 
reactions (Devlin, 1982). The enzyme 5'-nucleotidase is 
responsible for converting AMP to adenosine. This enzyme is 
inhibited by the presence of ATP and ADP, but not by ATP-Mg 
or ADP-Mg. As the nucleotides readily complex with Mg2+ ions, 
inhibition of 5 1 -nucleotidase is kept under control (Arch 
and Newsholme, 1979). As can be seen in Fig.2, p27,
51-nucleotidase forms a substrate cycle with adenosine 
kinase. If the magnesium ion concentration is reduced, this 
may cause an imbalance in the biochemical homeostasis, 
resulting in an increase in uncomplexed ATP and ADP. The 
increased inhibition of 5'-nucleotidase would reduce the 
formation of adenosine from AMP, while adenosine deaminase, 
which is not affected by magnesium and has a greater Km for 
adenosine than adenosine kinase (Arch and Newsholme, 1979), 
would rapidly break down the available adenosine.
Other enzymes in the adenosine metabolic pathway that 
require magnesium for optimal activity are
hypoxanthineguanine phosphoribosyltransferase (HGPRTase) and 
adenine phosphoribosyltransferase (APRTase) (Devlin, 1982).
A reduction in either of these enzymes would result in a 
decrease in AMP levels, the principal substrate for
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adenosine formation. Thus, in theory at least, a reduction 
in magnesium levels at the biochemical level could lead to 
an imbalance in adenosine metabolism, leading to an overall 
reduction in adenosine availability.
In the context of the present experiments it is possible 
that an imbalance in adenosine metabolism could increase 
adenosine uptake and catabolism such that the added 
adenosine is taken up and broken down, reducing its action 
at the receptor. However, the principal argument against 
this is that 2-chloroadenosine, which is not a substrate for 
the adenosine uptake system (Clanachan et al.,1986), is also 
affected by the lack of magnesium ions. Also, as with the 
ligand binding studies, it is unlikely that magnesium ions, 
particularly intracellularly, would be sufficiently reduced 
in the 10-20 minutes it takes for the adenosine inhibition 
to be reduced, to significantly affect the concentrations of 
nucleotide-Mg complexes, or the other enzymes in the 
metabolic pathways.
The concept of an interaction of magnesium ions with 
adenosine receptors to promote adenosine binding should not 
be dismissed altogether. Ligand binding studies repeatedly 
show that magnesium ions enhance adenosine receptor agonist 
binding. Similarly, other receptors have also been shown to 
be affected by the extracellular ion concentration (Baudry 
and Lynch, 1979; Tsai and Lefkoistz, 1978), and the levels
endogenous metal ions can affect neuronal functions
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(Davidson and Ward, 1988; Chung and Johnson, 1983). It is 
therefore not inconceivable that a ubiquitous neuromodulator 
such as adenosine might be influenced in its actions by the 
endogenous levels of ions, thus explaining some of the 
changes in neuronal functions and excitability. A regulatory 
role for magnesium ions could occur at the extracellular 
adenosine receptor with a specific site on the receptor 
requiring a magnesium ion for the effective binding of 
adenosine to take place. Alternatively, there may be a 
requirement for magnesium ions at the adenosine associated 
channel itself, in a similar manner to the NMDA channel.
1.4.6b.Inhibition of adenosine action by NMDA receptor 
channel activation.
In the present set of experiments the reduction in 
adenosine inhibition can more readily be explained by an 
increase in NMDA receptor operated channel activity. This 
presents the possibility that activation of NMDA channels 
may impair the action of adenosine directly, as opposed to a 
simple masking effect due to increased cell excitability.
An interaction between NMDA receptor operated channels 
and the adenosine effector mechanism is a possibility, 
although the published literature provides only sparse and 
indirect evidence.
An abstract by Stratton et al.(1988) reported a total 
loss of the inhibitory action of adenosine on rat dentate 
Sfyrus population potentials when magnesium was omitted from
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the ACSF. This effect could be prevented by 2-AP5 if added 
before, but not after, the period of magnesium free ACSF. 
Reintroduction of magnesium failed to restore the effect of 
adenosine unless the slice was not stimulated during the 
magnesium free period, indicating that activation of NMDA 
channels was needed to block the action of adenosine.
A recent report that may be linked to an effect of 
adenosine on NMDA channels was a study of the effect of a 
new adenosine antagonist on hippocampal CA3 neurones. 
Alzheimer et al.(1989) reported that addition of the 
specific adenosine antagonist,
8-cyclopentyl-l, 3-dipropylxanthine (DPCPX), resulted in 
spontaneous depolarizations of the CA3 cells that persisted 
even after 2-3 hours of washout of the drug. The addition of 
adenosine induced a hyperpolarization of the cells, apparent 
during intracellular recording. This action was reduced 
during addition of DPCPX but was restored upon washout, 
indicating the DPCPX was not irreversibly bound to the 
adenosine receptors. Similarly, addition of bicuculline 
produced an increase in the number of spontaneous bursts, 
indicating that the irreversible excitability was not due to 
reduced GABAergic activity. One possibility that was not 
explored was that a reduction in purinergic tone may result 
in activation of NMDA channels which, once activated, could 
not be deactivated by restoration of the action of
a d e n o s i n e .
Interesting studies by Schubert and colleagues have 
demonstrated a similar loss of effect of adenosine on 
synaptic calcium influx in magnesium free ACSF (Schubert and 
Kreutzberg, 1987; Schubert and Mager, 1989). These studies 
involved the use of calcium ion sensitive electrodes to 
measure the reduction in extracellular calcium upon rapid 
stimulation of the S .radiatum fibres to the CA1 pyramidal 
cell dendrites of the hippocampal slice. The calcium 
sensitive electrode was placed on the border of the 
S. radiatum and the S . pyramidale to record both presynaptic 
calcium influx and postsynaptic influx into the pyramidal 
cells. In low calcium (0.2mM), high magnesium (4mM) ACSF, 
synaptic transmission is blocked and pre- and postsynaptic 
calcium influx, theoretically, can be differentiated with 
orthodromic or antidromic stimulation. Under these 
conditions, adenosine (40pM) gave a 25% drop in the calcium 
signal during orthodromic stimulation, while antidromic 
stimulation produced only a 7% decrease. With normal levels 
of calcium (2mM) and magnesium (2.4mM) synaptic transmission 
was present and orthodromic stimulation resulted in a 
decrease in the calcium signal, representative of calcium 
uptake into presynaptic terminals and postsynaptic cells. 
Addition of 20pM adenosine reduced the drop in the calcium 
signal, indicating a decrease in calcium influx. Omitting 
magnesium from the ACSF led to a large increase in calcium 
influx and the addition of 20pM adenosine had no effect on 
the calcium influx in magnesium free ACSF. This observation 
supports the idea that the loss of adenosine inhibition in
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the present experiments is not simply a masking effect but a 
real loss of the ability of adenosine to inhibit presynaptic 
calcium influx in magnesium free ACSF.
In the report by Schubert and Kreutzberg (1987) the 
addition of theophylline (50pM) under the low magnesium 
conditions resulted in a further increase in calcium influx 
above that caused by magnesium free ACSF. The addition of 
2-AP5 blocked a large proportion of the increased calcium 
influx seen in magnesium free ACSF, while the addition of 
theophylline in the presence of 2-AP5 did not increase 
calcium influx further, indicating that endogenous adenosine 
is antagonizing an increase in calcium influx elicited by 
NMDA receptors.
Thus, it appears that endogenous adenosine can impose a 
tonic inhibition on activation of NMDA receptor channels, 
but this action is lost when NMDA channels are activated
by removing the magnesium ion block, as added adenosine is 
unable to reduce the 2-AP5 sensitive calcium influx. A 
proportion of NMDA channels might still be expected to be 
blocked by magnesium as it is unlikely that magnesium free 
ACSF will wash out the magnesium from all the NMDA channels. 
When theophylline is added the endogenous adenosine 
inhibition on the remaining NMDA channels may be removed and 
the calcium influx thus increased. The addition of 2-AP5 
blocks the enhancing action of theophylline on calcium 
influx supporting the idea of an action at NMDA receptor 
operated channels. This is the interpretation of the results 
suggested by Schubert and colleagues.
However, the possible limitations of this technique 
should be considered. The measured decrease in extracellular 
calcium cannot safely be attributed solely to influx into a 
specific cell type. In particular, glial cells can take up 
calcium (Hertz et al.,1989), and basket cells and other 
neuronal fibres may also take up calcium in response to the 
high frequency electrical stimulation. The evidence given by 
Schubert and colleagues to support the idea that calcium 
influx is into neuronal cells and not into other cells is 
the fact that anti- and orthodromic stimulation gives 
markedly different changes in the calcium signal, suggesting 
that calcium uptake is into different cell types or across 
different numbers of channels as might occur between pre- 
and postsynaptic regions. Similarly, changes due to 
experimental manipulations vary between the two forms of 
stimulation, and the size of the calcium signal also 
correlates well with the size and quality of the evoked 
potentials.
If the assumptions associated with this technique are 
accepted then these experiments provide evidence for a 
presynaptic action of adenosine on calcium influx and a 
magnesium sensitive component of adenosine action that may 
involve an interaction with NMDA receptor channels.
From the experimental evidence discussed above a 
postulated mechanism, for the loss of adenosine inhibition 
observed in the present experiments, can be put forward.
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Activation of NMDA channels in magnesium free ACSF may 
reduce the inhibitory action of adenosine, not simply due to 
increased excitability/ as adenosine is unable to produce a 
100% reduction in the evoked population potential in the 
absence of magnesium (Fig.1.6), but by actively impairing 
the functional effects of adenosine.
An interaction between adenosine and NMDA receptor 
mediated events would, presumably, require the receptors to 
exist in close proximity to each other. NMDA receptors are 
assumed to exist predominantly on the postsynaptic membrane, 
acting in response to presynaptic amino acid release (Fagg 
et al.,1986), while the adenosine receptors in this study 
are assumed to exist presynaptically. However, there is 
limited evidence for the existence of presynaptic NMDA 
receptors which could interact directly with presynaptic 
adenosine receptor sites. Collingridge et al.(1983) observed 
that high doses of iontophoretically applied NMA produced a 
2-AP5 sensitive reduction in the presynaptic fibre volley of 
CA1 evoked potentials. This suggests that either NMDA 
receptors exist presynaptically or that postsynaptic NMDA 
activation can reduce presynaptic activity. Errington et 
al.(1987) showed that 2-AP5 at high concentrations 
(50-l00pM) could reduce calcium dependent, potassium evoked 
[14C]glutamate release from rat dentate gyrus slices. This 
indicated that NMDA receptors could promote glutamate 
release from, presumably, presynaptic terminals, suggesting 
the existence of presynaptic NMDA receptors.
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Similarly, Arvin et al.(1986) showed that NMDA can 
increase the level of intracellular free calcium of rat 
brain synaptosomes as determined by quin 2. This increase 
was blocked by magnesium and 2-AP5. They argued that this 
indicated a presynaptic site of action for NMDA.
Thus it can be hypothesised that a population of 
presynaptic NMDA receptor operated channels act to reduce 
the presynaptic action of adenosine. This may occur via a 
number of speculative mechanisms.
Adenosine and NMDA may act at the same presynaptic 
calcium channel with opposing actions on calcium influx. 
However, the NMDA receptor operated channel is directly 
regulated by magnesium ions and is normally inactive during 
synaptic transmission (Coan and Collingridge, 1987), while 
exogenous adenosine is able to block synaptic transmission 
completely and so presumably acts at a calcium channel that 
plays a major role in synaptic transmission. It is possible
that the NMDA and adenosine receptor associated channels are
closely associated and activation of the NMDA associated 
channel is able to reduce the action of adenosine on its 
channel. Stratton et al. (1988) suggested that protein 
kinase c activation may be involved in inhibition of 
adenosine action by NMDA channel activation. Addition of 
Phorbol esters, which activate protein kinase C, to 
hippocampal slices blocked the action of adenosine on 
dentate gyrus potentials in a similar manner to that
observed when NMDA channels were activated.
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Another possibility is a direct or allosteric interaction 
at a common binding site. However, there is no evidence, to 
my knowledge, of an interaction between adenosine and NMDA 
in binding studies. Studies of direct NMDA binding provide 
only poor results possibly due to the transient nature of 
NMDA binding to this receptor (Foster and Fagg, 1984). The 
use of radiolabelled NMDA antagonists or [3H]L-glutamate 
binding in the presence of NMDA antagonists can be used to 
distinguish NMDA binding sites indirectly (Cotman et 
al.,1987). Studies of NMDA on adenosine binding may also 
prove of interest. However, the fact that 2-AP5 had no 
effect on adenosine inhibition or cell excitability if added 
after magnesium had been removed suggests that it is the 
open NMDA calcium channel, rather than the receptor, which 
affects the inhibitory action of adenosine.
Alternatively, postsynaptic NMDA receptor activation may 
be able to affect presynaptic adenosine action by some, as 
yet undefined, mechanism (Collingridge and Bliss, 1987). 
Current research into the mechanisms of long term 
potentiation (LTP) is focussing on specific proteins (Fazeli
al.,1988) and arachidonic acid (Lynch et al.,1989) that 
are released when LTP is triggered. These are hypothesized 
to act as retrograde messengers that are released from a 
postsynaptic site and pass to the presynaptic membrane to 
regulate neurotransmitter release. It is possible that a 
similar system exists that exerts an inhibitory action on 
presynaptic adenosine receptors when postsynaptic NMDA
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receptor channels are activated. Indeed, LTP may be one 
system where a regulation of adenosine receptor action may 
be of benefit (see general discussion), and the retrograde 
messengers being studied in relation to LTP may also prove 
to act on adenosine.
Finally, a postsynaptic activation of NMDA receptors 
might also affect postsynaptic adenosine action, possibly 
reducing or overriding the hyperpolarization of the 
postsynaptic membrane by adenosine. However, the fact that 
adenosine is effective against magnesium free spontaneous 
depolarizations, presumably by a postsynaptic action as 
discussed earlier, argues against this possibility.
In this discussion an attempt has been made to discuss in 
detail the possible mechanisms by which a reduction in 
extracellular magnesium might influence the inhibitory 
action of adenosine. An inhibition of adenosine action by 
NMDA receptor activation is an interesting possibility, 
although one that is so far supported by indirect evidence 
only. The possible benefits that an interaction of this type 
might have in vivo will be discussed in the general 
discussion.
CHAPTER 2
130
CHAPTER 2
INTERACTIONS BETWEEN ADENOSINE AND THE DIHYDROPYRIDINE 
CALCIUM CHANNEL BLOCKERS.
2.1. INTRODUCTION
The action of adenosine in reducing synaptic transmission 
is strongly associated with a reduction in neurotransmitter 
release which involves, in some way, a regulation of calcium 
mobilization at the site of neurotransmitter release. This 
action has led to adenosine analogues being referred to as 
"calcium antagonists" (Silinsky, 1981). The other 
established organic calcium channel antagonists, the 
phenylalkylamines, dihydropyridines and benzothiazepines, 
are potent blockers of calcium influx into muscle and 
cardiac tissue but appear to have only weak or undetectable 
effects on neuronal calcium channels. As discussed in the 
main introduction the dihydropyridines, in particular, bind 
to multiple high affinity binding sites in the central 
nervous system (Gould et al.,1982) but appear to have no 
effect on calcium influx (Daniell et al.,1983) or only act 
on a small population of calcium channels in neuronal tissue 
(Thayer et al.,1986) .
However, a number of studies, mainly involving ligand 
binding, have reported an interaction between adenosine 
teceptor binding and the dihydropyridines. This reveals a 
potent displacement of adenosine receptor ligands by the 
dihydropyridines, in particular nifedipine and BayK 8644
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(Murphy and Snyder, 1983; Hu et al.,1987). On the other hand, 
the few functional studies that have been carried out show a 
marked enhancement of the effect of adenosine on neuronal 
firing by nifedipine (Phillis et al.,1984). This appears to 
be related to a reduction in adenosine uptake in the 
presence of the dihydropyridines (Phillis et al.,1984;
Morgan et al.,1987). However,the action of R-PIA on 
noradrenaline release from hippocampal slices was reduced by 
BayK 8644 but not nifedipine. (Fredholm et al.,1986).
These interactions, between adenosine and the 
dihydropyridines, may explain some side effects of the 
dihydropyridines in clinical use. Nifedipine is of 
particular interest. This drug is used clinically to treat 
chronic angina and is also effective in the treatment of 
hypertension, achalasia (chronic constriction of the stomach 
cardiac sphincter muscle), and Raynauds syndrome (prolonged 
vasoconstriction of the arterioles in the extremities). The 
prophylactic effects on these conditions occur via a block 
of slow calcium channels, resulting in smooth muscle 
relaxation. However, the use of nifedipine has a much higher 
incidence of side effects than the other established calcium 
blockers, verapamil and diltiazem (Swanson and Green, 1985). 
In particular, the use of nifedipine to treat angina has 
been reported to increase anginal pain and even induce 
myocardial ischaemia in a small percentage of cases in 
clinical studies (Stone et al.,1983; Boden et al.,1985). The 
Possible cause of this detrimental side effect has been
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studied in animal models and suggests that nifedipine 
interferes with the regulation of coronary blood flow by 
adenosine. Merrill et 31.(1983), using an in vivo canine 
heart preparation to study coronary blood flow, showed that 
coronary vasodilatation induced by added adenosine could be 
significantly attenuated by nifedipine. Adenosine is 
released in response to a brief period of myocardial 
ischemia induced by coronary artery occlusion. The addition 
of nifedipine inhibited the post ischaemic blood flow 
increase (reactive hyperaemia) indicating that nifedipine 
also blocks the action of endogenous adenosine. A similar 
effect on reactive hyperaemia was observed on rat cerebral 
blood flow (Phillis et al.,1986).
A recent study by Borea et al. (1989) has also 
demonstrated the interaction between the dihydropyridine 
calcium channel agonist BayK 8644 and adenosine analogues in 
guinea pig atria. The A 1 adenosine receptor analogues R-PIA, 
CHA and NECA, but not the A2 agonist CV1808, reduced the 
contractile tension and the frequency of spontaneous beating 
of the atria while BayK 8644 enhanced these effects. However 
the adenosine analogues antagonized the positive inotropic 
effects of BayK 8644 when added together. Thus, adenosine 
analogues can interact with both dihydropyridine calcium 
agonists and antagonists. This appears to occur at the A1 
receptor, at least in the heart. [3H]nitrendipine binding 
studies indicated this interaction was not direct 
competitive inhibition at the dihydropyridine receptor.
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Other effects of nifedipine, both beneficial and 
detrimental, can also be attributed to the effects on 
adenosine. Tourette's syndrome, thought to be a disorder of 
purine metabolism in the CNS (Van Woert et al.,1977), has 
been successfully treated with nifedipine. As nifedipine 
itself is relatively inactive in central neuronal 
preparations (Phillis et al.,1984; Daniell et al.,1983; this 
chapter) it is possible that nifedipine is potentiating the 
action of endogenous adenosine to alleviate the symptoms of 
Tourette's syndrome.
It is not clear what interactions are occurring in these 
systems. If nifedipine is acting to reduce the action of 
adenosine, possibly by displacing it from its receptor, then 
this would explain the observations in the heart preparation 
where nifedipine blocks the vasodilatory action of adenosine 
in coronary arteries (Merrill et al.,1983). However, if 
nifedipine is acting by inhibiting adenosine uptake and 
thereby increasing its potency, this would explain any 
beneficial effects it may be having on conditions where 
purine metabolism is impaired, such as Tourette's syndrome. 
There may also be a functional difference between the 
peripheral and central actions of nifedipine on adenosine.
As nifedipine is also known to affect ATP action (Bulloch 
and McGrath, 1988; Stone, 1981b) and is thought to be active 
mainly on peripheral neurones, it is possible that the 
action of nifedipine in peripheral tissues is being elicited 
via an action on ATP, rather than adenosine, while an
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adenosine / nifedipine interaction, different from that 
exerted on ATP, is involved in the CNS.
These proposed interactions of the dihydropyridines with 
the adenosine system are still very speculative, 
particularly in relation to the prophylactic effects of 
these drugs in certain conditions. However, these 
interactions with adenosine will hopefully lead to a better 
understanding of the actions of adenosine and possibly may 
provide a route towards utilizing drugs that alter the 
action of adenosine for clinically beneficial purposes.
The initial aim of this study was to try and determine a 
common effect between adenosine and the dihydropyridines on 
calcium associated events. As nifedipine has been shown to 
reduce electrically induced epileptiform activity in vivo 
(Meyer et al., 1986*0, the action of nifedipine on 
epileptiform bursts was determined. Also, as no published 
studies have reported the effect of adenosine analogues and 
the dihydropyridines on electrophysiological population 
potential studies, it was decided to try and resolve the 
rather confusing, and apparently conflicting, information by 
looking at the effect of a range of adenosine analogues and 
calcium channel blockers on evoked population potentials in 
the hippocampal slice.
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2.2. MATERIALS and METHODS.
2.2.1.Compounds.
Dihydropyridines were a gift from Bayer. BayK 8644 was a 
gift from Dr.Franckowiak.
The dihydropyridines were dissolved in ethanol as a lOmM 
stock, and protected from light. Fresh stock solutions were 
made up each day.
2.2.2.Methods.
The preparation of hippocampal slices, and the recording 
of orthodromic evoked population potentials from the CA1, or 
spontaneous activity from the CA3, were carried out as 
described in chapter 1.
Dihydropyridines and adenosine analogues were bath 
applied via the gravity feed system.
All experiments were carried out under sodium lamp 
lighting to protect the light sensitive dihydropyridines.
All results are expressed as mean ± standard error of the 
mean (sem) unless stated otherwise. Statistical significance 
was determined using a paired sample t-test on the Oxstat 
statistical analysis computer programme.
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2.3. RESULTS.
2.3.1.The action of nifedipine on spontaneous epileptiform 
activity.
The ability of the dihydropyridine, nifedipine to block 
calcium channels in the hippocampal slices was assessed by 
determining its effect on epileptiform activity induced by 
magnesium free ACSF in the CA3 region of the hippocampal 
slice. (Fig.2.1.).
Initial results were very erratic due to the sensitivity 
of the bursts to small changes in ACSF flow rate and 
temperature. This was kept to a minimum by using the same 
perfusion tube for control and test solutions and ensuring 
the separate beakers were at the same height in the gravity 
feed system. Despite this, small variations were seen when 
the solutions were changed even when no drug was present.
This explains the variability between the different 
nifedipine concentrations. No significant or consistent 
effect on the burst frequency was observed with nifedipine.
Single experiments were carried out with BayK 8644, 
nitrendipine and nimodipine (data not shown). No significant 
effects on magnesium free ACSF induced spontaneous activity 
was observed with any of the dihydropyridines.
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Fig. 2.1.The effect of nifedipine on spontaneous activity 
induced by magnesium free ACSF
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Fig.2.1 Bars represent the percentage change in the burst 
frequency with respect to the frequency immediately before 
addition of nifedipine. Burst frequency was determined as 
bursts per minute measured over a 10 minute period. Points 
are mean + sem of 4-8 determinations. **= p<0.05 (PTT).
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2.3.2.The action of dihydropyridines on the evoked CA1 
population potential: Interactions with adenosine and 
adenosine analogues.
The addition of nifedipine at concentrations up to 50pM 
had no effect on the CA1 evoked population potential.
However, when adenosine was added in the presence of 
nifedipine, there was a significant potentiation of the 
inhibitory action of adenosine on the population potential.
The action of adenosine and related analogues on evoked 
CA1 population potentials was determined in the presence of 
various calcium channel blockers, in particular the 
dihydropyridines.
The two compounds that significantly affected the action 
of adenosine and its analogues were the dihydropyridines 
nifedipine and BayK 8644, a calcium channel antagonist and 
agonist respectively.
Dose response curves to nifedipine and BayK 8644 were 
determined (Figs. 2.2-2.3). Control responses to adenosine and 
2-chloroadenosine were determined prior to the addition of 
the dihydropyridines which were allowed to perfuse for 20 
minutes. The effect of the adenosine compounds in the 
presence of the dihydropyridines was then determined. A 30 
minute washout period was allowed between each 
dihydropyridine concentration. At the end of the experiment, 
the dihydropyridines were allowed to wash out for up to 2 
tour. However, a return to control adenosine responses was 
not observed in any of the experiments.
139
Fig. 2.2.The effect of nifedipine and BayK 8644 on the
inhibitory action of 2-chloroadenosine.
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Fig 2.2 a. Effect of nifedipine on the percentage decrease 
of the CA1 population potential by 0.5pM 2-chloroadenosine. 
Points are mean +- sem of 8-14 determinations. ***= p<0.001 
(PTT) .
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Figs 2.2b. Effect of BayK 8644 on the percentage decrease 
°f the population potential by 0.5pM 2-chloroadenosine. 
Points are meant sem of 8-14 determinations. **= P<0.05 
(PTT) .
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Fig. 2.3.The effect of nifedipine and BayK 8644 on the
inhibitory action of adenosine.
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Fig 2.3 a. Effect of nifedipine on the percentage decrease 
of the population potential by 25 pM adenosine. Points are 
mean + sem of 8-14 determinations. **= P<0.05, ***= p<0.01 
(PTT).
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Responses to cyclohexyladenosine (CHA) and 
R-phenylisopropyladenosine (R-PIA), A1 specific agonists, 
and to N-ethylcarboxamidoadenosine (NECA), an agonist with 
partial affinity for the A2 receptor, were also determined. 
The use of CHA and R-PIA as agonists was complicated by the 
long onset and longer washout periods of these drugs. The 
length of time required for a concentration of compound that 
gave a submaximal inhibition to attain a steady depression 
of the potential varied between 17 and 38 minutes 
(Mean 26 ± 1.7, n=9 for CHA at 50nM). Washout times were 
longer, requiring up to 60 minutes for recovery to control 
levels, with some slices failing to attain complete 
recovery. To overcome this problem, comparable studies were 
performed using two separate, but matched, slices from the 
same area of the hippocampus. The percentage decrease by the 
analogues was determined in both slices, one in the presence 
of lOpM nifedipine.
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Fig. 2.4. The effect of nifedipine on the inhibitory action
of other adenosine analogues.
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Fig.2.4a. Bars represent the percentage inhibition of the 
population potential by N-ethylcarboxamidoadenosine (250nM) 
in the presence or absence of lOpM nifedipine. Mean ± sem of 
4 determinations. ***=p<0.01. (PTT).
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Pig.2.4b. Bars represent the percentage inhibition of the 
population potential by cyclohexyladenosine (50nM) in the 
presence or absence of lOpM nifedipine. Mean + sem of 6 
determinations. *** = P<0.001 (PTT).
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Fig.2.4c. Bars represent the percentage inhibition of the 
population potential by R-phenylisopropyladenosine (lOOnM) 
in the presence or absence of lOpM nifedipine. Mean + sem of 
6 determinations. *** = P<0.001 (PTT)
144
2.3.3. The effect of increasing concentrations of 
2-chloroadenosine on the blocking action of nifedipine.
To determine whether the loss of 2-chloroadenosine 
inhibition was due to a down regulation of adenosine 
receptors or irreversible binding of nifedipine, increasing 
concentrations of 2-chloroadenosine were added in the 
presence of nifedipine (Fig.2.5.).
The antagonism by nifedipine of the inhibitory action of 
2-chloroadenosine could be overcome by increasing the 
concentration of 2-chloroadenosine. Concentrations of 5pM or 
greater were required to obtain levels of inhibition 
comparable to control.
After nifedipine perfusion had been discontinued, the 
percentage decrease of the potential by 2-chloroadenosine 
did not recover to control levels even after 2 hours 
perfusion with control ACSF. However, if increasing 
concentrations of 2-chloroadenosine were added in the 
post-nifedipine period, the potential could be abolished at 
concentrations of 5pM and above. Once the 2-chloroadenosine 
had been washed out pre-nifedipine responses to 
2-chloroadenosine (0.5pM) were restored.
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Fig. 2.5.The action of increasing concentrations of 
2-chloroadenosine on the population potential in the 
presence of nifedipine.
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Bars represent the percentage decrease in the population 
potential by 2-chloroadenosine. Mean + sem of 5 
determinations. *** = P<0.001 (PTT).
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2.3.4. The action of nifedipine in the presence of adenosine 
and 2-chloroadenosine.
Experiments were carried out to determine whether 
nifedipine could exert an effect when adenosine and 
2-chloroadenosine were already present.
The addition of 25pM adenosine produced a 35 + 4.3% (n=5) 
decrease of the population potential. When lOpM nifedipine 
was added in the presence of adenosine, the potential was 
gradually reduced by 75 + 4.9% (n=5) over a period of 
28 +_ 1.9 minutes (n=5).
2-chloroadenosine (0.5pM) inhibited the population 
potential by 63 + 2.3 (n=5). The addition of nifedipine 
(lOpM) with 2-chloroadenosine resulted in a gradual recovery 
of the potential to control levels over 37-50 minutes 
(43 ± 2.8, n=5).
Figures 2.6a & b show the change in the population 
potential size over time for a . single, representative 
experiment.
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Fig. 2.6. Change in the inhibitory action of adenosine and
2-chloroadenosine upon addition of nifedipine.
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Fig 2.6a. The change in the size of the CA1 evoked 
population potential over time with 2-chloroadenosine and 
nifedipine. Points represent the size of~tITe potential as a 
percentage of the control potential size (100%). Values are 
taken from one representative experiment only.
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Fig 2.6b. The change in the size of the CA1 evoked 
population potential over time with adenosine and 
nifedipine. Points represent the size of-the potential as a 
percentage of the control potential size (100%). Values are 
taken from one representative experiment only.
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2.3.5.The effect of other calcium channel antagonists on 
adenosine and 2-chloroadenosine.
The effect of the dihydropyridines, nimodipine and 
nitrendipine and the phenylalkylamine, verapamil on the 
inhibitory action of adenosine and 2-chloroadenosine was 
determined.
These compounds had a largely non-significant effect on 
the action of adenosine or 2-chloroadenosine, although there 
was a small but significant increase in the level of 
inhibition by both adenosine and 2-chloroadenosine in some 
experiments.
Verapamil itself depressed the population potential when 
added at concentrations of 20pM and above, so any increase 
in inhibition by adenosine in the presence of verapamil 
cannot be attributed to an interaction between the two 
compounds.
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Fig. 2.7 The effect of nitrendipine on the inhibition of the 
CAl population potential by adenosine and 2-chloroadenosine.
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Figs 2.7a. Effect of nitrendipine on the percentage decrease 
of the population potential by 25pM adenosine. Points are 
mean ± sem of 4 determinations. * = P<0.1 (PTT)
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Figs 2.7b. Effect of nitrendipine on the percentage decrease 
of the population potential by 0.5pM 2-chloroadenosine. 
Points are mean + sem of 4 determinations.
Fig. 2.8. The effect of nimodipine on the inhibition of the
CAl population potential by adenosine and 2-chloroadenosine.
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Figs 2.8a. Effect of nimodipine on the percentage decrease 
of the population potential by 25pM adenosine. Points are 
mean + sem of 4 determinations.
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Pigs 2.8b. Effect of nimodipine on the percentage decrease 
of the population potential by 0.5pM 2-chloroadenosine. 
Points are mean + sem of 4 determinations. ** = P<0.05 
(PTT) .
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Fig 2.9. The effect of verapamil on the inhibition of the
population potential by 2-chloroadenosine.
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The effect of verapamil on the percentage decrease of the 
CA1 evoked population potential by 0.5pM 2-chloroadenosine. 
Bars represent the mean ± sem of 5 determinations.
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2.3.6 The action of nifedipine on the anticonvulsant 
properties of adenosine and 2-chloroadenosine.
The original experiments showed that nifedipine had no 
effect on spontaneous activity induced by magnesium free 
ACSF in the CA3 region of the hippocampal slice. Adenosine, 
on the other hand, is a potent anticonvulsant in this model 
of epilepsy. The effect of adenosine and 2-chloroadenosine 
on spontaneous activity was determined in the presence of 
nifedipine for comparison with the above studies.
Control responses to adenosine or 2-chloroadenosine were 
determined in triplicate to ensure the percentage depression 
of burst frequency remained constant. Nifedipine was then 
added for 10 minutes and the adenosine responses repeated.
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Fig.2.10.The effect of nifedipine on the inhibition of 
magnesium free ACSF induced CA3 spontaneous activity by 
adenosine and 2-chloroadenosine.
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Figs 2.10a. Effect of nifedipine on the percentage decrease 
of magnesium free induced bursts by 5pM adenosine. Burst 
frequency was recorded over 10 minutes. Bars represent the 
mean + sem of 5 determinations. *** = P<0.01 (PTT).
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Figs 2.10b. Effect of nifedipine on the percentage decrease 
of magnesium free induced bursts by 0 . 5pM 2-chloroadenosine 
Burst frequency was recorded over 10 minutes. Points are 
mean + sem of 5 determinations. *** = P<0.001 (PTT).
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For a comparison with the magnesium free bursts, and to 
ensure that the observed effect of nifedipine was not due to 
the absence of magnesium, the experiments were repeated 
using raised extracellular potassium (8.5mM) to induce 
spontaneous activity. For these experiments a stable 
decrease in burst frequency was established with adenosine 
or 2-chloroadenosine. Nifedipine (lOpM) was then added with 
the adenosine compounds still present (Fig.2.11).
Nifedipine itself had no significant effect on the bursts 
induced by magnesium free ACSF or high potassium.
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Fig.2.11.The effect of nifedipine on the inhibition of 8.5mM
potassium induced CA3 spontaneous activity by adenosine and 
2-chloroadenosine.
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Figs 2.11a. Effect of nifedipine on the percentage decrease 
of 8.5mM potassium induced bursts by 5pM adenosine. Burst 
frequency was recorded over 10 minutes. Bars represent the 
mean ± sem of 5 determinations. *** = P<0.01 (PTT).
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Figs 2.11b. Effect of nifedipine on the percentage decrease 
°f 8.5mM potassium induced bursts by
0•5pM 2-chloroadenosine. Burst frequency was recorded over 
10 minutes. Points are mean ± sem of 5 determinations.
*** = P<0.001. (PTT).
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Similar experiments were carried out to determine the 
effect of verapamil on the action of adenosine on magnesium 
free ACSF induced bursts.
As verapamil itself inhibited the spontaneous activity 
(Fig 2.12c.)/ the apparent increase in the percentage 
inhibition in the presence of 25pM verapamil was probably 
due to the overall reduction in burst frequency, rather than 
any direct effect on the action of adenosine or 
2-chloroadenosine by verapamil.
I
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Fig. 2.12 The effect of verapamil on inhibition of magnesium 
free ACSF induced spontaneous activity by adenosine and 
2-chloroadenosine.
20-
10-
TJ
oontrol
verapamil
Fig. 2.12a. Effect of verapamil on the percentage decrease 
of magnesium free induced bursts by 5pM adenosine. Bars 
represents the mean +. sem of 3 determinations. ** = P<0.05 
(PTT).
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Figs 2.12b. Effect of verapamil on the percentage decrease 
of magnesium free induced bursts by 0.5pM 2-chloroadenosine. 
Bars represent the mean ± sem of 3 determinations.
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Fig. 2.12c. The effect of verapamil on magnesium free ACSF 
induced bursts. Points are mean ± sem of 3 determinations.
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2.3.7.The role of adenosine uptake in increasing the level 
of adenosine inhibition in the presence of nifedipine.
The key observation of these experiments was the 
difference between the effect of nifedipine and BayK 8644 on 
adenosine as compared to its analogues, the effect of 
adenosine being potentiated while the effect of the 
analogues was attenuated.
The contribution of the adenosine uptake system to the 
effect of nifedipine on adenosine was determined. A low 
concentration of adenosine (lOpM) was added and a stable 
inhibition of the evoked CA1 population potential was 
obtained. Dipyridamole (lOpM), an adenosine uptake blocker, 
was then added in the presence of the adenosine. This 
resulted in a significant increase in the level of 
inhibition by adenosine. The addition of dipyridamole to a 
slice on its own also resulted in a depression of the 
potential, presumably as a result of blocking endogenous 
adenosine uptake. Nifedipine (lOpM) was then added to the 
adenosine and dipyridamole. The result was a significant 
decrease in the level of inhibition but not to 
pre-dipyridamole levels.
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Fig. 2.13. The effect of nifedipine on adenosine in the 
presence of an adenosine uptake blocker.
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Bars represent the percentage decrease of the CA1 evoked 
population potential by lOpM adenosine in the presence of 
dipyridamole and dipyridamole plus nifedipine. Values are 
mean + sem of 6 determinations. * = P<0.1/ ** = P<0.05
(PTT). Inhibition by dipyridamole plus nifedipine is not 
significantly different from control.
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2.4. DISCUSSION
It is apparent from the results reported in this chapter 
that the dihydropyridines have little effect on evoked or 
spontaneous neuronal activity in the hippocampal slice. In 
magnesium free ACSF/ the principle initiator of spontaneous 
activity is an influx of calcium across voltage dependent 
and/or NMDA operated calcium channels. If the 
dihydropyridines have any effect on these channels then a 
change in the burst frequency would be expected to occur.
Some studies have reported that a small proportion of 
calcium channels in neuronal tissue may be affected by the 
dihydropyridines (Docherty and Brown, 1986), but these 
appear to play no part in the activation of spontaneous 
activity or evoked synaptic transmission. Other reports of 
the action of the dihydropyridines on epileptiform models 
are limited and largely negative. Frank et al.(1988) showed 
that epileptiform bursts induced in the rat hippocampal 
slice by caffeine, 4-aminopyridine and penicillin were all 
unaffected by nifedipine at concentrations up to lOOpM.
Studies of the dihydropyridines on epileptic seizures in 
vivo have shown a varied action. Vezzani et al.(1988), 
studying limbic seizures in rats induced by injections of 
kainic or quinolinic acid into the hippocampus, found that 
nifedipine injected intraperitoneally at 40mg/kg was 
ineffective against the seizures. However, nifedipine was 
effective against kindled seizures, blocking them completely 
at 40mg/kg. In similar in vivo studies in rabbits,
systemically administered nimodipine was effective against 
seizures induced by electrical stimulation of the cortical 
surface (Meyer et al.,1986a), seizures induced by cefazolin 
(Morocutti et al.,1988) and seizures induced by ischemia, 
bicuculline and pentylenetetrazol (Meyer et al.,1986b).
Thus, it appears that the dihydropyridines are able to 
prevent or inhibit seizures in some animal models of 
epilepsy. However, as all the in vivo models involved 
peripheral administration of the dihydropyridines, it is 
possible that peripheral actions of the dihydropyridines, 
such as an increase in cerebral blood flow, were responsible 
for the attenuation of the bursts. In the study by Vezzani 
et al.(1988), the use of kainic or quinolinic acid produced 
bursts that were unaffected by nifedipine. Quinolinic acid 
activates NMDA receptors to produce seizures, as is the case 
with magnesium free ACSF, so nifedipine appears to have no 
effect on excitatory amino acid mediated epileptiform 
activity.
However, when the action of the calcium channel blockers 
on evoked or spontaneous activity is studied in conjunction 
with adenosine, there is a clear interaction between the 
inhibitory action of adenosine and its analogues, and the 
dihydropyridine class of calcium antagonists. This appears 
to involve more than one type of interaction, as the effects 
of the dihydropyridines on adenosine is the opposite of that 
observed with the adenosine analogues. The dihydropyridines 
sre known to bind to distinct, high affinity binding sites
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in brain tissue (Belleman et al.,1983) which may be 
associated with calcium channels (Skattebol and Triggle, 
1987). However, it does not appear that the dihydropyridines 
are exerting an effect on adenosine via a direct action on 
calcium channels as both the dihydropyridine channel 
antagonist (nifedipine) and agonist (BayK 8644) exert the 
same effect on adenosine. Also, verapamil, that has a weak 
effect on neuronal calcium channels, but stronger than the 
dihydropyridines (Wei and Chang, 1986; White and Bradford, 
1986), had no effect on adenosine. As adenosine is thought 
to act via calcium channels, the possibility arises that 
receptors for adenosine and the dihydropyridines may occur 
in close proximity, possibly associated with the same 
calcium channel.
The action of the dihydropyridines on adenosine was to 
increase the level of inhibition by adenosine. It is 
possible that a small decrease in calcium influx by the 
dihydropyridines, acting as calcium channel blockers, is 
being enhanced by adenosine, resulting in an apparent 
increased inhibition by adenosine. The dihydropyridines on 
their own do not decrease the evoked potential, but the 
fiction of adenosine may be to enhance the weak effect of the 
dihydropyridines and increase the total inhibition on 
calcium channels. However, this does not seem likely as both 
the calcium channel antagonist and the agonist BayK 8644 
had the same effect on adenosine. Also, the effect of the 
dihydropyridines on the adenosine analogues is to reduce
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their inhibitory action, an effect that cannot readily be 
explained by a decreased calcium influx. The evidence for an 
action of dihydropyridines on neuronal calcium channels is 
also very poor. Thus, an inhibition of calcium channels by 
the dihydropyridines, to explain the increased inhibition by 
adenosine, can effectively be ruled out.
Another possibility that needs to be considered is that 
the increase in the inhibition by adenosine may be due to a 
simple decrease in the viability of the slice, which does 
occur after a number of hours (>6) at 30°c. However, this 
can be ruled out for a number of reasons. The increased 
inhibition by adenosine occurred immediately after a 20 
minute period of perfusion with nifedipine or BayK 8644, too 
rapid to be due to slice deterioration. There was no 
decrease in the normal potential size, which is usually 
observed in deteriorating slices. The ethanol vehicle had no 
effect on adenosine, even at 1%, a concentration higher than 
that used for vehicle (0.1%). A series of experiments were 
carried out where nifedipine was added in the presence of 
adenosine (Fig.2.6a). The presence of nifedipine gradually 
increased the inhibition of the population potential by 
adenosine. This indicates that the enhanced effect of 
adenosine is due to the nifedipine and not to any decrease 
in slice viability.
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The effect of the dihydropyridines on the adenosine 
analogues was to attenuate the inhibition of the population 
potential by the analogues. This response does not suggest 
an inhibition of calcium influx, although a number of other 
possible effects can be considered.
A simple chemical interaction in the ACSF was considered. 
It is always possible that when two compounds are mixed in 
solution, one may affect the other so as to impair its 
activity. This possibility was eliminated by adding ACSF 
containing 2-chloroadenosine and nifedipine direct to the 
perfusion system. The potential was decreased by the same 
percentage as with 2-chloroadenosine alone. This indicates 
that; 1) there is no inactivation of the 2-chloroadenosine 
by nifedipine, 2) the effect of nifedipine is not an 
immediate interaction, but requires time to bind to its own 
receptor or displace 2-chloroadenosine from the adenosine 
receptor.
It is also possible that there is an apparent 
desensitization per se of the adenosine receptors to explain 
the loss of response to the adenosine analogues. This seems 
unlikely as consistent responses to 2-chloroadenosine and 
NECA were performed in triplicate before the addition of 
nifedipine and BayK 8644. If a high concentration of the 
dihydropyridines (lOpM) was then added and perfused for 10 
minutes or more, the response to subsequent additions of the 
analogues was abolished. Similarly, if 2-chloroadenosine was 
added and maintained for up to 30 minutes after a maximal
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inhibition had been achieved, there was no reduction in the 
percentage inhibition. If, however, nifedipine (lOpM) was 
added while the 2-chloroadenosine was still present, the 
inhibition by 2-chloroadenosine could be totally abolished 
after 37-50 minutes (43 ± 2.8 mins, n=5) (Fig.2.6b). This 
demonstrates that the decreased efficacy of 
2-chloroadenosine is a result of the presence of the 
nifedipine, as opposed to any non-specific "desensitization" 
of adenosine receptors.
The most plausible explanation for the effect of the 
dihydropyridines on adenosine and the adenosine analogues 
can be obtained from studies of the interactions between 
calcium channel antagonists and adenosine compounds.
Murphy and Snyder (1983) were the first to report the 
displacement of [3H]CHA binding by nifedipine. They used rat 
and bovine brain membranes to study the effect of a range of 
calcium channel blockers on [3H]CHA and [3H]DPX 
(1,3-diethyl-8-phenylxanthine) binding. Verapamil and 
diltiazem had no effect on [3H]CHA or [3H]DPX binding, while 
nimodipine and nitrendipine displaced [3H]CHA binding at 
relatively high concentrations only
(IC50: nimodipine = >100pM, nitrendipine = 60pM). However, 
nifedipine potently displaced both [3H]CHA and [3H]DPX with 
an IC50 of 4 and 0.5pM respectively. Studies of 
[3H]nitrendipine binding in both rat heart and brain showed 
that the other dihydropyridines could displace 
[3H]nitrendipine, but verapamil and diltiazem were
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ineffective. This indicates that the dihydropyridines bind 
to a distinct receptor site separate from that at which 
verapamil and diltiazem act. Taking the study one step 
further, Murphy and Snyder determined the Bmax and Hill 
coefficient of the effect of nifedipine on [3H]CHA binding. 
These values did not correlate with a simple competitive 
inhibition and suggested that the dihydropyridines and 
adenosine analogues bind to separate sites, the binding of 
the dihydropyridines possibly allosterically modulating 
adenosine binding.
A study by Phillis et al.(1984) demonstrated functional 
interactions between the dihydropyridines and adenosine by 
showing the ability of nifedipine to attenuate [3H]adenosine 
uptake into rat cortical synaptosomes. This occurred in a 
dose dependent manner with an IC50 of l.lpM for nifedipine.
In the same study the inhibitory action of iontophoretically 
applied adenosine on the acetylcholine stimulated firing of 
single cortical neurones of the rat in vivo, was shown to be 
markedly potentiated by the addition of nifedipine. This 
could be explained by the inhibition of adenosine uptake by 
nifedipine increasing the level of endogenous adenosine.
In a later study by Fredholm et al.(1986), the effect of 
BayK 8644 and nifedipine on [ 3H ] noradrenaline release from 
hippocampal slices was studied. BayK 8644 and nifedipine had 
no effect on electrically stimulated [3H]noradrenaline 
release on their own, while R-PIA inhibited release by 25%.
However, in the presence of BayK 8644 (lpM), R-PIA 
inhibition of release was completely blocked. This was not 
the case with nifedipine which had no effect on R-PIA at 
lpM. Ligand binding studies performed by the same group 
showed both BayK 8644 and nifedipine to displace [3H]R-PIA 
binding. However, the displacement by BayK 8644 at lpM was 
comparatively weak, reducing R-PIA binding by only 15% at 
sub-optimal concentrations of R-PIA, as compared to the 
effect of lpM BayK 8644 on [3H]noradrenaline, where release 
was completely blocked. This suggests that BayK 8644 is not 
simply displacing R-PIA to reduce its effect. These studies 
were subsequently extended (Hu et al.,1987) to show that the 
inhibition of R-PIA action by BayK 8644 had no effect on the 
ability of R-PIA to reduce cAMP accumulation. Similarly, 
there was no effect of added GTP on the interaction of BayK 
8644 and R-PIA binding, nor was there any difference between 
binding in intact and solubilized membranes. This suggests 
that BayK 8644 is not acting via any interaction with the 
G-proteins that are thought to link the adenosine receptor 
with its effector site. The fact that verapamil and 
diltiazem do not share this interaction with adenosine 
analogues was also confirmed.
Other, more extensive, ligand binding studies have also 
reported the ability of the dihydropyridines to interact 
with adenosine receptors. Morgan et al.(1987) showed that 
binding to a and p adrenergic, muscarinic, opiate, GABA and 
benzodiazepine receptors by their respective ligands are all
unaffected by nifedipine in rat cortical membranes, while 
both [3H]CHA and [3H]DPX binding was potently inhibited by 
nifedipine and BayK 8644. Nitrendipine and nimodipine 
displaced [3H]DPX, but were ineffective against [3H]CHA, a 
result similar to that reported by Murphy and Snyder (1983). 
The binding of [3H]NBI, a ligand specific to the nucleoside 
transport (adenosine uptake) system, was shown to be reduced 
by the dihydropyridines in a competitive manner, BayK 8644 
and nifedipine being equipotent, with nitrendipine and 
nimodipine slightly less effective. Again verapamil and 
diltiazem were ineffective. They also repeated the work of 
Phillis et al.(1984) and showed that uptake of [3H]adenosine 
into synaptosomes was significantly inhibited by the 
dihydropyridines, with nitrendipine and nimodipine being 
slightly more potent than nifedipine. This demonstrates that 
the dihydropyridines can also affect the adenosine uptake 
system. Verapamil had no effect on uptake, although 
diltiazem was effective at inhibiting uptake.
A final experiment by Morgan et al.(1987) was to look at 
the effect of the adenosine analogues, CHA and 
2-chloroadenosine, on [3H]nitrendipine binding. This showed 
there was no effect in the reciprocal situation, Ki being 
greater than 200pM in both cases, suggesting that the 
dihydropyridines are acting on adenosine binding sites, as 
opposed to any shared adenosine / dihydropyridine receptor 
site. A similar study was carried out by Cheung et al.(1987) 
with comparable results.
All these studies show that the dihydropyridines, in 
particular nifedipine and BayK 8644, can affect the binding 
of adenosine analogues to the adenosine receptor (probably 
the h 1 receptor) and can also interact with the adenosine 
uptake system to promote [3H]adenosine uptake or displace 
[3H]NBI. From these studies it is possible to explain the 
results reported in this chapter.
The dihydropyridines appear to bind to a distinct site 
that interacts with, but is not the same receptor as, the 
adenosine receptor. Analysis of ligand binding indicates 
there is not a straightforward competitive inhibition 
between nifedipine and adenosine analogues (Murphy and 
Snyder, 1983), although scatchard analysis by Morgan et 
al.(1987) suggests a mixed competitive / non-competitive 
inhibition, with both the KD and Bmax altering, indicating a 
decrease in the number of adenosine binding sites and the 
receptor affinity. This suggests the dihydropyridines are 
exerting an allosteric modulation of the adenosine receptor 
via a receptor site, the identity of which remains unclear. 
As mentioned earlier, ligand binding studies suggest that 
the effect of the dihydropyridines does not appear to be 
exerted via the dihydropyridine calcium channel receptor, 
neither via action on a calcium channel nor, according to 
Morgan et al.(1987), via allosteric modulation of the 
adenosine receptor. This last conclusion is drawn because of 
the differential effect of the different dihydropyridines, 
nifedipine and BayK 8644 being very effective, nimodipine
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and nitrendipine virtually ineffective, while all these 
ligands can bind with high affinity to brain dihydropyridine 
receptors (Belleman et al.,1983). Also, the concentrations 
of the dihydropyridines required to exert an effect on 
adenosine are very much higher than those required to exert 
a maximal effect in smooth muscle.
However, it is always possible that the dihydropyridines 
can bind to a low affinity site on the same receptor 
molecule once the high affinity sites are fully saturated.
All the dihydropyridines studied could displace the 
adenosine antagonist [3H]DPX, which presumably binds to the 
adenosine receptor, so an allosteric interaction direct from 
the main dihydropyridine receptor cannot be ruled out.
Another possibility is the existence of a distinct low 
affinity dihydropyridine receptor site, specific for 
nifedipine and BayK 8644, which allosterically modulates 
adenosine binding sites. This may exist on the same receptor 
molecule as the high affinity binding sites as suggested 
above, or it may be a separate receptor located near the 
adenosine receptor. The existence of distinct high and low 
affinity binding sites for BayK 8644 have been demonstrated 
in cardiac tissue (Sarmiento et al.,1987). The high affinity 
site is thought to be associated with calcium channels while 
the function of the low affinity site is unclear. If a 
similar situation exists in neuronal tissue, then the low 
affinity site may be involved in modification of the 
adenosine binding site. There is a structural difference
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between the active and inactive dihydropyridines that could 
allow for a specific receptor site for subclasses of 
dihydropyridines. Nifedipine and BayK 8644 have a nitro 
(N02) group on site 3 of the phenol ring, as does 
nisoldipine which is also an active displacer of [3H]CHA 
(IC50=15pM) (Murphy and Snyder, 1983), while nitrendipine and 
nimodipine are 2-nitrophenol derivatives (Fig.3).
If an allosteric interaction is taking place, this would 
presumably act by decreasing the number of binding sites, as 
indicated by ligand binding studies. However, an argument 
against a specific allosteric down regulation of the number 
of adenosine binding sites can be obtained from an 
observation in the present studies that has not been 
reported in other functional studies. The reduction in 
inhibition by 2-chloroadenosine in the presence of 
nifedipine could be overcome by increasing the concentration 
of 2-chloroadenosine. Also, the use of higher concentrations 
of 2-chloroadenosine during the post-nifedipine phase 
restored responses to 2-chloroadenosine to control levels. 
This suggests a straight-forward competitive inhibition with 
2-chloroadenosine displacing nifedipine if added in high 
enough concentrations. Morgan et al.(1987) showed that 
adenosine analogues could not displace [3H]nitrendipine 
binding, suggesting that an increase in 2-chloroadenosine 
concentration could not simply displace the dihydropyridines 
from their receptor to relieve the allosteric hinderance. Of 
course it is possible that a distinct site exists, as
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described above, where only nifedipine and BayK 8644 can 
bind, and where 2-chloroadenosine can interact to displace 
the dihydropyridines at high concentrations (> lpM). Studies 
of [3H]nitrendipine binding would not show this action. A 
study of the effects of adenosine analogues on the 
displacement of [3H]nifedipine and [3H]BayK 8644 may resolve 
this argument. Whatever form the interaction takes, it is 
clear that adenosine analogue binding is hindered in the 
presence of the dihydropyridines nifedipine and BayK 8644. 
This will need to be taken into account should any adenosine 
analogues come into clinical use.
The effect of the dihydropyridines on adenosine is 
exerted via a different route. This appears to involve an 
action of the dihydropyridines on the nucleoside transport 
system, reducing the uptake of adenosine and subsequently 
enhancing its action by increasing its availability. The 
action of the dihydropyridines on the nucleoside transport 
system, as with the adenosine receptors, appears to be 
differential, with nifedipine and BayK 8644 being more 
effective than nimodipine and nitrendipine. The effect on 
adenosine uptake is indicated by an inhibition of 
[3H]adenosine uptake into brain synaptosomes (Phillis et 
al.,1984; Morgan et al.,1987), and by [3H]NBI binding 
studies (Marangos et al.,1984; Morgan et al.,1987). The 
effect of the dihydropyridines on the nucleoside transporter 
has also been reported in other tissues including human 
erythrocyte ghost membranes (Striessnig et al.,1985).
Marangos et al.(1984) used dog brain and heart membranes 
to show that [3H]NBI binding could be potently inhibited by 
the dihydropyridines with nimodipine being the most potent 
(nimodipine, Ki=21nM; nifedipine, Ki=4600nM in brain). 
Verapamil and diltiazem exhibited low potencies only. In 
this study, Scatchard analysis indicated that inhibition of 
[3H]NBI binding by the dihydropyridines was strictly 
non-competitive, in contrast to the study by Morgan et 
al.(1987). Other differences are also apparent between the 
two studies, in particular the relative potency of the 
different dihydropyridines in displacing [3H]NBI. Nifedipine 
is equipotent but nimodipine is of a significantly lower 
potency in rat brain (Ki=16700nM c.f. 21nM). This loosely 
corresponds to the results obtained in the present 
experiments where nimodipine and nitrendipine had little 
effect on adenosine inhibition. However, nimodipine and 
nitrendipine were able to displace [3H]NBI at relatively low 
K1 values (nim=16.7pM, nit=7.95pM), but this does not 
correlate with the present functional studies. The reason 
for this is not clear, but as binding studies do not 
necessarily dictate the functional profile of a drug, 
neuronal dihydropyridine studies being a good example, no 
great emphasis will be placed on this discrepancy.
To show that the dihydropyridines are acting to impair 
adenosine uptake, experiments were carried out using 
dipyridamole to block the nucleoside transport system. 
Dipyridamole (lOpM) increased the potency of lOpM adenosine
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3.6 fold (n=5). When nifedipine (lOpM) was added in the 
presence of adenosine and dipyridamole, the inhibition by 
adenosine was reduced over a period of 30 minutes. This 
appears to support the hypothesis that nifedipine is acting 
on the nucleoside transport system, as nifedipine is unable 
to increase the potency of adenosine in the presence of a 
more effective uptake blocker. In fact, the action of 
nifedipine on adenosine appears to be reversed.
There may be two possible explanations for this.
Nifedipine may be acting to reduce the action of adenosine 
at its receptor, as occurs with the analogues. The presence 
of dipyridamole prevents nifedipine from interacting with 
the nucleoside transport system and allows it to exert a 
maximal effect on the adenosine receptor. However, the level 
of inhibition by adenosine does not return to, or fall 
below, control (pre-dipyridamole) levels in the presence of 
nifedipine, so there is no evidence that the nifedipine is 
directly reducing the inhibitory action of adenosine at its 
receptor.
Alternatively, nifedipine is acting by displacing 
dipyridamole from the uptake site, allowing more adenosine 
to be taken up and reducing the inhibition of the population 
potential. This would suggest that the action of nifedipine 
on the nucleoside transport system is relatively weak, at 
least in comparison with dipyridamole. This is supported by 
the fact that nifedipine does not further enhance the action 
of adenosine in the presence of dipyridamole. Similarly, if 
nifedipine was a potent adenosine uptake blocker, it might
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be expected to enhance the action of endogenous adenosine 
when added on its own, as was the case with dipyridamole 
where there was an 18% inhibition of the population 
potential, presumably as a result of enhanced inhibition by 
endogenous adenosine. Thus, the dihydropyridine compounds 
can interact with the nucleoside transporter to increase the 
level of extracellular, active adenosine.
One matter that requires consideration is why adenosine 
and the analogues do not appear to be affected by both 
actions of the dihydropyridines; inhibition of nucleoside 
transport and decreased ligand binding.
The adenosine analogues are thought to be poor ligands 
for the nucleoside transporter (Miller and Paton, 1979), 
although 2-chloroadenosine in particular is known to bind 
(Jarvis et al.,1985) and 2-chloroadenosine and CHA can 
displace [3H]NBI binding (Marangos et al.,1982). However, 
despite binding with the transporter binding sites, the 
analogues do not appear to be transported into the cells 
(Clanachan et al.,1986). So the overall potency, already 
greater than adenosine, does not increase significantly if 
the uptake system is inhibited by the dihydropyridines. What 
is not clear is, if adenosine receptor binding for the 
analogues is being impaired by the dihydropyridines, why 
does this not impair the action of adenosine, counteracting 
the increased potency of adenosine due to the inhibited 
adenosine uptake system?. It is possible that the 
concentration of adenosine used in these experiments (25pM)
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is sufficiently high to overcome any block of adenosine 
receptors by nifedipine, particularly after its potency has 
been increased by reduced adenosine uptake. This did not 
occur with the adenosine analogues as there was no 
interaction of the analogues with the nucleoside transport 
system and therefore no increased potency. Higher 
concentrations of 2-chloroadenosine, however, did overcome 
the block, supporting the above possibility. Similarly, in 
experiments where an adenosine uptake blocker was present, 
lower concentrations of adenosine were used (lOpM) and a 
small decrease in inhibition by adenosine was observed, 
possibly as a result of nifedipine blocking the adenosine 
receptors.
A final discrepancy that needs to be discussed is the 
effect of nifedipine on human patients mentioned in the 
introduction to this chapter. Patients being treated for 
angina with nifedipine have been reported to show increased 
heart problems in a small number of cases which, according 
to experiments on dog heart (Merrill et al.,1983), may be 
due to an inhibition of the action of endogenous and added 
adenosine on vasodilatation. The results reported in this 
chapter, and the apparent explanation from ligand binding 
studies, do not appear to explain the interactions in the 
heart. If nifedipine acts to increase the potency of 
adenosine by blocking adenosine uptake, then an enhanced 
vasodilatation would be expected. There may be two possible 
explanations for this discrepancy. The vasodilatation of
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smooth muscle is thought to act via an A2 receptor (Kusachi 
et al.,1983). An increase in the potency of endogenous 
adenosine may act on h1 receptors to counteract the A2 
vasodilatatory effects. However, as Ax receptors do not 
cause vasoconstriction and there is no evidence for Ax 
receptors directly antagonizing A2 effects, this possibility 
seems unlikely. Alternatively, vasodilatation may act via 
ATP input, while enhanced Ax activation would exert the 
opposite effect. Either way, it is apparent that the 
adenosine system in the heart does not respond in the same 
way to the dihydropyridines as that observed in the brain.
Referring back to the behavioural effects of the 
dihydropyridines discussed in the main introduction 
(Page 38), the majority of the behavioural effects observed; 
mild sedation, interference with sleep patterns, ataxia that 
could be overcome under stress and inhibition of seizures, 
could be explained by an increase in the action of adenosine 
as a result of inhibition of the nucleoside transporter by 
the dihydropyridines. The behavioural effects of the 
dihydropyridines may result, in part, from an action on the 
adenosine system, rather than any action on calcium 
channels.
This chapter has demonstrated the effect of calcium 
channel blockers, principally the dihydropyridines, on the 
action of adenosine in in vitro electrophysiological 
responses in the rat hippocampus. This appears to involve an
action of 2-nitro dihydropyridines on both adenosine 
receptors, competitively blocking their action, and the 
nucleoside transport system, inhibiting its action and 
increasing the availability and potency of adenosine. The 
possible relevance this might have to the role of calcium 
channels in the action of adenosine will be looked at in the 
general discussion.
CHAPTER 3
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CHAPTER 3
THE ACTION OF ADENOSINE ON SYNAPTOSOMAL VOLTAGE SENSITIVE 
CALCIUM CHANNELS.
3.1. INTRODUCTION
The exact site, or sites, of action of adenosine have 
not, as yet, been fully elucidated. In the peripheral 
nervous system the inhibitory action of adenosine is due to 
a reduction in the release of neurotransmitter from nerve 
terminals (Ginsborg and Hirst, 1972). In the central nervous 
system the site of action of adenosine cannot be determined 
as easily, although adenosine is able to reduce 
neurotransmitter release from brain slices (Dolphin and 
Archer, 1983; Corradetti et al.,1984) and synaptosomes 
(Michaelis et al.,1979), suggesting a presynaptic site of 
action for adenosine.
A well established prerequisite for neurotransmitter 
release is calcium influx (Augustine et al.,1987). If 
adenosine is acting on neurotransmitter release, a possible 
route of action is on calcium mobilization into or within 
the synaptic terminal. This may be via a number of routes:
(1) By partially inhibiting voltage sensitive calcium 
channels (Wu et al.,1982). (2) By inhibiting receptor 
operated calcium channels. (3) By reducing the effects of 
calcium at intracellular sites (e.g. synaptic vesicles, 
Silinsky 1986a). (4) By increasing calcium sequestration by 
intracellular organelles (Dutta et al.,1984). (5) By 
promoting calcium efflux (Frischknecht and Ferrero, 1984).
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The first of these actions, inhibition of voltage 
sensitive calcium channels (VSCC), can be studied in 
neuronal tissue using isolated synaptic terminals or 
synaptosomes. As neurotransmitters are released in response 
to depolarization of the presynaptic terminal, it is 
reasonable to assume that adenosine could act on VSCCs.
3.1.1.Synaptosomes.
To study presynaptic calcium fluxes, a rat brain 
synaptosomal preparation was used. Synaptosomes, pinched off 
nerve terminals, are an established preparation that enables 
the chemical mechanisms of neurotransmission, including 
membrane ion channels and receptors, to be studied.
Since Gray and Whittaker (1962) first isolated nerve 
endings from homogenized brain, the viability of the 
synaptosome as an isolated, working, neuronal compartment 
has been determined by a vast number of studies. (Reviews: 
DeBelleroche and Bradford, 1973; Bradford, 1975). During 
homogenization of neuronal tissue, the nerve terminals are 
torn from their axons and post synaptic membranes and reseal 
to form a self contained "package" of viable synaptic 
terminal components. Electron microscopy studies show the 
presence of vesicles and mitochondria (Jones and Brearly, 
1972). Metabolic respiration at a high and linear rate, and 
the production of neurotransmitters and amino acids, can be 
measured (Bradford, 1968; Bradford and Thomas, 1969) which 
indicates that the complex enzymatic processes of the 
synaptic terminal are still intact and remain so for a 
number of hours after preparation.
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As synaptic transmission is a calcium dependent process 
(Augustine et al.,1987), calcium channels and calcium influx 
in synaptosomes have been studied in detail (Blaustein,
1975; Naschen and Blaustein, 1980; Gripenberg et al.,1980; 
Scott et al.,1980). The standard method is to use 
radioactive calcium (45Ca) isotope and to measure its uptake 
across voltage sensitive calcium channels (VSCC). The 
channels can be activated by depolarizing the surface 
membrane. This can be achieved by electrical stimulation via 
electrodes, by using the alkaloid veratridine to open sodium 
channels or by increasing the extracellular potassium 
concentration to alter the potassium diffusion potential. 
Potassium depolarization provides a simple and rapid method 
of activating calcium channels. Addition of TTX has no 
effect on potassium stimulated calcium influx (Blaustein, 
1975), indicating there is no influx via opened sodium 
channels during potassium mediated depolarization.
3.1.2.Adenosine and calcium.
The relationship between adenosine and calcium has been 
shown by a number of studies. Kuroda et al.(1976) 
demonstrated that adenosine inhibition of field excitatory 
post synaptic potentials (EPSP) in olfactory cortex could be 
antagonized by increasing the extracellular calcium 
concentration in a dose dependent manner. However, similar 
studies by Dunwiddie (1984) in rat hippocampal slices 
indicated that, although increases in extracellular calcium 
did reduce the inhibitory effect of adenosine on the EPSP, 
this was dependent on the stimulus amplitude and, when the
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non-linear summation of EPSPs was taken into account, there 
was no correlation between inhibition by adenosine and the 
calcium concentration. A counter argument was put forward by 
Ribeiro and Sebastiao (1986), who pointed out that 
postsynaptic effects of adenosine, i.e. hyperpolarization of 
the postsynaptic membrane, may be partly responsible for the 
adenosine effects that were independent of the calcium 
concentration.
Hollins and Stone (1980) postulated that adenosine may 
act to reduce calcium availability, after observing that 
adenosine decreased calcium dependent GABA release from 
potassium stimulated rat cortical slices.
Studies of long term potentiation (LTP) in the 
hippocampus have shown it to be highly dependent on external 
calcium; a reduction from 2.4 to ImM totally abolishing LTP 
(Dunwiddie and Lynch, 1979). The addition of 
2-chloroadenosine also inhibits LTP if given during the high 
frequency stimulation of the perforant pathway required to 
induce LTP, but not if given afterwards (Dolphin, 1983).
This indicates that the 2-chloroadenosine is inhibiting 
calcium influx during the stimulus, having the same effect 
as reducing extracellular calcium.
Schubert et al.(1986) used ion-sensitive microelectrodes 
to measure changes in extracellular calcium during evoked 
field potentials in rat hippocampal slices. Synaptic 
transmission was blocked by lowering calcium to 0.2mM and 
increasing the magnesium concentration. Pre- and
184
postsynaptic calcium fluxes could then be differentiated, 
changes in [Ca2+]e being still detectable under these 
conditions. Repetitive orthodromic stimulation resulted in a 
decrease in [Ca2+]e that was thought to be representative of 
influx into presynaptic terminals. Addition of 40pM 
adenosine reduced the size of the calcium signal, i.e. the 
decrease in [Ca2+]e was reduced. When adenosine deaminase was 
added the calcium signal increased, demonstrating that 
endogenous adenosine imposed a tonic inhibition on calcium 
influx.
Studies of calcium channels in single and cultured cells, 
using voltage and patch clamping techniques, have 
demonstrated the ability of adenosine to reduce or block 
calcium channels in a number of tissues including; 
hippocampal neurones (Proctor and Dunwiddie, 1983; Madison 
et al.,1987), superior cervical ganglion (Henon and McAfee, 
1983) and dorsal root ganglion (Dolphin et al.,1986;
Macdonald et al.,1986).
All the aforementioned studies indicate that there is 
good evidence to show a link between the action of adenosine 
and calcium availability. However, the most direct approach 
is to study the calcium channels on nerve terminals in 
isolation.
A number of reports have demonstrated the inhibitory 
action of adenosine and related analogues on voltage 
dependent calcium influx into synaptosomes.
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Ribeiro et al.(1979) were the first to show a significant 
effect of adenosine on calcium influx. They used a crude 
synaptosomal preparation and were able to show that 
potassium stimulated (71mM) 45Ca influx was blocked by 
adenosine (0.1 - 2mM) over 2 minutes. However, as noted by 
Fredholm and Hedqvist (1980), the initial 30 seconds showed 
an increase in influx over control levels at the lower 
(O.lmM) concentrations. The concentration of adenosine used 
can also be criticised as being far in excess of that 
required for maximal inhibition of synaptic transmission as 
seen in electrophysiological studies.
Wu et al.(1982) confirmed the findings of Ribeiro et 
al.(1979) and took the study further by demonstrating 
antagonism of the effect by theophylline, as well as using a 
range of analogues at pharmacologically acceptable 
concentrations. They also used a crude synaptosomal 
preparation, but were careful to show that potassium 
stimulated (60mM) 45Ca uptake was confined to synaptosomes 
only. i c 50 values for adenosine and 2-chloroadenosine were 
200nM and 25nM respectively, these ranges being used in the 
initial experiments reported in this chapter.
Kuroda et al.(1983) presented a brief report of the 
action of 2-chloroadenosine (50pM) on potassium depolarized 
(30mM) 45Ca influx into guinea pig cerebral cortex 
synaptosomes. He demonstrated a small (37%) decrease in 
calcium uptake measured over 15 seconds that could be 
antagonized by theophylline.
186
Arvin et al.(1988) used quin 2 to show that intracellular 
calcium levels increased in response to a brief pulse of 
30mM potassium and this increase could be reduced with 
2-chloroadenosine in a dose dependent manner. This effect 
could be antagonized by theophylline (lOOpM). However, the 
use of quin 2 does not allow the origin of the calcium to be 
determined, so that the increase could have been due to 
release from intracellular stores, as well as from outside 
the synaptosome.
A number of reports have also been published that fail to 
show an effect of adenosine. Barr et al.(1985) used 
adenosine (10pM) and 2-chloroadenosine (10 - lOOpM) at 1 to 
15 second uptake times. A significant decrease was seen at 
5 seconds uptake, but this was negated by opposing results 
at 1 and 15 seconds that showed an increase in uptake with 
both drugs. Most recently, Garritsen et al.(1989) used a 
range of experimental parameters, including varying 
preincubation and incubation times, crude and purified 
synaptosomes, potassium and veratridine depolarization, and 
addition of adenosine deaminase to remove endogenous 
adenosine. All failed to show an effect of R-PIA on calcium 
influx. It would have been interesting to see the effect of 
other adenosine analogues besides R-PIA.
Michaelis et al.(1988) used a crude P2 synaptosomal 
fraction to study 45Ca influx. They pretreated the 
synaptosomes with adenosine deaminase and preincubated them
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at 37°c for 10 minutes with 2-chloroadenosine (0.01-10pM). 
Uptake was measured over 20 seconds with 60mM potassium 
stimulation or 50pM veratridine. They were unable to show 
any effect on calcium influx. In this case it is possible 
that the use of adenosine deaminase to remove endogenous 
adenosine may have had some detrimental effect on the 
system. In the present study, the use of adenosine deaminase 
decreased the overall increase in calcium influx, possibly 
by a non-specific block of channels. A similar observation 
was reported by Garritsen et al.(1989) who traced the 
problem to the (NH4)2S04 that the deaminase was suspended in.
3.1.3. Sodium / calcium exchange.
As calcium influx via a secondary, and initially 
unforeseen, route may influence the results obtained in this 
study, it is appropriate to mention the background to the 
action of Na+/Ca2+ exchange.
Using a high potassium concentration to depolarize the 
synaptosomes requires a corresponding decrease in the sodium 
concentration to maintain the ionic balance. This has led to 
criticism that Na+/Ca2+ exchange mechanisms across the 
membrane may contribute to the measured influx of calcium 
(Coutinho et al, 1984). Na+/Ca2+ exchange is thought to 
control intrasynaptic calcium levels by removing calcium 
ions in exchange for sodium (Blaustein and Oborn, 1975).
This is dependent on the sodium gradient across the membrane 
find may also be reversed upon depolarization of the membrane 
(Coutinho et al, 1984). Synaptosomes maintained in a sodium
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rich ACSF tend to have increased intrasynaptic sodium levels 
that reduce the sodium gradient (Blaustein and Oborn, 1975). 
When potassium rich ACSF is used to depolarize the 
synaptosomes, the reduced extracellular sodium further 
reduces the sodium gradient and may lead to a reversal of 
Na+/Ca2+ exchange resulting in calcium influx via a route 
other than VSCC.
Studies carried out have attributed varying importance to 
this phenomenon. Naschen and Blaustein (1980) attributed 
less than 15% of the measured calcium influx to being 
dependent on [Na+]e. This was found to be constant regardless 
of the depolarizing potassium concentration, uptake time or 
calcium concentration. Akerman and Nicholls (1981) found 
that verapamil could completely inhibit potassium stimulated 
45Ca influx, indicating that no influx due to Na+/Ca2+ 
exchange was taking place. If verapamil was also inhibiting 
Na+/Ca2+ exchange, then an increase in basal 45Ca levels 
would be expected due to reduced efflux via the exchanger; 
this was not observed.
On the other hand, Coutinho et al.(1984) demonstrated 
that altering [Na+]i or [K+]n- affected 45Ca influx. 
Synaptosomes allowed to attain a high [Na+]i showed a high 
45Ca influx when depolarized with 150mM potassium, while 
synaptosomes equilibrated in high potassium ACSF showed a 
much lower stimulated 45Ca influx. This is not altogether 
surprising as 150mM potassium (<5mM sodium) ACSF would 
result in a very steep sodium gradient out of the
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synaptosome, while the synaptosomes preincubated in high 
potassium would have no membrane potential to induce voltage 
sensitive calcium influx. They also used the ionophore 
monensin to destroy the sodium gradient, resulting in a loss 
of calcium uptake by the synaptosomes.
However, studies by Suszkiew et al.(1986) give more 
convincing evidence as to the contribution of Na+/Ca2+ 
exchange to calcium influx. Comparison of synaptosomes 
resuspended in normal (140mM) sodium or in ACSF with choline 
replacing the sodium, showed a large increase in [Na+]i of 
77mM immediately upon resuspension of the synaptosomes in 
the ACSF. This increased to 104mM after 30 minutes, as 
compared to a maximal increase of 5mM sodium into 
synaptosomes resuspended in the choline ACSF. Also, the 
membrane potential between the two preparations varied by 
26mv (-78mv to -52mv). However, there was little difference 
in [Ca2+]i between them, as determined by quin 2, indicating 
the calcium gradient was not upset to any great extent in 
basal (resting) synaptosomes. Upon depolarization with 52mM 
potassium a greater increase in 45Ca influx was observed in 
the sodium rich synaptosomes.
These experiments demonstrate that the sodium gradient 
across the synaptosomal membrane must be taken into account 
when calcium influx is quantified. However, the use of 
potassium rich ACSF, with potassium totally replacing 
sodium, as used in some experiments, greatly exaggerates the
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problem. Although there is a component of Ca2+ influx 
attributable to Na+/Ca2+ exchange, if a shallow sodium 
gradient (70mM) is used, and preincubation of the 
synaptosomes in sodium rich (basal) ACSF is reduced to a 
minimum (20 minutes), then this factor can be reduced.
As the existing studies, on the effect of adenosine on 
synaptosomal calcium flux, fail to show a clear cut or 
consistent action of adenosine, it was decided to carry out 
a detailed study. The following experiments attempt to 
determine the optimum conditions for measuring calcium 
influx and look at the effect of a range of adenosine 
analogues on synaptosomal 45Ca influx. In addition the effect 
of adenosine on calcium influx into hippocampal slices is 
studied to determine if the action of adenosine is apparent 
in a more intact preparation and to tie in with the 
electrophysiological studies reported in the preceding 
chapters.
191
3.2. MATERIALS AND METHODS
The experiments reported in this chapter were carried out 
over two limited time periods of three and four months spent 
in the labs of Dr. M.G.Wyllie at Pfizer Central Research, 
Sandwich, Kent.
3.2.1.Compounds.
Analar grade compounds were obtained from BDH Chemicals 
Ltd. U.K.. Lanthanum chloride, adenosine hemisulphate and 
adenosine deaminase (Type II, powder) were obtained from 
Sigma Chemical Co., U.K.. Adenosine agonists and antagonists 
were from RBI (Semat Technical Ltd, U.K.). 45CaCl2 was from 
Amersham International PLC, U.K.. Scintillation fluids were 
from Packard or National Diagnostics.
CHA and CPA were dissolved in ethanol and R and S-PIA 
were dissolved in DMSO to give a stock solution. The final 
concentration of vehicle was never more than 0.5%. All other 
compounds were dissolved in basal ACSF to give the desired 
concentration when added to the incubation volume.
o
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3.2.2. Experimental solutions.
The synaptosomal basal ACSF was composed of:
NaCl, 135mM; KCl# 5mM; Tris HC1, 20mM (pH 7.4 at 37°c); 
MgCl2.6H20 / 1.2mM; CaCl2.6H20 / 1.25mM; D-glucose, lOmM; 
saturated with 02.
This solution was used in all basal test experiments and 
to resuspend the synaptosomes. The depolarizing ACSF was 
adjusted to give 70 mM KC1# 70mM NaCl.
The lanthanum stop solution contained:
NaCl, 135mM; KCl, 5mM; Tris HCl, 20mM (pH 7.4 at 5°c);
LaCl3, ImM.
The hippocampal slice basal ACSF contained:
KH2P04, 2. 2mM; MgCl2.6H20, 1.2mM; D-glucose, lOmM;
NaHC03, 25mM; NaCl, 115mM, gassed with 95%02/5%C02, pH 7.4.
The hippocampal slice lanthanum stop solution contained: 
NaCl, 135mM; KCl, 5mM; HEPES, 20mM; MgCl2.6H20, 1.2mM;
LaCl3, lOmM.
The dissolving fluid for the hippocampal slices consisted 
of 36g NaOH (3M), 150mls methanol and 45mls Triton X-100 in 
300mls water.
193
3.2.3. Preparation of synaptosomes.
All procedures were carried out at 5°c. Two male 
Sprague-Dawley rats (250g) were used per experiment.
The animals were killed by stunning and cervical 
dislocation and the brains dissected out into ice cold 0.32M 
sucrose plus 20mM tris, pH 7.4 at 5°c.
The brains were chopped manually using scissors and then 
homogenized. A Potter S homogenizer (B.Braun) with a loose 
fitting pestle and mortar was used to homogenize the tissue 
with five steady up and down strokes at 850 rpm.
The homogenate was then centrifuged and passed through a 
discontinuous density sucrose gradient to produce a purified 
synaptosomal fraction. Details are shown in fig. 3.0.
The synaptosomes were used immediately after preparation, 
or held on ice in pellet form if necessary, to reduce the 
influx of sodium that may upset the Na+/Ca2+ exchange (see 
section 3.3.5).
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BRAIN (whole brain less cerebellum)
I
Homogenise (5 strokes, 850 rpm): 
in 0.32M Sucrose/10mM Tris.
I
Centrifuge (1000g, 10 mins.)
performed twice
Resuspend
V  j \Pel let>^
t
Centrifuge (14500g, 20 mins.) 
Supernatant
Discard supernatantvtResuspend pellet in 0.32M Sucrose 
place on discontinuous Sucrose gradient
Centrifuge (75000g, 130 mins.)
t
Pipette off 0.8M/1.2M interface 
Dilute with 20mls basal Krebs
t
Centrifuge (14500g, 20 mins.)
Discard supernatant-
T
Resuspend pellet in basal Krebs 
and store on ice
Fig. 3.0. Flow diagram of the synaptosome preparation.
195
3.2.4. Synaptosome viability.
The viability of the synaptosomes was confirmed by the 
ability of potassium to depolarize the synaptosomes, as was 
apparent by the increased calcium influx.
When the preparation was originally set up in the Pfizer 
laboratories, a series of experiments was carried out to 
ensure the preparation technique could produce viable 
synaptosomes. Measurement of oxygen levels using 02 
electrodes showed an increase in the rate of oxygen 
consumption upon addition of veratridine or potassium when 
glucose was present. This was taken to show that the 
components of the purified synaptosomal fraction were 
metabolically active and the activity increased upon 
depolarization of the synaptosomes.
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3-2.5. Measurement of calcium uptake into synaptosomes.
Test solutions were of 1ml volume consisting of 50pl 
45CaCl2 (lpCi), 50pl drug or vehicle and 850}il basal or 
depolarizing ACSF. All drug concentrations were performed in 
triplicate.
The tubes were placed in racks in a water bath at 37°c 
and allowed to equilibrate. Uptake was started by the 
addition of 50pl synaptosomes using an Eppendorf repeat 
dispenser pipette. The synaptosomes were piElncubated with 
the compounds and prewarmed to 37°c for 10 minutes unless 
stated otherwise. After the required incubation time, uptake 
was stopped by using a lanthanum stop buffer (3mls).
Lanthanum is a potent calcium channel blocking metal ion 
which rapidly blocks calcium influx and efflux. It also 
displaces externally bound calcium over 15-30 minutes 
(Jansson et al., 1977).
The tubes were placed on ice for 20 minutes to allow the 
lanthanum to displace any externally bound calcium. The 
solutions were then filtered through presoaked GFB filters 
and washed with approximately 3x3mls of lanthanum stop 
buffer using an Ilicon cell harvester. The filters were 
placed in scintillation vials (skatron) with 3mls of 
Ecoscint scintillation fluid and counted for 1 minute in an 
LKB p counter.
To account for any passive uptake or remaining externally 
bound calcium, blank values were determined by adding 
synaptosomes to tubes already containing 3mls of lanthanum 
stop buffer.
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3.2.6. Measurement of 1 second calcium uptake.
A modified procedure was used to measure calcium influx 
over 1 second to ensure maximum possible mixing of the 
synaptosomes with 45Ca and drug.
ACSF - Tris buffers were the same as for longer uptake 
experiments except for the depolarizing ACSF where the NaCl 
was totally replaced with KCl (140mM).
The incubation volume was 0.5mls. 50pl of drug or vehicle 
in basal ACSF was added to 200pl of synaptosomes in basal 
ACSF. The tubes were then preincubated for 10 mins at 37°c.
45 +CaCl2 stock was added to aliquots of basal (5mM K ) or 
depolarizing (140mM K+) ACSF to give a final activity of 
2pCi/ml, and prewarmed to 37°c.
The 1 second preincubation period was started by the 
addition of 250pl of basal or depolarizing ACSF using 
Eppendorf repeat dispenser pipettes. The 140mM K+ mixed to 
give a final concentration of 72.5mM K+. Uptake was 
terminated by the addition of 2mls iced lanthanum stop 
buffer from a 50ml Eppendorf. A metronome was used to 
maintain a rhythm of addition as close to 1 second as 
possible.
The action of pipetting the 45Ca containing ACSF directly 
onto the synaptosomes ensures thorough mixing of the 
solution and this, together with the larger volume of 
synaptosomes and increased activity, ensures good counts can 
be obtained.
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3*2.7. Measurement of calcium uptake into hippocampal 
slices.
Hippocampal slices were prepared from Sprague-Dawley 
rats of either sex weighing approximately 250g as described 
in section 1.2.5. The slices were incubated at room 
temperature for 1 hour, then cut to a standard size using a 
cut pipette tip (internal diameter 4.5mm) and left for a 
further 30 mins. A calcium free ACSF was used during the 
preparation to deplete the intracellular calcium and give a 
greater stimulated uptake (Retz and Coyle, 1984), as 
determined by preliminary studies.
The experiments were carried out in 24 well culture 
plates (Falcon). Basal and test incubations were carried out 
in triplicate. Slices were preincubated in 1ml of basal ACSF 
plus drug for 10 mins at 37°c. lpCi/ml 45CaCl2 and 0.625mM 
CaCl2 was added to the ACSF.
lml of basal (2.2mM K+) or depolarizing (70mM K+) ACSF 
was added to the wells together with the appropriate drug or 
drug vehicle. After preincubation, slices were tipped into a 
plastic petri dish and a single slice was added to each well 
using a sieve spatula (Pfizer workshops). The slices were 
incubated for 10 minutes at 37°c.
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Uptake was terminated by transferring the slice by 
pasteur pipette through two 100ml beakers of ice cold lOmM 
lanthanum HEPES buffered ACSF and then to 5mls of cold 
lanthanum ACSF for lhr. HEPES was used, as lanthanum cannot 
be added to bicarbonate buffered ACSF due to precipitation 
problems.
After lhr, the slices were removed, drained on filter 
paper, weighed and transferred to scintillation vials 
(Beckman) containing 0.25mls of dissolving fluid. The tubes 
were incubated at 50°c for 10 minutes after which the vials 
were vortexed, 2mls of Hionic Fluor scintillation fluid 
(Packard) added, and the vials capped and vortexed before 
being counted on a Beckman scintillation counter.
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3*2.8. Determination of calcium uptake in nmol45Ca/mq 
protein and DPM/wet wt. tissue.
Values of calcium uptake into the synaptosomes were 
determined by the following calculation:
Depolarized - Basal
total DPM/ 1000 
mg protein
Total DPM was determined by counting 50pl of 45Ca. The 
protein concentration of a sample of the synaptosomal stock 
was determined by Bio-rad protein assay.
Calcium uptake for the slices was measured in DPM/mg wet 
weight tissue.
After being touched with a piece of filter paper to draw 
off excess fluid, the individual slices were placed on a 
piece of preweighed foil and weighed on a Sartorius 7 figure 
balance before being transferred to the scintillation vial. 
The DPM values from each tube were divided by the weight to 
give the DPM in mg wet weight of tissue
3.2.9. Protein determination.
lOOpl samples of the synaptosome stock were diluted 1 in 
10, lOOpl of 0.1M NaOH added and incubated at 50°c for 10 
mins to break down the tissue. lOOpl was then mixed with 
5mls of Bio-Rad (Bradford) reagent, left for 10 minutes and 
the absorbance measured at 595nM on an LKB spectrometer.
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3.3. RESULTS
3*3.1.Determination of the optimum parameters for studying 
calcium uptake.
A series of experiments were carried out to determine the 
optimum parameters for studying calcium uptake into 
synaptosomes.
3.3.1 (i).Potassium concentration.
To determine a suitable potassium concentration for 
depolarization of the synaptosomes, the uptake of calcium was 
measured at increasing extracellular potassium 
concentrations over the three time periods used in these 
studies (Fig.3.1.).
The EC50 values determined for each uptake time were 50mM 
for 120 secs, 55mM for 20 secs and 50mM for 1 sec.
A concentration of 50mM potassium was used in some 
initial experiments, but a more consistent increase in 
uptake was found to be obtained when a slightly higher 
potassium concentration was used, particularly at 20 second 
uptake periods.
It was therefore decided to use a potassium concentration 
of 70mM to ensure rapid depolarization.
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Fig. 3.1. Potassium concentration effect curves for
stimulation of calcium uptake into synaptosomes.
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Fig . 3.1a. Determination of synaptosomal 45Ca uptake 
measured in nmol/mg protein at increasing extracellular 
potassium concentrations. Uptake was measured over 1 and 20 
secs. Points are mean + sem of 6 determinations. 
Synaptosomes were prewarmed before addition.
The EC50 values for each curve are 55mM for 20 secs and 
50mM for 1 sec.
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Fig . 3.1b. Determination of synaptosomal Ca uptake at 
increasing extracellular potassium concentrations. Uptake 
was measured over 120 secs. Points are mean ± sem of 6 
determinations. Synaptosomes were prewarmed before addition. 
The EC50 value is 50mM.
3.3.1 (ii).Uptake of calcium over time.
Calcium uptake over increasing time periods was measured 
(Fig. 3.2 .) .
Maximum depolarized uptake was reached after 30 seconds 
and trailed off over longer periods up to 2 minutes. Basal 
uptake also increased over 30 seconds and continued to rise 
over 2 minutes (Fig. 3.2a ). An optimal uptake period was 
taken as 20 seconds as this gave maximal stimulated uptake 
after basal uptake had been subtracted.
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Fig. 3.2. Time response curves for potassium stimulated
calcium uptake into synaptosomes.
c
©■+-o
a
O)
E
\a
o
in
o
E
c
8
6
4
a  depolarized 
O basal
2
0
0 20 40 60 80 100 120
Time (secs)
Fig. 3.2a. Basal (5mM K+) and depolarized (70mM K+) calcium 
uptake into synaptosomes measured over increasing time 
periods.
Points are mean + sem of 6 determinations. Potassium 
concentration was VOmM, synaptosomes were prewarmed at 37°c
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Fig. 3.2b. Stimulated calcium uptake (depolarized minus 
basal) over time. Data calculated from graph above.
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3.3.2. Experimental conditions
In all subsequent experiments, unless otherwise stated, 
the synaptosomes were depolarized with 70mM potassium and 
the results expressed as stimulated uptake, i.e. the 
difference between basal and depolarized uptake. Uptake is 
calculated in nmol 45Ca/mg protein for the synaptosomes and 
DPM/mg wet weight tissue for the hippocampal slices. (See 
methods for calculation of values.)
3.3.3. Inhibition of calcium uptake by metal ions
Divalent cations, particularly certain transition metal
ions, bind to calcium channels and block the passage of 
calcium through the channel (Naschen, 1984). To determine 
the viability of the synaptosomes and to show that uptake 
across voltage sensitive calcium channels could be blocked, 
dose response curves to cadmium, cobalt and nickel were 
determined (Figs. 3.3-3.4).
Cadmium and nickel are thought to differentiate between 
the different proposed calcium channel subtypes (Tsien et 
al., 1987). N and L channels, associated with neurones, are 
blocked by cadmium and resistant to nickel while T channels 
are blocked by nickel. This is reflected in the relative 
potency of cadmium and nickel in blocking uptake. The IC50 
values are 15pM for cadmium and 400pM for nickel at 
2 minutes uptake. Cobalt was used to show the calcium 
channel blocking properties of this compound to support its 
use in the magnesium replacement experiments in chapter 1.
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Fig. 3.3.The effect of cadmium on synaptosomal calcium
uptake.
Dose response curves to cadmium at 1, 20 and 120 secs 
were determined. For all experiments, metal ions were added 
directly to the tubes and synaptosomes were prewarmed for 10 
mins at 37°c.
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Fig. 3.3a.The effect of increasing concentrations of cadmium 
on stimulated calcium uptake measured over 120 secs. Points 
are mean ± sem of 6 determinations. The IC50 value is 15pM.
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Fig. 3.3b. The effect of increasing concentrations of 
cadmium on stimulated calcium uptake measured over 1 and 20 
secs. Points are mean +. sem of 3-6 determinations. The IC50 
values are 0.3pM for 20 secs and 35pM for 1 sec.
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Pig.3.3c shows the data for 3.3a as basal and depolarized 
calcium uptake. This shows that passive calcium influx is 
also reduced, cadmium tending to block all sites of calcium 
influx.
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Fig.3.4. The— effect of nickel and cobalt on synaptosomal
calcium uptake. ■ --------
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Fig. 3.4a. Inhibition of stimulated calcium uptake by 
nickel. Uptake was measured over 2 minutes. Points are mean 
± sem of 6 determinations. Synaptosomes were prewarmed for 
10 mins at 37°c. IC50 = 400p m ,
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Figs. 3.4b. Inhibition of stimulated calcium uptake by 
cobalt. Uptake was measured over 2 minutes. Points are mean 
i sem of 6 determinations. Synaptosomes were prewarmed for 
10 mins at 37°c. IC50 = 130pM
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3.3.4. Sodium/calcium exchange
As discussed in the introduction to this chapter, a 
component of the observed calcium uptake may occur via the 
Na+/Ca2+ exchange mechanism. An idea of the degree of calcium 
uptake from Na+/Ca2+ exchange can be determined by the 
following experiment.
Dose response curves to potassium were determined in the 
presence of variable or fixed (60mM) sodium. For the control 
(variable) curve, the sodium concentration was reduced as 
the potassium was increased to maintain the ionic balance at 
140mM Na+ plus K+. For the "fixed sodium" curve, sodium was 
maintained at 60mM and the ionic balance was maintained by 
adding choline chloride.
It is apparent from the graph (Fig.3.5.) that calcium 
uptake is increased by low extracellular sodium. At 5raM K 
there is an 87% increase in calcium uptake which is 
presumably due to uptake across the Na+/Ca2+ exchange. If the 
level of stimulated uptake at 80mM K+ is taken as 100%, then 
56% of the total uptake can be accounted for by passive 
Na+/Ca2+ influx. However, as the gradient of the two lines 
remains roughly constant, it is reasonable to assume that 
the other 44% is due to voltage sensitive calcium channel 
activated uptake or at least not via a sodium gradient 
dependent uptake.
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Fig. 3.5. The effect of a reduced concentration of sodium on
potassium stimulated calcium uptake into synaptosomes.
25-,
20-
O control 
A60mM sodium
0 40 60 8020
[K+]
The effect of a reduced ACSF sodium concentration on 
synaptosomal calcium uptake at increasing potassium 
concentrations. The synaptosomes were preincubated in basal 
ACSF at 37°c and uptake was determined over 120 secs. Points 
are mean + sem of 6 determinations.
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3.3.5. The action of adenosine and adenosine analogues on 
synaptosomal calcium uptake.
The effect of adenosine and six adenosine analogues on 
calcium uptake across voltage sensitive calcium channels was 
determined.
In preliminary studies a range of experimental conditions 
was tried to see if uptake could be inhibited in 
sub-optimal conditions.
3.3.5.(i) Direct addition of synaptosomes to the test 
solutions.
If adenosine or its analogues can act to block calcium 
uptake by a non-specific route, such as direct block of 
channels or chelation of calcium, then direct addition of 
the synaptosomes to test solutions containing the drugs 
should be enough to reduce the uptake of calcium.
The data in table 3.1. shows that calcium uptake was 
unaffected by adenosine or its analogues under these 
conditions.
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3.3.5.(ii). Preincubation of synaptosomes with the adenosine
compounds.
As adenosine is known to act via a receptor, preincubation 
of the synaptosomes with the drugs should allow binding to a 
maximum number of receptor sites. The receptors should then 
be activated upon depolarization of the membrane.
The data in table 3.2. shows that the adenosine compounds 
had no significant or consistent effect on calcium uptake. 
Two values were significantly different from control values 
(* = P<0.1, paired t-test.).
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3.3.6. Preincubation and prewarminq of synaptosomes with the 
adenosine compounds.
The receptor to which adenosine binds is thought to act 
via G-proteins to exert an effect on ion channels (Fredholm 
and Dunwiddie, 1988). If this is the case then prewarming of 
the synaptosomes will allow biochemical pathways to be 
reactivated after the preparation process and allow 
adenosine to exert an effect.
The synaptosomes were preincubated with the adenosine 
compounds for 10 minutes at 37°c prior to experimentation 
and calcium uptake measured over 1 and 20 seconds (Figs. 3.6 
and 3.7).
Optimal parameters were determined as 20 seconds uptake 
with preincubation and prewarming of the synaptosomes with 
the adenosine analogues.
The adenosine analogues 2-chloroadenosine and NECA showed 
a small but significant inhibition of the stimulated calcium 
uptake measured over 20 second uptake periods. The maximum 
inhibition was a 32% reduction in calcium uptake by 
2-chloroadenosine (P<0.01/ paired t-test.). CHA and CPA also 
showed significant decreases in calcium uptake at low 
concentrations but not at higher concentrations.
The small but significant decrease in calcium uptake by 
some of the adenosine analogues was apparent in the 
depolarized synaptosomes only (Fig 3.8.) indicating that 
inhibition of the voltage activated calcium channels was 
responsible for the decreased calcium uptake.
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Fig. 3.6. The effect of adenosine compounds on synaptosomal
calcium uptake measured over 1 second.
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Figs. 3.6.a-d. represent the effect of adenosine 
compounds on calcium uptake measured over 1 second.
Synaptosomes were preincubated for 10 minutes with the 
compounds at 37°c. Bars represent the mean + sem of 6 
determinations. No significant decrease was observed. 
(P>0.1, paired t-test).
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Fig. 3.7. The effect of adenosine compounds on synaptosomal
calcium uptake measured over- 20 seconds
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Figs.3.7 a-d represent the effect of adenosine compounds 
on calcium uptake measured over 20 seconds. Synaptosomes  ^
were preincubated for 10 minutes with the compounds at 37 c. 
Bars represent the mean ± sem of 6 determinations,
A significant decrease is shown by the asterisks.
(** = P<0.05/ *** = P<0.01; paired t-test).
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Figs 3 7 0 —g represent the effect of adenosine compounds 
on calcium uptake measured over 20 seconds. Experimental 
parameters as for figs.3.7 a-d. Bars represent the mean + 
sem of 6 determinations. (** = P<0.05, paired t-test).
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Fig. 3.8. The effect of 2-chloroadenosine on basal and 
depolarized calcium uptake.
C D  baaal 
Y Z A  depolarized
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20 -
0 0.01 0.1 1 0 0.01 0.1 1
Chloroadenosine (jjlM)
Data from fig.3.7b showing the effect of 2-chloroadenosine 
on calcium uptake into basal and depolarized synaptosomes. 
Bars represent the mean ± sem of 6 determinations.
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3.3.7. The effects of 8-phenyltheophylline and adenosine 
deaminase.
It was possible that endogenous adenosine might already 
be exerting an inhibitory action on calcium uptake and so 
reducing control levels of calcium uptake or reducing the 
efficacy of added analogues by reducing their binding. To 
control for this, studies were carried out using adenosine 
antagonists to remove the presence, or inhibit the action 
of, endogenous adenosine.
3.3.7 (i). 8-phenyltheophylline.
8-phenyltheophylline (8PT), a potent adenosine 
antagonist, was added at varying concentrations and uptake 
times to block the action of endogenous adenosine. An 
increase in calcium uptake would indicate the presence and 
action of any endogenous adenosine (Fig.3.9).
No increase in calcium uptake was observed in any of the 
experiments, suggesting either that no endogenous adenosine 
was present or that it was not exerting a tonic inhibition 
on synaptosomal calcium uptake.
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Fig. 3.9. The effect of 8-phenyltheophylline on synaptosomal
calcium uptake.
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Fig.3.9a. 8PT was preincubated at 37°c with the synaptosomes 
for 10 mins. Uptake was measured over 1, 20 and 120 seconds. 
Bars represent the mean ± sem of 3 determinations. There was 
no significant difference between treated and untreated 
synaptosomes (P>0.1, PTT).
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Pigs. 3.9b & 3.9c. 8PT at increasing concentrations was 
added directly to the tubes. The synaptosomes were prewarmed 
for 10 mins at 37°c and uptake was measured over 20 and 120 
seconds. Bars represent the mean ± sem of 3 determinations. 
No significant or consistent difference was observed.
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3.3.7 (ii). Adenosine deaminase.
Synaptosomes were pretreated with adenosine deaminase 
(1.7 units/ml, Type II, Sigma) to remove any endogenous 
adenosine. The effect of 2-chloroadenosine and 
N-ethylcarboxamidoadenosine (NECA) was assessed (Fig 3.10).
An increase in the percentage inhibition of calcium 
uptake by these drugs might be expected when endogenous 
adenosine is removed if it is reducing control levels of 
calcium uptake or impairing the binding of the analogues.
2-chloroadenosine and NECA significantly inhibited 
calcium uptake in the absence of adenosine deaminase but the 
level of inhibition was not improved in the presence of 
adenosine deaminase and was, in fact, reduced. Adenosine 
deaminase itself appeared to decrease calcium uptake 
possibly via a non-specific block of channels by the protein 
molecule.
223
Fig. 3.10. The effect of removing endogenous adenosine on 
the inhibition of synaptosomal calcium uptake by adenosine 
analogues.
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Pigs. 3.10a & 3 10b. The synaptosomes were preincubated at
37 c for 30 minutes with adenosine deaminase (1.7 units/ml, 
Type II, sigma). For the last 10 minutes the analogues were 
added. Uptake was measured over 20 seconds. Bars represent 
the mean ± sem of 3 determinations. (* - P<0.05, paired 
test. )
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3.3.8. Adenosine and magnesium
A study was made of the possibility that the action of 
magnesium on adenosine inhibition, observed in the 
hippocampal slices (chapter 1 ), could also be observed in 
the synaptosomes. If the hypothesis is valid, removal of 
magnesium should reduce the inhibition of calcium uptake by 
adenosine. It would also increase calcium uptake by removing 
the magnesium block on calcium channels (Hagiwara and 
Byerly, 1981) so any loss of inhibition by adenosine would 
be impossible to distinguish from the overall increase in 
calcium uptake. Instead the magnesium concentration was 
raised to try and enhance the action of adenosine 
(Fig.3.11).
The synaptosomes were prepared in a magnesium rich ACSF 
(4mM) and adenosine and 2-chloroadenosine were preincubated 
with the synaptosomes at 37°c for 10 minutes prior to 
experimentation. Uptake was measured over 20 seconds.
The increased magnesium had no significant effect on 
calcium uptake or the ability of adenosine and 
2-chloroadenosine to reduce voltage dependent uptake.
Fig* 3.11. The effect of 4mM magnesium on the inhibition of
calcium uptake by adenosine and 2-chloroadenosine.
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Fig 3.11a & 3.11b. Synaptosomes were resuspended and 
preincubated with adenosine or 2-chloroadenosine irV  
magnesium rich ACSF (4mM) for 10 minutes at 37 c . Uptaxe w 
determined over 20 secs. Bars represent the mean ± sem 
determinations. (* = P<0.05, PTT) .
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3.3.9. The action of adenosine analogues on calcium uptake 
into hippocampal slices.
To determine the effect of adenosine on calcium uptake in 
a more intact tissue preparation, and to tie in with the 
electrophysiological studies, a series of experiments was 
carried out using hippocampal slices.
Experiments were carried out to determine the optimal 
experimental conditions for the slices.
Determination of calcium uptake over time showed 
stimulated uptake to be greatly enhanced if the slices were 
prepared and incubated in low calcium (0.12mM) ACSF. Uptake 
increased over 10 minutes after which it levelled off.
A potassium concentration response curve showed the EC50 
for stimulation of calcium uptake to be 50mM. However, to 
maintain some level of comparison with the synaptosomal 
experiments, a potassium concentration of 70mM was used to 
depolarize the slices.
The effect of the adenosine compounds on calcium uptake 
into the hippocampal slices was determined. Uptake was 
determined over 10 minutes (Fig.3.13a-e).
Adenosine and 2-chloroadenosine significantly inhibited 
calcium uptake at high concentrations. CPA significantly 
inhibited uptake at low concentrations but not at higher 
concentrations, in a similar manner to that observed with the 
synaptosomes.
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Fig.3.12. Determination of the optimum parameters for the
study of calcium uptake into hippocampal slices.
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Fig. 3.12a. Calcium uptake into hippocampal slices over time 
in the presence of normal or low (0,. 2mM) extracellular 
calcium. The slices were depolarized using 70mM potassium. 
Points are mean ± sem of 6 determinations.
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Pig. 3.12b. Calcium uptake into hippocampal slices with 
increasing potassium concentrations. Uptake was measured 
over 10 minutes. Slices were prepared and preincubated in 
low calcium (0.12mM) ACSF. Points are mean ± sem of 6 
determinations.
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Fig. 3.13. The effect of adenosine compounds on potassium
stimulated calcium uptake into hippocampal slices.
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Figs.3.13 a-d. Effect of adenosine compounds on calcium 
uptake into rat brain hippocampal slices. 70mM K , 10 mins 
uptake. Mean ± sem of 12-18 determinations. Drugs were 
preincubated with the slices for 10 minutes at 37 c.
(* = P<0.1, ** = P<0.05; paired t-test).
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Fig.3.13e. Effect of 2-chloroadenosine on calcium uptake 
into rat brain hippocampal slices. 7 0mM K+, 10 mins uptake. 
Mean + sem of 18 determinations. 2-chloroadenosine was 
preincubated with the slices for 10 minutes at 37°c.
(** = P<0.05, *** = P<0.01; paired t-test).
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To confirm that the effects of the adenosine compounds 
were being exerted via a receptor mediated action, 
8-phenyltheophylline was added to antagonize the action of 
2-chloroadenosine (Fig.3.14).
8PT totally blocked the inhibition of calcium uptake by 
2-chloroadenosine in a dose dependent manner. 8PT on its own 
had no significant effect on calcium uptake.
23 1
Fig. 3.14. Antagonism by 8-phenyltheophylline of the action
 2-chloroadenosine on hippocampal slice calcium uptake.
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Fig.3.14. The inhibition of calcium uptake into 
hippocampal slices by 2-chloroadenosine in the absence and 
presence of 8-phenyltheophylline. Bars represent the mean + 
sem of 6 determinations (*** = P<0.01; paired t-test).
(inset) The action of 8PT on its own had no significant 
effect on calcium uptake, n=3.
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3.4. DISCUSSION
The reduction in calcium influx across voltage sensitive 
calcium channels by adenosine analogues is small (^32%) but 
significant. This can be demonstrated in both synaptosomes, 
representing presynaptic nerve terminals; and in hippocampal 
slices, representing a more intact region of brain tissue 
known to be rich in adenosine receptors (Fastbom et 
al.,1987). However, inhibition of calcium influx was not 
shown by all the adenosine analogues and the agonist profile 
was different between the synaptosomes and the slices. The 
possible reasons for this, and whether the results show a 
real action of adenosine on neuronal calcium channels, are 
discussed below.
As the whole rat brain, minus cerebellum, is used to 
prepare the synaptosomes, the resulting preparation contains 
a heterogeneous population of nerve terminals. However, the 
properties of voltage dependent calcium channels on nerve 
terminals are thought to be consistent throughout the brain 
(Suszkiw et al.,1986). Also, although adenosine receptors 
are not distributed evenly throughout the brain (Fastbom et 
al.,1987), the inhibitory action of adenosine has been 
demonstrated on most, if not all, neurotransmitters in the 
brain. Consequently, adenosine should have the potential to 
act on the majority of synaptosomes in the preparation.
The synaptosomal preparation used in these studies was 
purified on a sucrose density gradient to reduce 
contamination from free mitochondria, a potential source of
calcium sequestration. Scott et al. (1980) showed that 79% 
of the calcium taken up by synaptosomes is sequestered by 
the intracellular mitochondria, while Adron Harris (1984) 
found that 97% of the glutamate stimulated calcium uptake in 
a crude mitochondrial (P2) fraction could be attributed to 
mitochondrial sequestration. This was reduced to 65% in a 
purified synaptosomal fraction and was attributed to 
mitochondria within the synaptosomes. Wu et al. (1982), who 
used a crude P2 fraction to study the effect of adenosine on 
potassium stimulated calcium influx, showed that high 
potassium produced very little stimulation of calcium uptake 
in a mitochondrial fraction. So, if only the stimulated 
calcium uptake is measured, this can be attributed to uptake 
predominantly into synaptosomes. A purified preparation is 
still preferable to reduce sequestration of calcium by free 
mitochondria/leaving more available for synaptosomal uptake.
The glial cells are another possible contaminant of the 
synaptosomal fraction. These are capable of taking up 
calcium and adenosine (Hertz et al.,1989; Lewin and Bleck, 
1979). Studies by Barnes and Mandel (1981), using cultured 
glial cells from chick brain, showed basal Ca uptake of 
only 20% of that seen in cultured neurones and this uptake 
was not increased by potassium depolarization (60mM). A 
similar lack of potassium stimulated calcium influx was 
observed in mouse cultured astrocytes (Walz and Wilson,
1986). in contrast to these studies, Hertz et al.(1989) were
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able to show a stimulation of 45Ca uptake into cultured mouse 
astrocytes by 50mM potassium. This was achieved only if the
45
Ca was added a minute before the potassium. In the present 
experiments the synaptosomes were added directly to the 
stimulating solution and were in contact with the 45Ca for 
only as long as the incubation period (20 secs). This should 
have limited the potential uptake of calcium into glial 
cells. Even if a percentage of the stimulated uptake was 
into glial cells, there is no evidence that adenosine can 
act on glial cells to reduce calcium uptake.
Synaptosomes are metabolically active and able to 
synthesize ATP using glucose as substrate (Bradford, 1969). 
This can be metabolized to adenosine that may impose a tonic 
depression on calcium influx (Silinsky, 1986a) or, 
alternatively, affect the binding of added analogues 
(Williams et al.,1986). If a tonic inhibition by endogenous 
adenosine is present, then addition of 8-phenyltheophylline 
(8PT) should block this effect, showing up as an increase in 
calcium influx. If endogenous adenosine is preventing 
binding/ the addition of adenosine deaminase should break 
down the adenosine and allow the added analogues to exert a 
maximal effect. No effect on calcium influx was seen using 
8PTjwhile adenosine deaminase actually decreased influx, 
possibly by a non specific effect. Similar experiments and 
results were obtained by Garritsen et al. (1989). However, 
this group also showed that binding of [ H] DPCPX, an Ax 
receptor antagonist, was increased in the presence of
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adenosine deaminase indicating that endogenous adenosine is 
reducing binding to A1 receptors. Also, R-PIA was able to 
displace [ H] DPCPX, indicating that adenosine analogues are 
able to bind to Ax receptors in the absence of endogenous 
adenosine. What was not clear was the effect of R-PIA 
binding in the presence of adenosine. However, the fact that 
removing endogenous adenosine did not increase the effect of 
the analogue suggests that endogenous adenosine is not able 
to exert any significant effect on depolarized calcium 
influx.
Following the observation that the action of adenosine 
was enhanced by increasing the extracelluar magnesium ion 
concentration (Fig.1.4) in electrophysiological studies 
(chapter 1 ), a short study was carried out to determine if 
the extracelluar magnesium concentration had any effect on 
the action of adenosine on synaptosomal calcium influx. An 
increase in extracellular magnesium might be expected to 
reduce calcium influx by blocking calcium channels. However, 
the current experiments did not show a significant reduction 
in calcium influx in high magnesium (4mM), nor was there any 
increase in inhibition by adenosine or 2-chloroadenosine. 
Unfortunately, the synaptosomal preparation does not readily 
lend itself to the study of a specific interaction of 
magnesium with adenosine due to the calcium channel 
regulatory nature of magnesium.
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A number of factors have to be considered concerning 
calcium influx over time periods longer than 1 second and 
the use of potassium to depolarize the synaptosomes.
It is possible that the inhibition of 45Ca influx by 
adenosine observed in these experiments is being partially 
masked by the use of potassium to depolarize the 
synaptosomes. Studies by Shinozuko et al. (1985), using 
synaptosomes prepared from guinea pig ileum myenteric 
plexus, showed a depression of K+ (40mM) stimulated 45Ca 
influx by adenosine (lOOpM) of 58%. However, when electrical 
stimulation was used, adenosine completely abolished the 
uptake. This effect was also observed by Pinto et al. (1989) 
in rat cortical synaptosomes.
Electrical stimulation, even at high frequency, may 
activate calcium channels without allowing them to reach a 
fully inactivated state so that they are constantly opening 
and closing over the long (2 mins) period of stimulation.
This is in contrast to potassium evoked depolarization where 
the membrane potential is permanently altered and channels 
open and close only once in the first second and are then 
inactivated, possibly by the increased intracellular calcium 
levels (Suszkiew et al.,1989).
Another piece of experimental evidence reported by 
Fredholm and Dunwiddie (1988) may also be appropriate to 
this argument. They studied the phosphorylation of 
synapsin I, a protein that is phosphorylated in the presence 
of calcium, the resulting phosphorylated state being
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important in the control of transmitter release. Addition of 
cyclohexyladenosine (CHA) reduced the calcium dependent 
phosphorylation of synapsin I induced by brief bursts of 
depolarization by potassium, but the CHA was ineffective on 
phosphorylation induced by sustained potassium 
depolarization. This fits with the idea that channels 
activated by brief depolarizations, such as electrical 
stimulation, can be blocked by adenosine, while potassium 
stimulated depolarization is so intense it partially 
overcomes the inhibitory action of adenosine.
A second possibility is that sodium/calcium (Na+/Ca2+) 
exchange is partly responsible for the late, slow phase of 
calcium influx observed after the first couple of seconds. 
This is supported by a number of reports (Coutinho et 
al.,1984; Turner and Goldin, 1985; Suszkiew et al.,1986) as 
well as the present study (fig.3.5). This presents two 
possibilities :
1) The potency of adenosine on VSCC influx is being 
partially masked by adenosine insensitive Na+/Ca2+ exchange 
calcium influx. This idea is also supported by the 
electrical stimulation experiments discussed above as 
electrical stimulation would not affect Na /Ca exchange.
2) Na+/Ca2+ exchange is responsible for all the late phase 
calcium influx and it is this which adenosine is acting 
upon. To do this adenosine would need to inhibit the 
reversal of Na+/Ca2+ exchange, reducing calcium entry via 
this route. If this was the case then a similar block would
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be expected on the basal uptake resulting in an increase in 
basal calcium levels due to a drop in efflux. This was not 
observed. A similar argument could be applied if adenosine 
actively promoted calcium efflux, as has been suggested for 
adenosine action on the guinea pig taenia-coli (Frischnecht 
and Ferrero, 1984). There was no significant reduction of 
basal calcium influx (Fig.3.8 ).
3.4.1. Fast and slow calcium channels.
Calcium influx into nerve terminals occurs in two phases 
with an initial rapid phase followed by a late, slow phase 
(Gripenberg et al.,1980). The initial rapid phase possibly 
corresponds to influx across the N type channel (Nowsky et 
al.,1985) that predominate on nerve terminals (Reynolds et 
al.,1987). This rapid and transient influx is probably 
responsible for neurotransmitter release in response to 
synaptic depolarization. If adenosine acts on calcium 
channels, it would presumably act on this rapid phase to 
reduce neurotransmitter release.
The late slow phase of calcium uptake may be related to 
influx across the L type calcium channels. As adenosine 
appears to show an effect predominantly on longer uptake 
periods (20 to 120 secs), it may be acting on this channel 
to reduce presynaptic calcium uptake. However, an effect of 
adenosine on this channel is not consistent with an 
immediate action on neurotransmitter release. Also, the 
dihydropyridines are thought to act on the L channel but 
have little effect on synaptic transmission.
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A third possibility is that of a distinct calcium 
current in nerve terminals as suggested by Suszkiew et al. 
(1989). This potassium depolarization dependent calcium 
channel (Jca) was first identified in Xenopus oocytes 
injected with rat brain mRNA (Leonard et al.,1987). The 
kinetic properties are distinct from the other three 
established calcium channels (T,N and L); it activates at 
moderate ( -50mv) depolarizations, inactivates slowly 
(0.8 sec) and is insensitive to dihydropyridines and 
w-conotoxin. The inactivation time can be increased to 
almost 10 secs if depolarized with low (25mM) potassium and 
low calcium medium, calcium being thought to decrease the 
inactivation time. Jca is also much more sensitive to block 
by cadmium as compared with cobalt.
If Jca is the predominant voltage activated calcium 
channel in rat brain synaptosomes then it is possible that 
adenosine is acting on this channel. Maximum influx is seen 
at around 20 seconds. Assuming the calcium channels are not 
all activated at the same time then a channel exhibiting a 
slow inactivation rate, the population of which takes a 
number of seconds to reach full inactivation, would fit with 
the data presented in this chapter and in a number of other 
publications (Ribeiro et al.,1979; Wu et al.,1982). The 
membrane potential of synaptosomes prepared by the technique 
used for the present experiments was calculated by the 
Pfizer scientists to be -73mv at rest, rising to -38mv upon 
depolarization with 70mM K+. This further supports the
240
existence of a distinct synaptosomal calcium channel 
activated at low membrane potentials.
The fact that adenosine effects could not be observed at 
shorter (1 sec) uptake times, in this or other studies (Barr 
et al.,1984; Garritsen et al.,1989), may be due to the fact 
that maximum uptake is not reached in this short period, and 
the relatively small percentage decrease in calcium influx 
by adenosine can only be shown to be significant after 
maximum influx has occurred. Alternatively, there may be 
insufficient mixing of the synaptosomes with the potassium, 
calcium and adenosine compounds during this brief period, 
preventing maximum activation of the calcium channels. The 
apparatus used by Suszkiew et al. (1986) involved 
instantaneous, electronically controlled mixing that allowed 
measurement of uptake down to 50 msecs. It would be 
interesting to see the effect of adenosine on rapid calcium 
fluxes using this system.
3.4.2.Adenosine Receptors.
The agonist profile determined in this study does not fit 
either the Ax or the A2 established profiles, so it is not 
clear what type of adenosine receptor on the synaptosomes is 
being acted upon by the adenosine analogues. It is possible 
that the action of CHA and R-PIA was impaired by the vehicle 
used to dissolve them (see below), in which case the 
analogues may prove to be acting at an Ax receptor. However, 
there are other possibilities.
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Ribeiro and Sebastiao (1986) have proposed a third A3 
adenosine receptor that is not coupled to adenylate cyclase 
but instead regulates calcium flux. This could be either via 
direct action; the receptor linked to, or part of, a voltage 
sensitive calcium channel; or indirectly, the activation of 
the receptor leading to a conformational change in the 
membrane that alters VSCC activity. This proposed receptor 
would be found on nerve terminals and heart tissue, as 
calcium influx is a major component of cell excitability in 
these tissues. The basis for proposing a third receptor is 
the continual observation of agonist profiles that fit 
neither A : nor A2 established profiles, particularly in 
studies on heart and neuronal tissue (e.g. Jonzon and 
Fredholm, 1984; Hughes and Stone, 1983). In particular, 
functional studies on neuronal preparations rarely show 
agonist profiles that suggest an A2 receptor, while 
functional effects of adenosine, designated as acting via A x 
receptors, are based upon the stereoselectivity of the PIA 
isomers rather than the agonist profile as a whole. Ribeiro 
and Sebastiao (1986) suggest that the A3 receptor can 
account for those profiles that do not neatly fit an Ax 
receptor profile. The A3 profile is CHA, R-PIA, NECA 
equipotent, with 2-chloroadenosine being less potent. 
Unfortunately, the adenosine receptor that is being acted 
upon in my study does not fit the profile of an A3 receptor 
as stipulated by Ribeiro and Sebastiao (1986). 
2-chloroadenosine is as potent as NECA, and R-PIA has no 
effect at the concentrations used. This is also the case in
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the study by Wu et al. (1982) where 2-chloroadenos ine was 
the most potent.
Another claim for a new A3 adenosine receptor linked to 
calcium systems in the brain has been put forward by Chin 
and Delorenzo (1986). Using 2-chloro[3H]adenosine (cl[3H]adn) 
as a ligand they demonstrated an adenosine binding site in 
cortical membranes with a micromolar affinity. Cl[3H]adn 
binding to this receptor was unaffected by R-PIA, 8PT or NEM 
treatment. Pretreatment of the tissue with adenosine 
deaminase exposed a high affinity receptor with preference 
for R-PIA which was the A 1 receptor. Untreated tissue did 
not show the A1 receptor, only the "novel" receptor. The 
order of potency for displacement of Cl[3H]adn was 
2-chloroadenosine > NECA > R-PIA. 8PT had no effect on 
binding up to 10 pM. This also differentiated it from the A2 
receptor. This "A3" receptor was found to be particularly 
rich in hippocampal membranes (Chin et al.,1985). Cl[3H]adn 
binding was also stimulated by the addition of cobalt, 
nickel and lanthanum, this stimulation being antagonized by 
calcium (Chin and Delorenzo, 1985). The agonist profile for 
this receptor fits the profile determined in the present 
study, so it is possible that a receptor, similar to the one 
proposed by Chin and Delorenzo (1986), is responsible for 
the effect of the adenosine receptor agonists on calcium 
influx observed in the present study. Unfortunately the 
characterization of this receptor is based entirely on 
Cl[3H]adn ligand binding studies with no functionally
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correlated studies to support it. However, there is room for 
a third adenosine receptor to explain a number of receptor 
studies that do not fit either of the established Ax or A2 
receptor classes. It is possible that the action of 
adenosine on presynaptic calcium channels will be one of the 
actions of this theoretical receptor.
3.4.3. Calcium uptake into hippocampal slices.
Brain slices have been used extensively to study the 
action of the excitatory amino acids on calcium influx 
(Ichida et al.,1982; Retz and Coyle, 1984; Crowder et 
al.,1987), but this has not been extended to studies on 
adenosine. It was therefore decided to see if potassium 
stimulated calcium influx into hippocampal slices could be 
affected by adenosine.
Trial studies were carried out with the slices to 
determine if electrically stimulated calcium uptake could be 
measured. However, it proved difficult to find suitable 
conditions under which a significant stimulation of calcium 
uptake could be observed, so this approach was abandoned due 
to lack of time.
In a slice of brain tissue there is no way to distinguish 
exactly which cells in the slice are taking up calcium or 
being affected by adenosine. Glial cells may contribute to
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the observed calcium uptake. As discussed earlier, Ca 
potassium stimulated influx into cultured astrocytes has 
been observed (Hertz et al.,1989) and the 10 minute
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incubation time for the hippocampal slices may have allowed 
a percentage of the 45Ca to be taken up into glial cells. 
However, a study by Walz and MacVicar (1988) found that 
astrocytes in hippocampal slices did not express calcium 
channels, unlike cultured astrocytes. The reason for this is 
unclear, although poor energy metabolism in the slices may 
have inactivated the astrocyte calcium channels rendering 
them undetectable. Whether the channels activate under 
potassium stimulation in the slice is also unclear, but 
again there is no evidence that adenosine acts on glial cell 
calcium influx, and the observed inhibition of calcium 
influx by adenosine is likely to have been into neurones 
rather than glial cells.
In the hippocampal slice experiments the adenosine 
analogues had a different order of potency from the 
synaptosomal studies. Adenosine itself produced a dose 
dependent decrease in calcium influx that was not observed 
in the synaptosomes. 2-chloroadenosine was effective in both 
studies, while NECA appeared to have no effect on 
hippocampal calcium influx. An obvious difference between 
the two studies was the greatly increased concentrations of 
drugs used in the slices. As the slice is a relatively 
intact piece of tissue, the drugs need to pass into the 
tissue before they can exert a maximal effect on as many 
receptors as possible. The actual concentration of drug 
around the receptor sites may be much lower than the added 
concentration. A second reason, as discussed by
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Dunwiddie (1985) and one that is also applicable to the 
synaptosomes, is that the concentration of potassium may 
reduce the observed inhibition so that higher concentrations 
of drug are needed to show a significant reduction.
A second, interesting comparison between the two studies 
is the action of cyclopentyladenosine (CPA). In both 
studies, CPA showed a decrease in calcium influx at low 
concentrations but not at higher concentrations. The reason 
for this is unclear. One possibility is that the vehicle 
used, ethanol, antagonized the effect of the agonist at 
higher concentrations, although the maximal concentration of 
ethanol was never more than 0.5%. CHA was also dissolved in 
ethanol and this also exhibited a small inhibition on 
synaptosomal calcium influx that was not dose dependent.
S and R-PIA were dissolved in DMSO (max final concentration 
<0 .5%) and it is possible that this vehicle also prevented 
the action of the analogues. However, although it is not 
made clear in the publications, there is no reason to 
believe that other studies (e.g. Wu et al.,1982) were able 
to dissolve these drugs without using the usual vehicle.
In conclusion, the adenosine analogues appear to be able 
to exert a partial inhibition on calcium influx. This may 
not be representative of the true ability of adenosine to 
block calcium channels, as the use of potassium to 
depolarize the synaptosomes may be attenuating the action of 
adenosine. There may also be a component of calcium influx
that occurs via the Na+/Ca2+ exchange which is unlikely to be 
sensitive to adenosine and will reduce the true level of 
inhibition by adenosine. Adenosine itself was ineffective on 
synaptosomal calcium influx, and active only at high 
concentrations in the slices. This may have been due to 
rapid metabolism or uptake of adenosine. Optimal parameters, 
under which the true effect of adenosine on calcium channels 
in synaptosomes could be ascertained, would be to use 
electrical depolarization, a short uptake time (1-5 secs) 
and the addition of an adenosine uptake inhibitor to 
maximise the effect of adenosine.
GENERAL DISCUSSION
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GENERAL DISCUSSION
The experiments reported in this thesis have attempted to 
look at the effect of adenosine on calcium associated events 
in the rat brain using electrophysiological and 
neurochemical techniques. This has revealed some interesting 
interactions between adenosine and other calcium associated 
mechanisms, namely the NMDA receptor operated channel and 
the dihydropyridine calcium channel antagonists. The 
author's conclusions about the possible actions occurring in 
the experiments are summarized below and the relevance of 
these effects to the role of adenosine in the CNS are 
discussed.
The results from chapter 1 show a reduction in adenosine 
inhibition in magnesium free ACSF that appears to be the 
result of increased NMDA receptor activation. When NMDA 
channels are activated, either by removing extracellular 
magnesium or by increasing cell excitability with 8 .5mM 
potassium, the inhibitory action of adenosine is greatly 
reduced. In magnesium free conditions the maximum level of 
inhibition by adenosine is also reduced so that, in some 
slices, ImM adenosine failed to completely abolish synaptic 
transmission.
Other reports of reduced inhibitory action by a lack of 
magnesium in functional studies are limited, but there is 
evidence to support the observations of the present 
experiments.
Artemenko and Gerasimov (1984) looked at the effect of 
magnesium and calcium ions on inhibition of synaptic 
transmission by adenosine in the rat hippocampal slice. An 
increase in the magnesium ion concentration increased the 
inhibitory action of adenosine on the CA1 EPSP, while a 
decrease reduced it. Changes in the calcium ion 
concentration had the opposite effect. The IC50 value for 
adenosine was between 10 and 25pM. When adenosine was tested 
in ACSF containing low magnesium (0.02mM) and high calcium 
(4mM) the IC50 for adenosine increased to 90pm, while the 
maximum inhibition by adenosine was only 65% even at ImM 
adenosine. This was taken to indicate that the increased 
calcium concentration was allosterically inhibiting the 
binding of adenosine to its receptor, or that calcium was 
competing with adenosine to occupy a site on a calcium 
channel. The possibility that a lack of magnesium ions was 
responsible for the reduced adenosine effect was not 
seriously considered due to a lack of evidence. However, the 
results of Artemenko and Gerasimov (1984) appear to support 
the idea of a lack of magnesium ions impairing the action of 
adenosine, and the increased calcium concentration may be 
enhancing the effect by increasing calcium influx across the 
NMDA channel.
A recent report also provides evidence to support a 
requirement for magnesium in the action of adenosine. Lloyd 
et al.(1989) looked at the effect of 2-chloroadenosine on 
the evoked monosynaptic reflex (MSR) in the isolated
249
neonatal rat spinal cord. The IC50 for depression of the MSR 
by 2-chloroadenosine in normal ACSF (1.25mM Mg) was 0.41pM. 
This increased to 3pM when magnesium was omitted.
Furthermore, the maximal inhibition of the MSR was reduced 
from 100% in normal ACSF to only 65% even at lOOpM 
2-chloroadenosine. A 30% increase in excitability of the 
cells was observed upon entry into magnesium free ACSF, but 
the reduction in the maximum obtainable depression was taken 
to show that the reduced inhibition was not simply a result 
of the increased excitability. Neither of these reports 
looked for a possible NMDA mediated effect, but it is 
possible that a similar mechanism to the one proposed in the 
present studies is also being exerted in the above studies.
To try to explain the drop in adenosine inhibition with 
increased NMDA receptor mediated calcium channel action, the 
possibility of an interaction between the NMDA channel and 
the adenosine receptor or associated channel has been 
considered. The evidence for such an interaction is limited 
and largely conjectural. Perhaps the most interesting report 
is by Stratton et al.(1988) who observed a loss of adenosine 
inhibition on the dentate gyrus population potential in 
magnesium free ACSF. This effect was irreversible upon 
reintroduction of magnesium and appeared to be mediated by 
activation of NMDA channels as the effect was blocked if 
2-AP5 was added before the magnesium free ACSF or if the 
slice was not stimulated during the magnesium free period.
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An interaction between adenosine and NMDA receptor 
operated channels may be of relevance to a number of 
hypothesized actions of NMDA channel activation including 
long term potentiation, kindling and epileptiform activity.
Long term potentiation (LTP) is the prolonged enhancement 
of synaptic transmission that follows tetanic afferent 
stimulation. This occurs most prominently in the hippocampus 
and is looked upon as a likely mechanism for learning and 
memory (Collingridge and Bliss, 1987). LTP is thought to 
involve activation of NMDA receptor channels, as NMDA 
antagonists readily block the induction of LTP (Harris et 
al.,1984). NMDA receptors are rich in the CA1 and dentate 
gyrus regions of the hippocampus (Cotman et al.,1987) where 
LTP is most readily recorded. Under normal conditions, NMDA 
receptor operated channels are not activated during synaptic 
transmission; glutamate acting at kainate and quisqualate 
receptors only (Collingridge et al.,1983). However, during a 
rapid burst of stimuli, the magnesium ions that normally 
block the voltage dependent NMDA receptor channel are 
removed by the depolarization of the membrane, and calcium 
ions, which are thought to play a role in activation of LTP, 
can enter. The calcium dependence of LTP has also been 
demonstrated as it can be prevented by reducing the 
extracellular calcium concentration (Dunwiddie and Lynch, 
1979) and induced by increasing calcium (Turner et 
al.,1982) .
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Modulation of LTP by other neurotransmitters and 
neuromodulators has been studied. The inhibitory 
neurotransmitter GABA is thought to regulate the activity of 
NMDA receptors in LTP. GABA antagonists such as picrotoxin, 
bicuculline and penicillin have been shown to facilitate the 
generation of LTP in hippocampal slices (Wigstrom and 
Gustafsson, 1983). The opiates may have some regulatory 
action on LTP, as naloxone can inhibit LTP in the CA3 
(Stringer et al.,1983), although opioid antagonists do not 
appear to promote LTP. Noradrenaline also has an effect on 
LTP, both attenuating and enhancing it (Collingridge, 1985) 
possibly depending on the receptor subtype affected (Stanton 
et al.,1987). Neurotransmitters, such as dopamine, 5HT and 
acetylcholine appear to have little or no effect on LTP 
(Collingridge, 1985). Thus, it appears that LTP can be 
regulated by other neurotransmitters and neuromodulators.
It is therefore not inconceivable that adenosine, which 
can oppose the depolarization necessary to overcome the 
magnesium block of NMDA channels, might be able to regulate 
LTP. Alternatively, the opposite interaction may occur 
whereby activation of NMDA channels is able to suppress the 
inhibitory action of adenosine. This may be important for 
LTP if the tonic inhibition imposed by endogenous adenosine 
(Ault and Wang, 1986) has to be reduced to allow LTP to be 
initiated and / or maintained. There may also be an 
increased release of adenosine as a result of the excitatory 
inputs that trigger LTP, the inhibitory action of which 
would also need to be reduced to allow LTP to occur.
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The reports of an effect of adenosine on LTP are limited, 
but suggest that adenosine can affect LTP. Dolphin (1983) 
looked at LTP induced in vivo in the rat dentate gyrus. 
Application of 2-chloroadenosine, via a cannula placed in 
the granule cell body layer of the dentate gyrus, blocked 
the onset of LTP normally observed upon tetanic stimulation 
of the perforant pathway. 2-chloroadenosine only needed to 
be present during the tetanic phase to prevent LTP, but was 
ineffective if added immediately after stimulation. The 
results were taken to indicate that 2-chloroadenosine could 
reduce calcium influx either pre- or postsynaptically, 
calcium influx being a vital component of LTP onset. The 
fact that 2-chloroadenosine was ineffective in blocking LTP 
if added after the tetanic stimuli may be due to a reduction 
in adenosine action as a result of NMDA channel activation.
A loss of 2-chloroadenosine action on synaptic transmission 
after LTP had been triggered was not reported by Dolphin, so 
adenosine action is not universally reduced, as is the case 
in the present study when the majority of NMDA channels are 
activated in magnesium free ACSF. However, a local effect on 
those synapses responsible for triggering LTP may occur.
A similar report by Mendoca and Ribeiro (1989) found that 
2-chloroadenosine inhibited LTP induced in the CA1 region of 
the hippocampus. As with the previous report, 
2-chloroadenosine was only effective if added prior to LTP 
onset.
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In a similar manner, kindling, a method of inducing 
spontaneous seizures by repeated electrical stimulation, 
either in vitro (Slater et al.,1985) or in vivo 
(Goddard et al.,1969), appears to involve an increase in 
NMDA channel activation. Studies of kindling in both the CA1 
(Wadman et al.,1985) and the dentate gyrus (Mody and 
Heinemann, 1987) have shown an increased excitability of 
kindled cells as compared to control and this excitability 
is readily blocked by 2-AP5. Similarly, kindled epilepsy in 
the amygdala of rats corresponds to a significant increase 
in glutamate release, the neurotransmitter thought to act at 
the NMDA receptor, while other amino acids showed no 
increase in release (Peterson et al.,1983).
Electrical stimulation and epileptiform activity have 
both been shown to increase adenosine release (Pull and 
Mcllwain, 1972; Winn et al.,1980). This might be expected to 
counteract the onset of spontaneous activity, while kindled 
epilepsy has been shown to be regulated by adenosine 
agonists and antagonists, attenuating and facilitating it 
respectively (Dragunow et al.,1985). However, if increased 
NMDA channel activity is responsible for the kindled 
seizures, in a similar manner to the induction and 
maintenance of LTP, then this might counteract the 
effectiveness of the released adenosine, preventing it from 
totally inhibiting the spontaneous activity.
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Finally, the spontaneous epileptiform activity observed 
in magnesium free ACSF, thought to be exerted via NMDA 
receptors (Stanton et al.,1987), may also be enhanced by a 
reduced presynaptic adenosine action. The anticonvulsant 
properties of adenosine tend to argue against this 
possibility, but the postsynaptic action of adenosine, 
possibly at extrasynaptic or even somatic sites (Tetzlaff et 
al.,1987), may be responsible for the anticonvulsant 
effects, while a reduced presynaptic adenosine effect 
initially allows the NMDA mediated action to go ahead.
These experimental models are likely situations where an 
interaction between NMDA and adenosine could occur. Assuming 
LTP is a naturally occurring phenomenon, this might be a 
condition where a depression of adenosine inhibition could 
be of physiological relevance.
Before the NMDA component of increased synaptic 
transmission became apparent, the original hypothesis to 
explain the reduced adenosine inhibition in magnesium free 
ACSF was a requirement for magnesium ions at or near the 
adenosine receptor to enable adenosine to bind to its 
receptor. This hypothesis is supported by ligand binding 
studies. Although the experimental evidence of the present 
experiments cannot be used to show a direct interaction 
between magnesium and adenosine at the adenosine receptor, 
there is still a rationale for suggesting a requirement for 
magnesium for effective adenosine action.
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A requirement for magnesium for effective regulation of 
neuronal function might be expected if it is of importance 
to the action of adenosine. This is found to be the case, 
with a number of reports demonstrating the importance of 
magnesium to neuronal function, and variations in magnesium 
levels being associated with pathological conditions.
The level of total and intracellular free magnesium has 
been shown to decrease following traumatic brain injury in 
rats (Vink et al.,1987). Intracellular magnesium levels were 
measured in vivo using 31P magnetic resonance spectroscopy. 
Following injury of the brain by forced injection of a bolus 
of 37°c isotonic saline directly into the cranial cavity, 
the intracellular free magnesium level fell by 70% within 
the first hour after injury and did not recover over the 
remaining 3 hours of observation. Total magnesium levels 
were determined after 4 hours by atomic absorption 
spectroscopy and were found to be 10% less than control. 
Treatment of rats with MgS04 (125pmol) 30 minutes after 
brain injury was performed, protected the animals from 
chronic neuronal damage. Treatment with ATP-MgS04 or ATP 
provided no significant protection (McIntosh et al.,1989). A 
70% reduction in intracellular magnesium concentration could 
explain a number of post-traumatic neurological effects, the 
majority of these effects ultimately leading to secondary 
cell death via injury processes that remain unclear. It is 
known that a wide range of fundamental biochemical processes 
depend on the presence of magnesium ions for effective
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enzymatic action (McIntosh et al.,1989; Cech et al.,1980).
It is possible that an effect on adenosine metabolism by a 
reduction in magnesium levels is one effect that contributes 
to the ultimate neuronal damage.
An effect of magnesium that may be more closely related 
to a possible interaction with adenosine is the effect of 
magnesium on epileptic seizures. Eclampsia, epileptic 
seizures experienced during pregnancy, have been regularly 
treated with magnesium sulphate administered intramuscularly 
or intravenously (Valenzuela and Munson, 1987; Dinsdale, 
1988). The pre-eclamptic state is typically characterized by 
a reduction in plasma magnesium levels together with acute 
hypertension. Administration of magnesium in the 
pre-eclamptic state prevents the onset of convulsions, and 
arrests convulsions if administered after onset. The way in 
which magnesium acts to inhibit seizures is unclear. A 
neuromuscular blocking action may be responsible for 
arresting the convulsions, as abnormal EEG patterns have 
been observed after effective magnesium treatment. 
Alternatively, vasodilatation of the cerebrovasculature may 
be a factor in seizure arrest. Studies in anaesthetized cats 
and dogs, and conscious primates (Borges and Gucer, 1978) 
showed that intravenous MgS04 could suppress neuronal burst 
firing and EEG spike generation induced by topical 
application of penicillin to the motor cortex. Plasma 
concentrations of magnesium were below levels that would 
produce neuromuscular block. The blood brain barrier is
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largely impermeable to magnesium, but permeability may be 
increased under pathological conditions which would allow 
magnesium administered i.v. to pass into the CSF (Borges and 
Gucer, 1978). Thus magnesium may act both peripherally and 
centrally to arrest seizures. The possibility that the 
anticonvulsant action of magnesium in these circumstances 
involves an increase or restoration of adenosine action, 
either directly by enhancing adenosine binding, or 
indirectly by reducing NMDA channel action, cannot be 
determined from these studies. However, it is interesting to 
speculate that adenosine plays a role in the anticonvulsant 
action of magnesium in the light of the results reported in 
this thesis.
The interaction of the dihydropyridine calcium channel 
blockers with the adenosine system appears to occur at both 
the adenosine receptor and the nucleoside transport system. 
This results in a differential action between adenosine and 
the adenosine analogues.
The action of dihydropyridines on the adenosine receptor 
appears to be exerted by a competitive binding of 
dihydropyridines to the adenosine receptor. A competitive 
interaction is supported by the observation that increased 
concentrations of 2-chloroadenosine were able to reverse the 
antagonistic action of nifedipine. An alternative 
possibility is the existence of a distinct low affinity 
dihydropyridine binding site that allosterically interacts
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with the adenosine receptor. Dihydropyridines that bind to 
this site require a chemical group on position 2 of the 
phenol ring for effective binding (Fig.3). This is the only 
consistent difference between the dihydropyridine compounds 
that interact with adenosine and those that do not.
Similarly, verapamil and diltiazem are also unable to 
interact with adenosine and are presumably unable to bind to 
the hypothesized low affinity dihydropyridine receptor.
The fact that interactions only occur at concentrations 
of dihydropyridines much higher than those required for 
saturated binding, that adenosine has no effect on 
nitrendipine binding (Morgan et al.,1987) and that, while 
verapamil and diltiazem can allosterically regulate 
dihydropyridine binding, they have no effect on adenosine 
binding (Morgan et al.,1987), strongly suggests that the 
usual high affinity dihydropyridine binding site is not the 
site from which adenosine binding is affected. However, the 
interaction between adenosine and the dihydropyridines 
indicates a possible association between the two types of 
receptors. Both receptor types appear to be closely 
associated with synaptic calcium channels. Murphy et 
al.(1982) showed that [ 3H ] nitrendipine binding was 
concentrated in synaptic regions, particularly in the 
molecular layer of the hippocampus and the plexiform layer 
of the olfactory bulb, areas rich in synaptic connections. 
White matter areas were devoid of binding sites. Similarly, 
adenosine binding sites are associated primarily with
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synaptic regions, particularly in the hippocampus (Tetzlaff 
et al.,1987).
A study by Thayer et al.(1986) used primary cultures of 
cells from various regions of rat brain to look at the 
action of dihydropyridines on potassium stimulated calcium 
influx as determined by fura 2 microspectrofluorimetry. 
Interestingly, the inhibition of calcium influx by 
nitrendipine (lpM) was greater in cultured hippocampal 
neurones (79% of stimulated influx inhibited) than in 
striatal neurones (31%), suggesting a differential 
distribution of dihydropyridine sensitive calcium channels. 
The distribution of adenosine receptors is also higher in 
the hippocampus as compared to the striatum (Goodman and 
Snyder, 1982; Fastbom et al.,1987). In light of the results 
reported in chapter 2, it is possible that the decreased 
calcium influx was the result of increased adenosine action 
via an interaction of endogenous adenosine with the 
dihydropyridine. This is unlikely for a number of reasons. 
Endogenous adenosine levels are likely to be low around 
isolated cultured cells. Nitrendipine was not very effective 
at decreasing adenosine uptake, as compared to nifedipine 
and BayK 8644, in the present study. BayK8644 was also used 
in the experiments by Thayer et al.(1986) producing an 
increase in calcium influx which would not be expected if an 
interaction with adenosine was involved. Skattebol and 
Triggle (1987) also studied the binding of nimodipine and 
BayK 8644 in different regions of the rat brain. Binding was 
greatest in the hippocampus and cortex and lowest in the
cerebellum. This is in contrast to adenosine binding where 
the hippocampus and cerebellum show the highest binding 
density of adenosine receptors in the brain (Goodman and 
Snyder, 1982; Fastbom et al.,1987). The dihydropyridine 
binding distribution was compared with 45Ca uptake into 
synaptosomes prepared from the same regions of the brain and 
was found to be comparable with the predominance of fast 
(1 sec) uptake components of calcium influx, assumed to be 
associated with neurotransmitter release, as is the action 
of adenosine. There is a loose correlation between the 
distribution of adenosine and dihydropyridine binding sites, 
with the hippocampus being rich in both types of receptors. 
However, the cerebellum is particularly rich in adenosine 
receptors, but comparatively low in dihydropyridine binding 
sites. A direct comparative study would be needed to 
determine any real correlation, but at present no direct 
association between dihydropyridine and adenosine receptors, 
and subsequently their associated calcium channels, can be 
drawn.
The main argument against a close association of the two 
receptors is the functional studies. Adenosine is a potent 
blocker of synaptic transmission while the dihydropyridines 
appear to have no effect on calcium channels involved in 
synaptic transmission. Indeed this is an advantage of the 
dihydropyridines in the treatment of hypertension and angina 
as they do not interfere with neuronal transmission (Miller 
and Freedman, 1984). This is despite the high density of
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dihydropyridine binding sites associated with synaptic zones 
(Murphy et al.,1982) and the fact that, under certain 
conditions, a block of calcium channels on neuronal cells by 
the dihydropyridines can be demonstrated (Carboni and 
Wojcik, 1988; Thayer et al.,1986). Behavioural studies also 
support the idea that dihydropyridines can affect neuronal 
activity directly, although it is possible that an 
interaction with the adenosine system is responsible for 
some of the behavioural effects of the dihydropyridines.
The dihydropyridines also interact with the nucleoside 
transport system to reduce adenosine uptake and increase its 
potency. This is apparent from [3H]NBI binding studies where 
the dihydropyridines can potently displace NBI from the 
nucleoside transport receptor (Morgan et al.,1987). In the 
present study the addition of dipyridamole effectively 
removed the interaction of nifedipine with the nucleoside 
transport system and allowed adenosine to act in a similar 
manner to the adenosine analogues. The nucleoside transport 
system is presumably not associated with calcium channels 
and this interaction demonstrates that the dihydropyridines 
can bind to sites not associated with the high affinity 
dihydropyridine binding site. The 2-phenol group 
dihydropyridines were again more effective than the other 
dihydropyridine molecules possibly suggesting that a similar 
low affinity dihydropyridine binding site is responsible for 
allosteric modulation of both adenosine receptor and 
nucleoside transport binding sites. However, uptake sites
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are not necessarily closely associated with the adenosine 
receptors, occurring on glial cells (Lewin and Bleck, 1979) 
as well as neurones, so a direct competitive interaction of 
dihydropyridine and adenosine at the nucleoside transport 
site may be a more likely interaction.
The determination of the action of adenosine on calcium 
influx into synaptosomes demonstrates that adenosine 
analogues can reduce calcium uptake into the components of a 
purified synaptosomal fraction of rat brain homogenate. The 
potassium stimulated component of this uptake is taken to 
represent uptake into presynaptic synaptosomes across 
voltage sensitive calcium channels. Contaminants of the 
synaptosomal preparation probably include glial cells and 
mitochondria. Stimulated calcium uptake into glial cells has 
been shown under certain conditions (Hertz et al.,1989), but 
it is not always apparent (Barnes and Mandel, 1981; Walz and 
Wilson, 1986). There is no evidence of adenosine affecting 
calcium sequestration by mitochondria.
The calcium channel at which adenosine might be acting 
cannot be directly determined using this synaptosomal 
technique. However, the fact that adenosine action is 
observed at incubation periods of 20 seconds, but not at 
1 second uptake times, may suggest action at a relatively 
slow inactivating channel such as the novel calcium channel 
proposed by Suszkiew et al.(1989). The agonist profile
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exhibited for the inhibition of calcium influx does not fit 
either of the established receptor profiles. A proposed A3 
adenosine receptor, possibly linked directly to calcium 
channels (Ribeiro and Sebastiao, 1986), may present a 
suitable model for the type of receptor present on the 
synaptosomes at which adenosine acts.
Unfortunately, the true action of adenosine may have been 
influenced by the use of potassium to depolarize the 
synaptosomal membrane together with an influx of calcium via 
a reversed Na+/Ca2+ exchange which would reduce the observed 
reduction in calcium influx by adenosine. Similarly, calcium 
influx into glial cells cannot be ruled out. If this is the 
case, the percentage reduction of calcium influx by 
adenosine is likely to be greater under "normal" 
physiological conditions. The reduction in calcium influx 
into hippocampal slices loosely parallels that of the 
synaptosomes. Inhibition by 2-chloroadenosine was shown to 
be antagonized by 8-phenyltheophylline, supporting the 
receptor mediated nature of the inhibition of calcium 
influx. It is assumed that the majority of calcium influx is 
into neurones and principally into synaptic terminals. As 
reported in the introduction to chapter 3, the published 
reports on the action of adenosine on synaptic calcium 
influx are largely contradictory. This inability to show a 
definite action of adenosine is similar to the attempts to 
determine an action of the dihydropyridines on synaptic 
calcium influx. Both groups of studies may suffer from the
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same technical problems in terms of subgroups of calcium 
channels not responding to the particular compounds or the 
true action of the compounds being masked by inactive 
channels or secondary effects such as reversed Na+/Ca2+ 
exchange. However, in contrast to the dihydropyridines, 
adenosine is able to exert a total block on synaptic 
transmission in electrophysiological studies and, if 
adenosine acts via calcium channels, the majority of calcium 
influx into the synaptosomes might be expected to be 
inhibited. A number of reasons why maximum inhibition by 
adenosine is not being expressed have been given in the 
discussion. These conditions would need to be eliminated or 
controlled to determine the true level of inhibition. What 
is clear in both the synaptosomes and the hippocampal slices 
is that adenosine is able to influence calcium influx across 
voltage sensitive calcium channels. The assumption that this 
occurs principally into synaptic terminals is based on a 
large body of experimental evidence from other studies.
The evidence for an action of adenosine on calcium influx 
is continually growing. Recent evidence includes the 
experiments of Schubert and colleagues, discussed in 
chapter 1, where extracellular calcium levels were shown to 
be reduced upon high frequency stimulation of Schaffer 
collaterals to CA1 pyramidal cells. This change in 
extracellular calcium is reduced when adenosine is added 
indicating that calcium influx is inhibited by adenosine. 
These experiments are comparable to the synaptosome
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experiments in that they study calcium influx across voltage 
sensitive calcium channels, but there is no potential effect 
from Na /Ca exchange. However, influx into glial cells and 
mitochondrial calcium sequestration cannot be ruled out. 
Direct recording of synaptic calcium influx is not possible 
on central neurones. Voltage clamp studies of calcium 
channels on cultured dorsal root ganglion cells have 
demonstrated the ability of adenosine to selectively block 
channels (Dolphin et al.,1986) with the characteristics of 
the N calcium channel (Gross et al.,1989). This is evidence 
that adenosine can block calcium channels directly. The 
possibility that N calcium channels or calcium channels with 
similar properties, such as the channel proposed by Suszkiew 
et al.(1989), exist on synaptic nerve terminals is very 
strong, and it is likely that adenosine will be shown to act 
on these channels when suitable techniques become available.
Summary
In conclusion, it is apparent that adenosine compounds 
can reduce calcium uptake into synaptosomes and hippocampal 
slices. The synaptosome preparation contains a predominance 
of presynaptic nerve terminals and it is reasonable to 
assume that presynaptic calcium influx is being reduced by 
the action of adenosine. Adenosine appears to act on a 
voltage sensitive calcium channel as only the potassium 
depolarized synaptosomes exhibited a reduction in calcium 
uptake. The nature of the voltage sensitive calcium channel 
on which adenosine acts is not clear. However, adenosine
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does not act on the same channel as the dihydropyridines 
which have no effect on synaptic transmission or spontaneous 
activity. The dihydropyridines do, however, influence the 
action of adenosine and its analogues by interacting at both 
the adenosine receptor and the adenosine uptake site. This 
may be via an allosteric interaction from a low affinity 
dihydropyridine binding site.
Finally, the action of adenosine on synaptic transmission 
appears to be influenced by activation of the NMDA receptor 
associated channel. As NMDA channels are normally inactive 
during glutamatergic neurotransmission this does not affect 
the action of adenosine. When the voltage sensitive NMDA 
channels are activated, by removal of magnesium or increased 
neuronal activation, the ability of adenosine to reduce 
synaptic transmission appears to be reduced. The mechanism 
by which this might occur is unclear but it could be of 
relevance to NMDA related events such as long term 
potentiation.
Future avenues of research.
A number of interesting avenues of research have been 
opened by the present studies. The nature of the interaction 
between adenosine and NMDA channels needs to be elucidated, 
in particular whether the interaction can be isolated to a 
pre- or postsynaptic site of action.
A possible method of determining whether postsynaptic 
actions of adenosine are involved in an interaction with 
NMDA channels would be to carry out the experiments reported
by Lee et al.(1984). Antidromic stimulation of CA1 pyramidal 
cells in calcium free ACSF results in multiple spikes 
following the antidromic potential. The magnesium 
concentration of the ACSF is usually increased to abolish 
spontaneous activity that interferes with the evoked 
potentials. The repetitive spikes are inhibited by adenosine 
and this action is assumed to be postsynaptic, as synaptic 
transmission is abolished and presynaptic inputs are not 
being stimulated. It may be possible to study the evoked 
repetitive spikes in the absence of magnesium and calcium, 
possibly with an anticonvulsant, such as baclofen, present 
if necessary. The postsynaptic action of adenosine could 
then be determined in the absence of magnesium and with 
increased NMDA channel activation. Attempts were made to 
study this response but the conditions were not suitable to 
maintain the multiple spikes, although they were apparent 
briefly. These responses are very susceptible to changes in 
flow rate and temperature (Fowler, 1988). These experiments 
will be pursued at a later date when the ideal conditions 
have been determined.
An effect, that may or may not be related to NMDA channel 
activation, was observed during preliminary HPLC analysis of 
amino acid release from the slices during these experiments. 
The release of aspartate from the slice increased during 
perfusion with adenosine in magnesium free ACSF. This was in 
contrast to control magnesium ACSF where aspartate release 
was largely unaffected. Glutamate release did not appear to
be affected by adenosine. The possibility arises that the 
loss of adenosine inhibition in magnesium free ACSF is due 
in part to the increased release of aspartate, which may act 
at the NMDA receptor. This may contribute to the reduced 
inhibitory action of adenosine by actively increasing the 
excitability of the cells when adenosine is added. It may 
also explain increases in potential size seen at low 
adenosine concentrations in magnesium free ACSF (Fig.1.4.). 
These observations have not been included in the results as 
the analysis was carried out on only 3 slices with large 
variations in amino acid release between the slices. 
Consequently/the increased aspartate release cannot be 
confirmed as a genuine response to adenosine. This does,
however, provide another avenue to explore in future studies
on the effects of adenosine.
Other lines of research include a study of other brain
regions to determine whether an interaction between 
adenosine and NMDA channels is widespread or confined to the 
hippocampus and dentate gyrus and elucidation of the 
mechanisms by which an interaction may occur, including the 
involvement of protein kinase C and the proposed retrograde 
messenger, arachidonic acid.
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